<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/244DB29F-915F-49C7-A968-87822A13AD3C"><gtr:id>244DB29F-915F-49C7-A968-87822A13AD3C</gtr:id><gtr:name>The Jackson Laboratory</gtr:name><gtr:address><gtr:line1>600 Main Street</gtr:line1><gtr:line2>Bar Harbor</gtr:line2><gtr:postCode>04609</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E2F752A3-43CD-4ED6-9D9A-4059F81729EB"><gtr:id>E2F752A3-43CD-4ED6-9D9A-4059F81729EB</gtr:id><gtr:name>Edison Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A7C9204-3449-41D8-9C19-F3547150B67B"><gtr:id>9A7C9204-3449-41D8-9C19-F3547150B67B</gtr:id><gtr:name>Muscular Dystrophy UK</gtr:name><gtr:address><gtr:line1>61A Great Suffolk Street</gtr:line1><gtr:postCode>SE1 0BU</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1C6F835-8DA5-46B7-8126-6E733892FE0F"><gtr:id>A1C6F835-8DA5-46B7-8126-6E733892FE0F</gtr:id><gtr:name>AVI Biopharma, Inc</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C96DB0B8-CEAC-4B25-B19B-81F9AF857DFF"><gtr:id>C96DB0B8-CEAC-4B25-B19B-81F9AF857DFF</gtr:id><gtr:name>University of Paris 6</gtr:name><gtr:address><gtr:line1>Bat 121</gtr:line1><gtr:line4>Paris</gtr:line4><gtr:postCode>F-75252</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/43ECF77B-CD97-49C9-812D-40CB69D1D03B"><gtr:id>43ECF77B-CD97-49C9-812D-40CB69D1D03B</gtr:id><gtr:name>San Raffaele Hospital</gtr:name><gtr:address><gtr:line1>29 Via Prinetti</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA"><gtr:id>7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA</gtr:id><gtr:name>University of Otago</gtr:name><gtr:address><gtr:line1>PO Box 56</gtr:line1><gtr:line4>Dunedin</gtr:line4><gtr:line5>9016</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B4CD670-EFA7-4A29-8208-6EE0C7AE6545"><gtr:id>3B4CD670-EFA7-4A29-8208-6EE0C7AE6545</gtr:id><gtr:name>Shire Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BA9BFCD1-C860-4387-B150-BD302EFE4049"><gtr:id>BA9BFCD1-C860-4387-B150-BD302EFE4049</gtr:id><gtr:name>Free University of Berlin</gtr:name><gtr:address><gtr:line1>Kaiserswerther Str. 16-18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8A621CD6-4DE9-4B35-992C-631871D7793E"><gtr:id>8A621CD6-4DE9-4B35-992C-631871D7793E</gtr:id><gtr:name>University of Rochester</gtr:name><gtr:address><gtr:line1>PO Box 270001</gtr:line1><gtr:line4>Rochester</gtr:line4><gtr:line5>New York</gtr:line5><gtr:postCode>NY 14627</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF056F42-5CA1-4C02-A8D3-AF6A9AA1A2FD"><gtr:id>BF056F42-5CA1-4C02-A8D3-AF6A9AA1A2FD</gtr:id><gtr:name>Salford Royal NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Cleveland House
Salford</gtr:line1><gtr:city>Greater Manchester</gtr:city><gtr:postCode>M6 8AL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516"><gtr:id>0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516</gtr:id><gtr:name>University Hospital Southampton NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Trust Management Offices Mailpoint 18, Tremona Road</gtr:line1><gtr:city>Southampton</gtr:city><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/617E7220-F6C8-489B-991E-AFD367E83A93"><gtr:id>617E7220-F6C8-489B-991E-AFD367E83A93</gtr:id><gtr:name>Aix-Marseille University</gtr:name><gtr:address><gtr:line1>Aix-Marseille University</gtr:line1><gtr:line2>Pharo</gtr:line2><gtr:line4>Marseille</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C36EE55B-5F90-4CC8-8133-9C6576DB6A0D"><gtr:id>C36EE55B-5F90-4CC8-8133-9C6576DB6A0D</gtr:id><gtr:name>Senexis Ltd Cambridge</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE43EBFA-3FC9-44BC-B6FF-001F11664C46"><gtr:id>CE43EBFA-3FC9-44BC-B6FF-001F11664C46</gtr:id><gtr:name>Aarhus University</gtr:name><gtr:address><gtr:line1>Nordre Ringgade 1</gtr:line1><gtr:line4>Aarhus C</gtr:line4><gtr:line5>DK-8000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E4F6BEA-8E66-490E-B61F-8CBB33116179"><gtr:id>5E4F6BEA-8E66-490E-B61F-8CBB33116179</gtr:id><gtr:name>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1EC5A569-85E9-44B3-AD1F-049F1003C9C6"><gtr:id>1EC5A569-85E9-44B3-AD1F-049F1003C9C6</gtr:id><gtr:name>University of Barcelona</gtr:name><gtr:address><gtr:line1>Universidad de Barcelona</gtr:line1><gtr:line2>Av Diagonal 647</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/244DB29F-915F-49C7-A968-87822A13AD3C"><gtr:id>244DB29F-915F-49C7-A968-87822A13AD3C</gtr:id><gtr:name>The Jackson Laboratory</gtr:name><gtr:address><gtr:line1>600 Main Street</gtr:line1><gtr:line2>Bar Harbor</gtr:line2><gtr:postCode>04609</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E2F752A3-43CD-4ED6-9D9A-4059F81729EB"><gtr:id>E2F752A3-43CD-4ED6-9D9A-4059F81729EB</gtr:id><gtr:name>Edison Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A7C9204-3449-41D8-9C19-F3547150B67B"><gtr:id>9A7C9204-3449-41D8-9C19-F3547150B67B</gtr:id><gtr:name>Muscular Dystrophy UK</gtr:name><gtr:address><gtr:line1>61A Great Suffolk Street</gtr:line1><gtr:postCode>SE1 0BU</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1C6F835-8DA5-46B7-8126-6E733892FE0F"><gtr:id>A1C6F835-8DA5-46B7-8126-6E733892FE0F</gtr:id><gtr:name>AVI Biopharma, Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C96DB0B8-CEAC-4B25-B19B-81F9AF857DFF"><gtr:id>C96DB0B8-CEAC-4B25-B19B-81F9AF857DFF</gtr:id><gtr:name>University of Paris 6</gtr:name><gtr:address><gtr:line1>Bat 121</gtr:line1><gtr:line4>Paris</gtr:line4><gtr:postCode>F-75252</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/43ECF77B-CD97-49C9-812D-40CB69D1D03B"><gtr:id>43ECF77B-CD97-49C9-812D-40CB69D1D03B</gtr:id><gtr:name>San Raffaele Hospital</gtr:name><gtr:address><gtr:line1>29 Via Prinetti</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA"><gtr:id>7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA</gtr:id><gtr:name>University of Otago</gtr:name><gtr:address><gtr:line1>PO Box 56</gtr:line1><gtr:line4>Dunedin</gtr:line4><gtr:line5>9016</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B4CD670-EFA7-4A29-8208-6EE0C7AE6545"><gtr:id>3B4CD670-EFA7-4A29-8208-6EE0C7AE6545</gtr:id><gtr:name>Shire Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BA9BFCD1-C860-4387-B150-BD302EFE4049"><gtr:id>BA9BFCD1-C860-4387-B150-BD302EFE4049</gtr:id><gtr:name>Free University of Berlin</gtr:name><gtr:address><gtr:line1>Kaiserswerther Str. 16-18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8A621CD6-4DE9-4B35-992C-631871D7793E"><gtr:id>8A621CD6-4DE9-4B35-992C-631871D7793E</gtr:id><gtr:name>University of Rochester</gtr:name><gtr:address><gtr:line1>PO Box 270001</gtr:line1><gtr:line4>Rochester</gtr:line4><gtr:line5>New York</gtr:line5><gtr:postCode>NY 14627</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF056F42-5CA1-4C02-A8D3-AF6A9AA1A2FD"><gtr:id>BF056F42-5CA1-4C02-A8D3-AF6A9AA1A2FD</gtr:id><gtr:name>Salford Royal NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Cleveland House
Salford</gtr:line1><gtr:city>Greater Manchester</gtr:city><gtr:postCode>M6 8AL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516"><gtr:id>0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516</gtr:id><gtr:name>University Hospital Southampton NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Trust Management Offices Mailpoint 18, Tremona Road</gtr:line1><gtr:city>Southampton</gtr:city><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/617E7220-F6C8-489B-991E-AFD367E83A93"><gtr:id>617E7220-F6C8-489B-991E-AFD367E83A93</gtr:id><gtr:name>Aix-Marseille University</gtr:name><gtr:address><gtr:line1>Aix-Marseille University</gtr:line1><gtr:line2>Pharo</gtr:line2><gtr:line4>Marseille</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C36EE55B-5F90-4CC8-8133-9C6576DB6A0D"><gtr:id>C36EE55B-5F90-4CC8-8133-9C6576DB6A0D</gtr:id><gtr:name>Senexis Ltd Cambridge</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE43EBFA-3FC9-44BC-B6FF-001F11664C46"><gtr:id>CE43EBFA-3FC9-44BC-B6FF-001F11664C46</gtr:id><gtr:name>Aarhus University</gtr:name><gtr:address><gtr:line1>Nordre Ringgade 1</gtr:line1><gtr:line4>Aarhus C</gtr:line4><gtr:line5>DK-8000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E4F6BEA-8E66-490E-B61F-8CBB33116179"><gtr:id>5E4F6BEA-8E66-490E-B61F-8CBB33116179</gtr:id><gtr:name>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1EC5A569-85E9-44B3-AD1F-049F1003C9C6"><gtr:id>1EC5A569-85E9-44B3-AD1F-049F1003C9C6</gtr:id><gtr:name>University of Barcelona</gtr:name><gtr:address><gtr:line1>Universidad de Barcelona</gtr:line1><gtr:line2>Av Diagonal 647</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/43DBCE3E-240B-4A6A-9BF0-DE2D811C7436"><gtr:id>43DBCE3E-240B-4A6A-9BF0-DE2D811C7436</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Koltzenburg</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E5AE01F6-DE01-4F3A-BFD5-CCD775DEA98F"><gtr:id>E5AE01F6-DE01-4F3A-BFD5-CCD775DEA98F</gtr:id><gtr:firstName>Elaine</gtr:firstName><gtr:surname>McColl</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/002FC006-2518-458A-AB1F-FF4586FFE8D7"><gtr:id>002FC006-2518-458A-AB1F-FF4586FFE8D7</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Hanna</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6A4534BA-ABC4-43A8-8811-4D6064526CBB"><gtr:id>6A4534BA-ABC4-43A8-8811-4D6064526CBB</gtr:id><gtr:firstName>Katherine</gtr:firstName><gtr:surname>Bushby</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601943"><gtr:id>80F7887F-88F2-4E5F-9AC8-C509F546F360</gtr:id><gtr:title>MRC Centre for Neuromuscular Diseases in Children and Adults</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601943</gtr:grantReference><gtr:abstractText>A large number of people in the UK have diseases which affect their muscles and the nerves supplying muscles. Many of these disease are genetic and may develop at a young age causing severe disabilty and early death. A well known example is Duchenne muscular dystrophy but there are many other diseses affecting muscle an nerves that cause a lot of disability. There has been much research into these conditions and advances have been made in understanding the molecular and genetic causes. Unfortunatley this has not translated into new treatments that benefit patients. There are a number of reasons why these discoveries have not benefited patients yet. In this research programme we want to continue making important molecular discoveries but we also want to address this problem of translating molecular discoveries into treatment for patients. We will do this by developing better ways of assessing both animal models and patients using new techniques such as MRI. We will organise better systems for doing clnical trials, we will establish better systems to allow scientists to do research on patient samples with their consent and we will establish better ways of training more new researchers in this important area. We believe that this combined approach of having a single centre that encompasess molecular discovery right through to clinical trials in the patient will be a big advance for helping patients with these disabling diseases.</gtr:abstractText><gtr:technicalSummary>In the UK there is a large gap between basic science discoveries and patient benefit in neuromuscular diseases. In order to reduce this gap, we will establish the first truly multidisciplinary UK translational research centre for children and adults with these disabling diseases. The centre will be based in the Institute of Neurology in collaboration with the Institute of Child Health, and will take full advantage of the largest UK neuromuscular patient populations at the co-located partner NHS Trusts: Great Ormond Street NHS Trust and the National Hospital for Neurology and Neurosurgery, UCLH, NHS Trust. The mission of the centre will be to translate basic science findings into clinical trials and new treatments for children and adults with disabling neuromuscular diseases.
The main programmes of research will build on existing funded [#10million] themes currently active across UCL. We will develop new cross cutting collaborations and will recruit new world class senior academic personnel to UCL acheiving critical mass. All programmes of research will impact upon and benefit from the following core areas that will be newly developed in the centre and which are a current hurdle to effective translational research in the UK; 1.education and training to produce a new generation of neuromuscular scientists 2.developing a range of specific clinical assessment tools to facilitate future clinical trials in the UK. 3.Establishing new cutting edge MRI of nerve and muscle disease in animals and humans. 4.Establishing a unique biobank of human neuromuscular patients tissues and cells. 5.Establishing a network and resource for elucidating the pathogenesis of neuromuscular conditions in mutant mice. The research programmes cover major diseases of muscle and nerve and include molecular mechanisms in muscular dystrophy, mitochondrial DNA neuromuscular disease, ion channel neuromuscular disease, muscle stem cells, genetic neuropathies, spinal muscular atrophy, generation of neuromuscular disease mutant mice, MRI of nerve and muscles in animals and humans and trials &amp;amp; outcomes in neuromuscular diseases. This combined approach will address unresolved aspects related to the pathophsyiology of common neuromuscular disorders and improve the chances of translation into patient benefit.</gtr:technicalSummary><gtr:fund><gtr:end>2013-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2302480</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Mitochondrial dysfunction in ALS</gtr:description><gtr:id>2EDC3830-88E1-4F34-A9C5-B9DFEAD91812</gtr:id><gtr:impact>Two PhD students; one paper - Bisland et al 2009. 
Multidisciplinary - cellular physiology and confocal fluorescent imaging.</gtr:impact><gtr:outcomeId>XfUDi56xutN-1</gtr:outcomeId><gtr:partnerContribution>Primary cultures of muscles, astrocytes and motoneurons from transgenic mice.</gtr:partnerContribution><gtr:piContribution>Clinical knowledge.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>San Raffaele Hospital</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>San Raffaele Scientific Institute (SRSI)</gtr:department><gtr:description>Notch and c-Jun signalling in Schwann cells</gtr:description><gtr:id>BF497308-62CE-46F2-8ADC-89D6307C3895</gtr:id><gtr:impact>Two papers: PMID 19525946 and PMID 18490512.</gtr:impact><gtr:outcomeId>QTKQVvV5pnA-1</gtr:outcomeId><gtr:partnerContribution>The collaboration enabled us to generate mice without RBPj and c-June in Schwann cells. The collaborator provided us with Po-CRE mice.</gtr:partnerContribution><gtr:piContribution>We mated the Po-CRE mice with other mice and analysed the result.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Barcelona (UB)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Natural History Study of Dysferlinopathy</gtr:description><gtr:id>2E684A3A-24BB-4C09-A26E-358690911BE3</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>GWvUciHGJLw-2</gtr:outcomeId><gtr:partnerContribution>Coordination of trial, patient recruitment and data management.Patient recruitment and data analysis.</gtr:partnerContribution><gtr:piContribution>Coordination of the study, patient recruitment and data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Schwann cell dedifferentiation and regeneration</gtr:description><gtr:id>6C7C04FA-7774-41E0-A43D-D3F8735A5084</gtr:id><gtr:impact>No papers to date.</gtr:impact><gtr:outcomeId>Xb4rXzxmuUU-1</gtr:outcomeId><gtr:partnerContribution>The collaboration has enabled us to study regeneration in the facial nerve. The collaborator provided knowledge of the facial nerve.</gtr:partnerContribution><gtr:piContribution>We analysed the results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>Schwann cell deymelination</gtr:description><gtr:id>A154A26B-305F-434B-BED3-E7812F4E65C2</gtr:id><gtr:impact>Paper PMID 18490512.</gtr:impact><gtr:outcomeId>RR5z5F7zkC3-1</gtr:outcomeId><gtr:partnerContribution>The collaboration enabled us to study c-Jun function in vivo. The collaborator provided us with GM mice.</gtr:partnerContribution><gtr:piContribution>Our lab bred the mice and and analysed the progeny.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Kennedy's Disease Research</gtr:description><gtr:id>E0C00B64-7EEC-4607-A2C6-20025FCD5CD8</gtr:id><gtr:impact>Research donation; PhD student, three papers in preparation.
Multi-disciplinary - basic and clinical neuroscience.</gtr:impact><gtr:outcomeId>H8UDU99F1ZS-1</gtr:outcomeId><gtr:partnerContribution>Investigating the pathogenesis of Kennedy's disease in vivo and in vitro</gtr:partnerContribution><gtr:piContribution>Skills and clinical knowledge</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Developing an In Vitro Model of Inclusion Body Myositis</gtr:description><gtr:id>9A1922D4-AAE1-4884-86FC-2A7D09C20050</gtr:id><gtr:impact>ARC grant, one clinical research fellow, one PhD student, one paper in preparation. Clinical trial initiated. 
Multi-dispclinary - basic and clinical neuroscience.</gtr:impact><gtr:outcomeId>VjxFPazp5aL-1</gtr:outcomeId><gtr:partnerContribution>Developing an in vitro model of Inclusion Body Myositis</gtr:partnerContribution><gtr:piContribution>Imparting clinical knowledge and skills.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Edison Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Edison and Mitochondrial Disease</gtr:description><gtr:id>843C286E-3434-4F2D-8A84-317CE5AEBAC0</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>GEquEUfBvAs-1</gtr:outcomeId><gtr:piContribution>Running planned clinical drug trial for mitochondrial disease. Supervision of a Clinical Research Fellow for one year.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aarhus University</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Institute of Human Genetics</gtr:department><gtr:description>Identifying causative genes and pathomechanisms in CMS</gtr:description><gtr:id>89736325-FA2F-437F-8FD3-80A69F633BB3</gtr:id><gtr:impact>Joint publications (Beeson et al 2006; Senderek et al. 2011) and grant applications.</gtr:impact><gtr:outcomeId>Y2P9NKnz16m-1</gtr:outcomeId><gtr:partnerContribution>Information regarding gene function in CMS has been made available to the Newcastle group. Collaborators provided samples, expertise and consumables.Information regarding gene function in CMS has been made available to the Newcastle group. Collaborators provided samples, expertise and consumables.</gtr:partnerContribution><gtr:piContribution>We have provided samples, expertise and consumables.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Child Health</gtr:department><gtr:description>Muscle stem cells for therapies in muscular dystrophy</gtr:description><gtr:id>11FD27B5-3F71-4C04-8BDC-8418F0EC3DE3</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>HVXE1q4QKUy-1</gtr:outcomeId><gtr:partnerContribution>Myogenic cell characterisation and lentiviral vector design.</gtr:partnerContribution><gtr:piContribution>Development of optimal dystrophin constructs for gene replacement.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Veterinary College (RVC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Veterinary Basic Sciences (VBS)</gtr:department><gtr:description>Therapeutic approaches in the dystroglycanopathies</gtr:description><gtr:id>7F9DCDAA-FFD0-4586-954C-491D6A22CC1C</gtr:id><gtr:impact>None as yet.
Multidisciplinary - clinicians and basic scientists.</gtr:impact><gtr:outcomeId>iLKDzdNVoVe-1</gtr:outcomeId><gtr:partnerContribution>Skills and experience.</gtr:partnerContribution><gtr:piContribution>Skills and experience imparted from team at Dubowitz Neuromuscular Centre, UCL Institute of Child Health.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Translational research in muscular dystrophy</gtr:description><gtr:id>5800AD52-663C-4E43-A450-88F9791B4935</gtr:id><gtr:impact>Numerous publications, particularly PMID 20405137 and 20346669, 20562457.</gtr:impact><gtr:outcomeId>JWm3TLB7wjz-1</gtr:outcomeId><gtr:partnerContribution>Patient material, clinical data, molecular analyses.Patient material, clinical data, molecular analyses.</gtr:partnerContribution><gtr:piContribution>Patient material, clinical data, molecular analyses.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Senexis Ltd Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Inclusion Body Myositis</gtr:description><gtr:id>E1B22514-3C0F-47D1-AA8C-36C370D19856</gtr:id><gtr:impact>One clinical research fellow working on IBM PhD project, jointly supervised by MRC Centre for Neuromuscular Diseases and University of Oxford.</gtr:impact><gtr:outcomeId>7D02E2EF549-1</gtr:outcomeId><gtr:partnerContribution>Sharing patient data and clinical knowledge.Sharing patient data and clinical knowledge. Joint supervision of one Clinical Research Fellow.</gtr:partnerContribution><gtr:piContribution>Sharing patient data and clinical knowledge. Joint supervision of one Clinical Research Fellow working on IBM PhD project.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Sciences Nottingham</gtr:department><gtr:description>New in vitro models for DMD using iPSC</gtr:description><gtr:id>3FEEE983-58FF-4A0F-835E-38BF3DA8EABD</gtr:id><gtr:impact>Joint grant applications (outstanding) and joint publications (Dick et al. 2010 and in preparation).</gtr:impact><gtr:outcomeId>XCcWQCgh96B-1</gtr:outcomeId><gtr:partnerContribution>The Nottingham group have provided us with iPSC cells and have trained our technician in their generation and maintenance.</gtr:partnerContribution><gtr:piContribution>By extending our collaborative links to a group working on iPSC we have gained valuable technological insights, unique experimental materials and access to a wider collaborative network. 
We have provided fibroblasts from dystrophic patients and technical support and expertise in analysing derived cardiomyocytes.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Investigating novel TDP43 mutant mice</gtr:description><gtr:id>2CD3113A-1E11-4520-90F5-CDBBB8174FA4</gtr:id><gtr:impact>One PhD student, two grants. 
Multidisciplinary - genetics and physiology.</gtr:impact><gtr:outcomeId>k2qGArzux9h-1</gtr:outcomeId><gtr:partnerContribution>Physiological phenotyping of mutant TDP43 mice.</gtr:partnerContribution><gtr:piContribution>Clinical expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biomedical Sciences</gtr:department><gtr:description>Muscle stem cells in mitochondrial disease</gtr:description><gtr:id>E4FB69C8-E0B3-4BAB-8F98-8A0B90F823C4</gtr:id><gtr:impact>Development of student's skill set. Publication in preparation.</gtr:impact><gtr:outcomeId>jNsRvPP6iDn-1</gtr:outcomeId><gtr:partnerContribution>Expertise in analysis of mitochondria.</gtr:partnerContribution><gtr:piContribution>Myoblast culture and analysis techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biomedical Sciences</gtr:department><gtr:description>Analysis of cardiac function in mouse models of muscular dystrophy</gtr:description><gtr:id>7A3CBC14-503C-4570-BEAE-DA4FCFAD68E7</gtr:id><gtr:impact>PMID 19913415, 19233868 and 19259135.</gtr:impact><gtr:outcomeId>ScMoSZRfgh7-1</gtr:outcomeId><gtr:partnerContribution>Expertise in haemodynamic measurements of cardiac function in rodents. Expertise in MRI analysis.</gtr:partnerContribution><gtr:piContribution>Provision of the mouse colony, personnel and consumables for the analyses.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Child Health</gtr:department><gtr:description>National Neuromuscular Database</gtr:description><gtr:id>F9ABA004-26E3-4605-B2C2-E42BE539B019</gtr:id><gtr:impact>Growth and development of national neuromuscular database comprising data from four individual databases:
IBM-Net
Smart-Net
NorthStar
Congenital Muscular Dystrophy database</gtr:impact><gtr:outcomeId>emkTDvryZH2-1</gtr:outcomeId><gtr:partnerContribution>Contribution of data and joint management of database.Contribution of data and joint management of umbrella database.Contribution of data and joint management of umbrella database.</gtr:partnerContribution><gtr:piContribution>Contributing to and shared management of national neuromuscular database.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rochester</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>FOR-DMD: a large-scale multi-centre trial of steroids in DMD</gtr:description><gtr:id>4C207AE3-0BDD-4BF9-8772-E350DFFFBE8C</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>616DA3A2DC0-1</gtr:outcomeId><gtr:partnerContribution>Coordination of trial, patient recruitment and data management</gtr:partnerContribution><gtr:piContribution>Patient recruitment and data analysis. Collecting and processing data, provision of our own patient data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Southampton University Hospitals NHS Trust (SUHT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>IBM-Net</gtr:description><gtr:id>428C86B3-2083-43A6-AA99-B80A5C965F77</gtr:id><gtr:impact>Development of IBM-Net database.</gtr:impact><gtr:outcomeId>GLHaRvXBcQ8-3</gtr:outcomeId><gtr:partnerContribution>Addition of patient data to web-based cohort of IBM patients.Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients.</gtr:partnerContribution><gtr:piContribution>Addition of patient data to web-based cohort of IBM patients.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Free University of Berlin</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Medical School Berlin</gtr:department><gtr:description>PTRF-cavin in muscle disease</gtr:description><gtr:id>404E6526-0DF9-49FE-BC41-0FCC695E4AAD</gtr:id><gtr:impact>PMID 20300641.</gtr:impact><gtr:outcomeId>eRwiB9jmSoy-1</gtr:outcomeId><gtr:partnerContribution>PTFR-cavin resources.</gtr:partnerContribution><gtr:piContribution>Patient material.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>SOD1 GFP Investigation</gtr:description><gtr:id>32ADC18E-4D04-46E1-9F0B-FE2157549C7C</gtr:id><gtr:impact>PMID 20221404.</gtr:impact><gtr:outcomeId>kKKKSVqMQ14-1</gtr:outcomeId><gtr:partnerContribution>Resources and skills.Facilities and skills.</gtr:partnerContribution><gtr:piContribution>Providing mice and skills.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Establishing a Biobank for the MRC Centre for Neuromuscular Diseases</gtr:description><gtr:id>FD9ABD28-2E93-43F8-8676-77D38D7D5452</gtr:id><gtr:impact>The Dubowitz Neuromuscular Centre is now fully functional and CPA accredited. It is a valuable resource and a centre of excellence, proving a unique research infrastructure to the MRC Centre for Neuromuscular Diseases.</gtr:impact><gtr:outcomeId>874F8766B69-1</gtr:outcomeId><gtr:partnerContribution>Provided infrastructure and guidance to establish Biobank for neuromuscular disease. Facilitated relocation of the Dubowitz Neuromuscular Centre to Queen Square.</gtr:partnerContribution><gtr:piContribution>Provided facilities and staff support in form of Biobank Technician.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Human Genetics</gtr:department><gtr:description>National Neuromuscular Database</gtr:description><gtr:id>67A973CE-582B-497B-A1E7-F44C7AF30A25</gtr:id><gtr:impact>Growth and development of national neuromuscular database comprising data from four individual databases:
IBM-Net
Smart-Net
NorthStar
Congenital Muscular Dystrophy database</gtr:impact><gtr:outcomeId>emkTDvryZH2-3</gtr:outcomeId><gtr:partnerContribution>Contribution of data and joint management of database.Contribution of data and joint management of umbrella database.Contribution of data and joint management of umbrella database.</gtr:partnerContribution><gtr:piContribution>Contributing to and shared management of national neuromuscular database.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Orphan &amp; Genetic Diseases Research Unit Pfizer</gtr:department><gtr:description>Evaluation of Biomarkers in DMD</gtr:description><gtr:id>9D5CF6EB-0B2D-4A31-BE23-57C9F141BD0D</gtr:id><gtr:impact>Further collaborative work in patient samples.</gtr:impact><gtr:outcomeId>nWDmw1sp6ZV-1</gtr:outcomeId><gtr:partnerContribution>Pfizer will shortly analyse the samples derived from our models for specific biomarkers.</gtr:partnerContribution><gtr:piContribution>We have provided mouse urine, tissue and myoblasts.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pierre and Marie Curie University - Paris 6</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>UMR 787 (Institute of Myology)</gtr:department><gtr:description>MRI analyses in muscular dystrophy</gtr:description><gtr:id>12FF1C49-E236-4D5A-A8D9-4F5EF05B99CD</gtr:id><gtr:impact>PMID 19856446.</gtr:impact><gtr:outcomeId>hQBUuE1JHJx-1</gtr:outcomeId><gtr:partnerContribution>Expertise in MRI.</gtr:partnerContribution><gtr:piContribution>Clinical Fellow (Dr Penny Garood) undertook research to develop MRI scanning techniques, and performed clinical research into MRI applications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research and Development GSK</gtr:department><gtr:description>GSK and Muscle MRI</gtr:description><gtr:id>1AFBF11A-3C95-429E-A213-E765FCF0BB65</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>YGFFATfanMs-1</gtr:outcomeId><gtr:piContribution>Management of MRI Physicist working on muscle MRI project for two years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Muscular Dystrophy UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IBM-Net</gtr:description><gtr:id>64D39DAE-E9D5-4942-963A-CEF2FAD57607</gtr:id><gtr:impact>Development of IBM-Net database.</gtr:impact><gtr:outcomeId>GLHaRvXBcQ8-1</gtr:outcomeId><gtr:partnerContribution>Addition of patient data to web-based cohort of IBM patients.Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients.</gtr:partnerContribution><gtr:piContribution>Addition of patient data to web-based cohort of IBM patients.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Copenhagen</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>MRI in LGMD2I</gtr:description><gtr:id>A9075336-8717-47AD-87DD-F6EAEB91716B</gtr:id><gtr:impact>Publication in preparation.</gtr:impact><gtr:outcomeId>FFcPwLjLLy4-1</gtr:outcomeId><gtr:partnerContribution>Expertise in functional analysis of muscle and MRI.</gtr:partnerContribution><gtr:piContribution>Clinical Fellow (Dr Tracy Willis) leading the Newcastle end of the collaboration. Provided patient recruitment resources and MRI scanning time.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aix-Marseille University</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Natural History Study of Dysferlinopathy</gtr:description><gtr:id>43778D88-1930-43DB-8E33-896EECD6F3C1</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>GWvUciHGJLw-1</gtr:outcomeId><gtr:partnerContribution>Coordination of trial, patient recruitment and data management.Patient recruitment and data analysis.</gtr:partnerContribution><gtr:piContribution>Coordination of the study, patient recruitment and data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Disease-causing mutant Hsp27 mutations</gtr:description><gtr:id>AAF62633-E12F-4AA5-9C19-F07792C41560</gtr:id><gtr:impact>One PhD student and one clinical research fellow sponsored by Ipsen.
Multidisciplinary - basic and clinical neuroscience.</gtr:impact><gtr:outcomeId>Edt4p4x5byS-1</gtr:outcomeId><gtr:partnerContribution>Modelling the pathogenesis of mutant Hsp27-induced peripheral neuropathy.</gtr:partnerContribution><gtr:piContribution>Clinical expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Jackson Laboratory</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Investigating Gars Mouse</gtr:description><gtr:id>8FEAC3DB-ED74-4798-A412-652AF0915914</gtr:id><gtr:impact>PMID 19470612.</gtr:impact><gtr:outcomeId>KTbf7jg5e1h-1</gtr:outcomeId><gtr:partnerContribution>Specific skills, experience and mouse models.</gtr:partnerContribution><gtr:piContribution>Providing mice and skills.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Molecular Medical Sciences Nottingham</gtr:department><gtr:description>iPSCs for modelling dystrophic cardiomyoctes</gtr:description><gtr:id>3E671167-9218-47D0-B34A-BF585B825196</gtr:id><gtr:impact>iPSCs derived and characterised. Publication in preparation.</gtr:impact><gtr:outcomeId>GDdcmALY6MJ-1</gtr:outcomeId><gtr:partnerContribution>Development of iPSC lines from DMD fibroblasts.</gtr:partnerContribution><gtr:piContribution>Derivation of patient fibroblasts, characterisation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Notch signalling in Schwann Cells</gtr:description><gtr:id>E988217C-EB10-4C3C-A1F9-7B1E263AD03C</gtr:id><gtr:impact>One paper: PMID 19525946</gtr:impact><gtr:outcomeId>Sh4r683uoAb-1</gtr:outcomeId><gtr:partnerContribution>The collaboration enabled us to generate mice without RBPj in Schwann cells. The collaborator provided us with DhhCRE mice.</gtr:partnerContribution><gtr:piContribution>We mated the DhhCRE mice with other mice, and analysed the result.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Human Genetics</gtr:department><gtr:description>UK Heart Protection Trial</gtr:description><gtr:id>259905C4-1628-4CA5-97FB-5C705C677194</gtr:id><gtr:impact>Contribution to the standards of care. 
PMID 19945913.</gtr:impact><gtr:outcomeId>nMqAqLZN4N1-1</gtr:outcomeId><gtr:partnerContribution>Clinical care and research.</gtr:partnerContribution><gtr:piContribution>Patient recruitment and data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>SOD1 GFP Investigation</gtr:description><gtr:id>88877679-1C4F-4186-82FF-C2A79D55E035</gtr:id><gtr:impact>PMID 20221404.</gtr:impact><gtr:outcomeId>kKKKSVqMQ14-2</gtr:outcomeId><gtr:partnerContribution>Resources and skills.Facilities and skills.</gtr:partnerContribution><gtr:piContribution>Providing mice and skills.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mitochondrial Biology Unit</gtr:department><gtr:description>Translational research in mitochondrial disease</gtr:description><gtr:id>19F69BFD-2ACF-477C-ADD2-F16B30FF73F9</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>B257955467B-1</gtr:outcomeId><gtr:partnerContribution>Patient data, lab skills, sharing of clinical knowledge.</gtr:partnerContribution><gtr:piContribution>Patient data from mitochondrial patient cohort.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Salford Royal NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>IBM-Net</gtr:description><gtr:id>502F7B5E-4571-47EF-8474-034609334AFC</gtr:id><gtr:impact>Development of IBM-Net database.</gtr:impact><gtr:outcomeId>GLHaRvXBcQ8-5</gtr:outcomeId><gtr:partnerContribution>Addition of patient data to web-based cohort of IBM patients.Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients.</gtr:partnerContribution><gtr:piContribution>Addition of patient data to web-based cohort of IBM patients.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Muscular Dystrophy UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>North-Star</gtr:description><gtr:id>4395484C-55F7-4515-8D4E-9F64438D8C0E</gtr:id><gtr:impact>Ongoing growth of database.</gtr:impact><gtr:outcomeId>rwQgEPAD7K6-1</gtr:outcomeId><gtr:partnerContribution>Administrative support.</gtr:partnerContribution><gtr:piContribution>Prospective data collection for natural history study of hundreds of children with Duchenne Muscular Dystrophy; coordination of 18 centres.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Veterinary College (RVC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Veterinary Basic Sciences (VBS)</gtr:department><gtr:description>Stem cell function in the dystroglycanopathies</gtr:description><gtr:id>D50C183C-1856-4393-AFA8-B2397279A7B1</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>PieEzirGfoc-1</gtr:outcomeId><gtr:partnerContribution>Skills and knowledge.</gtr:partnerContribution><gtr:piContribution>Skills and knowledge imparted from team at Dubowitz Neuromuscular Centre, UCL Institute of Child Health.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>Studying a novel gene for motor neuron degeneration</gtr:description><gtr:id>E51DFE33-6EBF-429C-B19B-E4E246519702</gtr:id><gtr:impact>Awarded a grant for &amp;pound;110,000 from the Motor Neuron Diseases Association for a PhD student.</gtr:impact><gtr:outcomeId>BNo5k1wYFj3-1</gtr:outcomeId><gtr:partnerContribution>The partnership has extended the research into new areas.</gtr:partnerContribution><gtr:piContribution>Providing new models for analysis of neurodegeneration.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great Ormond Street Hospital (GOSH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>National Neuromuscular Database</gtr:description><gtr:id>21C40827-810A-4B8D-B620-A34A78660F33</gtr:id><gtr:impact>Growth and development of national neuromuscular database comprising data from four individual databases:
IBM-Net
Smart-Net
NorthStar
Congenital Muscular Dystrophy database</gtr:impact><gtr:outcomeId>emkTDvryZH2-2</gtr:outcomeId><gtr:partnerContribution>Contribution of data and joint management of database.Contribution of data and joint management of umbrella database.Contribution of data and joint management of umbrella database.</gtr:partnerContribution><gtr:piContribution>Contributing to and shared management of national neuromuscular database.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Muscular Dystrophy UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Smart-Net</gtr:description><gtr:id>C1E50A5F-A8DF-4C9B-AA70-CCF9D723830A</gtr:id><gtr:impact>Continuing expansion of database.</gtr:impact><gtr:outcomeId>STjgktsxwT1-1</gtr:outcomeId><gtr:partnerContribution>Administrative support.</gtr:partnerContribution><gtr:piContribution>Prospective data collection for natural history study of hundreds of children with spinal muscular atrophy; coordination of 18 centres.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ETH Zurich</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Identification and characterisation of CMS genes</gtr:description><gtr:id>94B5FAFF-9BC2-4F4A-B7C6-2D055737670B</gtr:id><gtr:impact>Clinical paper submitted. Scientific paper in preparation.</gtr:impact><gtr:outcomeId>icH7ekX7kPz-1</gtr:outcomeId><gtr:partnerContribution>Large-scale mapping and sequencing resources.Patient material.</gtr:partnerContribution><gtr:piContribution>Patient material, consumables and personnel for gene analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>NMD-CHIP</gtr:description><gtr:id>AD8DAB67-E2D9-481D-A839-8283C245D7FB</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>jtcB96uyGZy-1</gtr:outcomeId><gtr:partnerContribution>By tracking the latest developments in NMD diagnostics, we have been able to analyse our patient cohorts for novel genes.</gtr:partnerContribution><gtr:piContribution>Development of diagnostic tests and reagents.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biomedical Sciences KCL</gtr:department><gtr:description>Schwann cell precursors and regeneration</gtr:description><gtr:id>A28B996C-8D09-4117-9EB9-092D3D1F6FDE</gtr:id><gtr:impact>One paper: PMID 18484102</gtr:impact><gtr:outcomeId>jpiaFgo4LMV-1</gtr:outcomeId><gtr:partnerContribution>The collaborator has enabled us to study regeneration in the spinal cord. The collaborator carried out operations on the spinal cord.</gtr:partnerContribution><gtr:piContribution>We provided Schwann cell precursors and analysed the results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Neurosciences</gtr:department><gtr:description>Inclusion Body Myositis</gtr:description><gtr:id>39A81944-5E2F-4165-95CE-9DB5FCCB92A8</gtr:id><gtr:impact>One clinical research fellow working on IBM PhD project, jointly supervised by MRC Centre for Neuromuscular Diseases and University of Oxford.</gtr:impact><gtr:outcomeId>7D02E2EF549-4</gtr:outcomeId><gtr:partnerContribution>Sharing patient data and clinical knowledge.Sharing patient data and clinical knowledge. Joint supervision of one Clinical Research Fellow.</gtr:partnerContribution><gtr:piContribution>Sharing patient data and clinical knowledge. Joint supervision of one Clinical Research Fellow working on IBM PhD project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Manchester</gtr:department><gtr:description>Inclusion Body Myositis</gtr:description><gtr:id>44BA2304-5B85-40D2-A319-85893387DA75</gtr:id><gtr:impact>One clinical research fellow working on IBM PhD project, jointly supervised by MRC Centre for Neuromuscular Diseases and University of Oxford.</gtr:impact><gtr:outcomeId>7D02E2EF549-3</gtr:outcomeId><gtr:partnerContribution>Sharing patient data and clinical knowledge.Sharing patient data and clinical knowledge. Joint supervision of one Clinical Research Fellow.</gtr:partnerContribution><gtr:piContribution>Sharing patient data and clinical knowledge. Joint supervision of one Clinical Research Fellow working on IBM PhD project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>Identifying causative genes and pathomechanisms in CMS</gtr:description><gtr:id>C16DEACB-9507-4FB0-8D90-6CBEC3EE2E38</gtr:id><gtr:impact>Joint publications (Beeson et al 2006; Senderek et al. 2011) and grant applications.</gtr:impact><gtr:outcomeId>Y2P9NKnz16m-2</gtr:outcomeId><gtr:partnerContribution>Information regarding gene function in CMS has been made available to the Newcastle group. Collaborators provided samples, expertise and consumables.Information regarding gene function in CMS has been made available to the Newcastle group. Collaborators provided samples, expertise and consumables.</gtr:partnerContribution><gtr:piContribution>We have provided samples, expertise and consumables.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>RDCRC Inherited Neuropathies Consortium</gtr:description><gtr:id>9FC4B19A-A882-4477-88E0-4B76B04A1387</gtr:id><gtr:impact>Two clinical research fellows in the UK have completed the training scheme. One clinical research fellow is currently on the scheme. 21 research fellows funded by non-NIHR sources have completed/are undergoing the programme.</gtr:impact><gtr:outcomeId>kVB6kaqCA9i-1</gtr:outcomeId><gtr:partnerContribution>International consortium for research into inherited neuropathies.</gtr:partnerContribution><gtr:piContribution>Provision of patient data, Fellowship training scheme. PI is Co-Director of the consortium.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brighton and Sussex Medical School</gtr:department><gtr:description>Investigating LOA mouse</gtr:description><gtr:id>50B2372B-A088-4DF3-A192-6126003BE865</gtr:id><gtr:impact>PMID 20382740.</gtr:impact><gtr:outcomeId>DcDjDRgYYJo-1</gtr:outcomeId><gtr:partnerContribution>Specific skills, experience and facilities.</gtr:partnerContribution><gtr:piContribution>Providing mice and skills.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AVI Biopharma, Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Research and Development AVI Biopharma</gtr:department><gtr:description>Dose ranging study of AVI-4658 to induce dystrophin expression</gtr:description><gtr:id>65C8453D-EA9E-4B81-BE0A-0697AAC1FFB1</gtr:id><gtr:impact>An intramuscular phase I/II clinical trial in seven DMD boys from October 2007-March 2009.</gtr:impact><gtr:outcomeId>PCTjBT75vQi-1</gtr:outcomeId><gtr:partnerContribution>Provided clinical grade study drug.</gtr:partnerContribution><gtr:piContribution>Study design; clinical, molecular and pathological assessment of DMD patients; Biobank. Clinical support for the trial, laboratory studies on the efficacy of the study drug.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neurology Service</gtr:department><gtr:description>IBM-Net</gtr:description><gtr:id>299143DF-B846-4B1C-B267-626FCBB5E2B4</gtr:id><gtr:impact>Development of IBM-Net database.</gtr:impact><gtr:outcomeId>GLHaRvXBcQ8-4</gtr:outcomeId><gtr:partnerContribution>Addition of patient data to web-based cohort of IBM patients.Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients.</gtr:partnerContribution><gtr:piContribution>Addition of patient data to web-based cohort of IBM patients.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Neurosciences</gtr:department><gtr:description>IBM-Net</gtr:description><gtr:id>12007D8F-A8F1-4BAA-84A7-E97060801FFB</gtr:id><gtr:impact>Development of IBM-Net database.</gtr:impact><gtr:outcomeId>GLHaRvXBcQ8-2</gtr:outcomeId><gtr:partnerContribution>Addition of patient data to web-based cohort of IBM patients.Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients. Addition of patient data to web-based cohort of IBM patients.</gtr:partnerContribution><gtr:piContribution>Addition of patient data to web-based cohort of IBM patients.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Studying new mouse models of ALS</gtr:description><gtr:id>71102CA0-1D6F-4637-8D94-22421021E15C</gtr:id><gtr:impact>One clinical research fellow. 
Multidisciplinary - genetics and physiology.</gtr:impact><gtr:outcomeId>oXTG8QFghus-1</gtr:outcomeId><gtr:partnerContribution>Phenotyping of mouse models of ALS.</gtr:partnerContribution><gtr:piContribution>Clinical expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Muscular Dystrophy UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Inclusion Body Myositis</gtr:description><gtr:id>8F6E774B-FCAF-4D71-87E7-583268B189AB</gtr:id><gtr:impact>One clinical research fellow working on IBM PhD project, jointly supervised by MRC Centre for Neuromuscular Diseases and University of Oxford.</gtr:impact><gtr:outcomeId>7D02E2EF549-2</gtr:outcomeId><gtr:partnerContribution>Sharing patient data and clinical knowledge.Sharing patient data and clinical knowledge. Joint supervision of one Clinical Research Fellow.</gtr:partnerContribution><gtr:piContribution>Sharing patient data and clinical knowledge. Joint supervision of one Clinical Research Fellow working on IBM PhD project.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Otago</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>Identification and characterisation of CMS genes</gtr:description><gtr:id>010AEF6A-D51D-4735-84D5-4F632468BE48</gtr:id><gtr:impact>Clinical paper submitted. Scientific paper in preparation.</gtr:impact><gtr:outcomeId>icH7ekX7kPz-2</gtr:outcomeId><gtr:partnerContribution>Large-scale mapping and sequencing resources.Patient material.</gtr:partnerContribution><gtr:piContribution>Patient material, consumables and personnel for gene analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Shire Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Mexiletine and Myotonia Congenita</gtr:description><gtr:id>5449AA93-6630-4F43-AA57-5AE2E8BEDB27</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>izHMsQAC2ri-1</gtr:outcomeId><gtr:piContribution>Providing clinical information regarding the side effects of mexiletine in myotonia congenita cohort.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Otago</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>Translational research in muscular dystrophy</gtr:description><gtr:id>EDD058E3-3208-46FF-B31F-81DCFDA2C348</gtr:id><gtr:impact>Numerous publications, particularly PMID 20405137 and 20346669, 20562457.</gtr:impact><gtr:outcomeId>JWm3TLB7wjz-2</gtr:outcomeId><gtr:partnerContribution>Patient material, clinical data, molecular analyses.Patient material, clinical data, molecular analyses.</gtr:partnerContribution><gtr:piContribution>Patient material, clinical data, molecular analyses.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>CMT Patient Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>53DA04AF-F200-4867-9EB1-7B77467680E3</gtr:id><gtr:impact>The centre for neuromuscular diseases held the first CMT patient education and information day in 2010. CMT patients and their families came from all over the UK to hear about different aspects of CMT including diagnosis, treatment and care. Members of the entire multidisciplinary CMT team at Queen Square were on hand to answer questions and explain the diagnostic process, care and treatment through practical demonstrations and posters. Patients also had the important opportunity to meet other families who were affected by CMT.

.</gtr:impact><gtr:outcomeId>CN8Yw5sek3V</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IvIg Patient Information Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4FF6C26C-8D8F-43EC-BE36-440EFF809CDE</gtr:id><gtr:impact>The centre for neuromuscular diseases held the first IvIg patient information day on 29th March 2010 at Queen Square. Patients receiving IvIg and their families came from all over the UK to hear about different aspects of the treatment. Members of the multidisciplinary team at Queen Square were on hand to answer questions and explain the treatment and process. Patients also had the important opportunity to meet other families who were undergoing IvIg treatment.

A second day is planned for 2011.</gtr:impact><gtr:outcomeId>jeDDJRsFn9h</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Channelopathy Patient Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>28A00239-4380-4116-ABA0-9B71212FFC43</gtr:id><gtr:impact>The centre for neuromuscular diseases held the first channelopathy patient education and information day on 23rd January 2010 at Queen Square. Channelopathy patients and their families came from across the UK to hear about different aspects of channelopathies including diagnosis, treatment and care. Members of the entire multidisciplinary channelopathy team at Queen Square were on hand to answer questions and explain the diagnostic process, care and treatment through practical demonstrations and posters. Patients also had the important opportunity to meet other families who were affected by channelopathies.

A second patient day is planned for 2011.</gtr:impact><gtr:outcomeId>Zo6k7ZxqcBA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mitochondrial Patient Days</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C78D4231-D5F6-4191-9CD8-E78B1021E262</gtr:id><gtr:impact>The centre for neuromuscular diseases held the first mitochondrial patient education and information day on the 15th November 2008 at Queen Square. Mitochondrial patients and their families came from across the UK to hear about different aspects mitochondrial disease including diagnosis, treatment and care. Members of the entire multidisciplinary mitochondrial NCG team at Queen Square were on hand to answer questions and explain the diagnostic process, care and treatment through practical demonstrations and posters. Patients also had the important opportunity to meet other families who were affected by mitochondrial disease. The second mitochondrial patient organisation day took place on 25th November 2009. The University of Newcastle has also held two mitochondrial patient organisation days in 
4th July 2009 and on 24th June 2010.

A third mitochondrial patient day is planned for 2011.</gtr:impact><gtr:outcomeId>GnxtRh2Wczj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Organisation Days</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5B580DDB-A051-4389-BF5F-C33BAD224745</gtr:id><gtr:impact>The aim of these meetings is to inform patient organisations about the activities of the centre, and ensure that they can work with the centre to achieve our goal of treating neuromuscular disease.

The area leads give updates on education, imaging, the Biobank, animal models and clinical neuromuscular trials across the UK, followed by the opportunity for questions and discussion. Representatives from over ten patient organisations attended the meetings.



Two patient organisations have part-funded one non-clinical three-year PhD studentship each as a result of these meetings (one CMT project, and one IBM project).</gtr:impact><gtr:outcomeId>Pf6QzeNMEak</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Ipsen Fund</gtr:department><gtr:description>Training Grant</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Ipsen</gtr:fundingOrg><gtr:id>5C6F7878-CE5D-492E-ADDB-B9B5BC47660F</gtr:id><gtr:outcomeId>HbsrUQ8msFA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>64350</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship/Child Health Research Appeal Trust</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>The Child Care Action Trust</gtr:fundingOrg><gtr:id>E4D886D8-D241-4051-934E-2833EF5D0CE9</gtr:id><gtr:outcomeId>r65UVqEqxWz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>21B8C178-A271-47A8-A9DA-86368708CDDD</gtr:id><gtr:outcomeId>UEiAbjuc2bq0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>51000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>023A98EC-845B-47C3-AA5E-0E323BCA32F8</gtr:id><gtr:outcomeId>VhZKb233Uzm0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Specialist Commissioning Service - Muscle channels disease service - Amount is per annum</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C1C0C168-7412-476E-9ADA-22E268AFAC0A</gtr:id><gtr:outcomeId>3724A032DEB0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/Department of Health - Health Innovation Challenge Fund</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>862E431C-5A5B-45E8-A163-36D1094F949F</gtr:id><gtr:outcomeId>WX6YmKcNjMs1</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>19000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>F7A4BDF3-6046-42EA-BAF4-B29781E878AD</gtr:id><gtr:outcomeId>J3nmvoCywwu0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>C5598847-3980-4455-B40F-FBFB9DE817B5</gtr:id><gtr:outcomeId>B87SUrbgCvu0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>242321</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>921CB0AE-EB26-48E5-AE71-536F0F118781</gtr:id><gtr:outcomeId>XMxgPYibMmL0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>460000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>Refurbishment Grant/UCL/UCLH Comprehensive Biomedical Research Centre</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>96560CB3-175C-4737-9203-D4DB74BAF4F7</gtr:id><gtr:outcomeId>qYdeaiEJqRR0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Proof of concept trial</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>35403374-36DA-4924-B3ED-B9184C145D9D</gtr:id><gtr:outcomeId>58a458898422b7.13275418</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>1C980658-C410-44B8-AE95-29D5DFD6AA11</gtr:id><gtr:outcomeId>PUSzzAccMk20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>160000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy Association</gtr:fundingOrg><gtr:id>AD7D213C-BAE2-4F7C-9CB1-929129ED5098</gtr:id><gtr:outcomeId>UBau35BBczr0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>32000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCLH/UCL CDRC Fast Track Grant</gtr:description><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>0EA59045-0385-4402-A8A6-28C37C41F92A</gtr:id><gtr:outcomeId>74F22BE3A060</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>133414</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Arthitis Research Campaign</gtr:description><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>518A4C94-18C3-4424-81F4-6B6C057642CB</gtr:id><gtr:outcomeId>XFSHU4J3uGo0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MDC Centre Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>99E9AA9C-5535-40FE-8801-91AC836D4984</gtr:id><gtr:outcomeId>noMXuaW17am0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>497024</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT Project Grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>15563026-C3E1-4901-8990-2A2B133BE1D1</gtr:id><gtr:outcomeId>rcBGUXnQwPw0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>914995</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC - Project Grant</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C00EC215-59AE-465F-A738-5FD1372BF4BA</gtr:id><gtr:outcomeId>08E1B0F8DE10</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>University College London Hospitals Charity (UCLH)</gtr:department><gtr:description>UCLH Charities - Fast Track Grant.</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>University College London Hospital</gtr:fundingOrg><gtr:id>36C52F79-75C4-40A1-A8CF-1DB2F83F86F1</gtr:id><gtr:outcomeId>ZV9JUTp6SyD</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2126000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Advanced Grant/European Research Council</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>0A2A6550-62D1-4AFF-8415-B76E829C919D</gtr:id><gtr:outcomeId>hVEp2crn2Se0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>56820</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Organon</gtr:description><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>B28C31BF-1933-4DE4-91C0-74B22D00D266</gtr:id><gtr:outcomeId>ZJScLhyKFx20</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCL/UCLH Comprehensive Biomedical Research Centre Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>2EB0F134-600B-4071-8E7F-42289BA027E5</gtr:id><gtr:outcomeId>LTjMgA59xMc0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>230208</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/International Collaborative Effort for DMD</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>International Collaborative Effort for DMD</gtr:fundingOrg><gtr:id>1E9BC8DA-2B75-4EAF-A7E3-25AA9408D6F1</gtr:id><gtr:outcomeId>MdekADJs8WQ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>Project Grant/UCLH CBRC</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>A33153EC-9FE6-436D-85D2-1E948EF737A2</gtr:id><gtr:outcomeId>H3FmFtHUGs80</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>85000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>Thierry Latran Foundation</gtr:fundingOrg><gtr:id>1BD3617B-5E7E-4928-8357-0CBD7D769C9F</gtr:id><gtr:outcomeId>dSqZTja9ysH0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator Award</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>F5081280-C20C-4EB6-9BEE-F415DD354896</gtr:id><gtr:outcomeId>kC1SEdfUAYv0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>9092B662-3DC4-4E26-9EE8-94ED9F160E3A</gtr:id><gtr:outcomeId>qKmFWBUWGj70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>480000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Gavriel Meier Trust</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>GM Trust (Gavriel Meir Trust Duchenne Muscular Dystrophy Charity)</gtr:fundingOrg><gtr:id>AB09C94F-33D5-48F7-AC69-C0CB3ACE0A93</gtr:id><gtr:outcomeId>RtcU3LaFbnS0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Action Duchenne</gtr:fundingOrg><gtr:id>E9F779C5-27C1-48CA-A05A-2BCFF3CAAEB5</gtr:id><gtr:outcomeId>p6VnLuHKK4Q0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Brain Research Trust</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Brain Research Trust (BRT)</gtr:fundingOrg><gtr:id>FB5B5B24-5126-468C-91D6-71AC0B69D1F2</gtr:id><gtr:outcomeId>BMwUqzSXDZt0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67793</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>D4651CDA-A8E3-4689-8526-77DBADD95201</gtr:id><gtr:outcomeId>A599UczRav80</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>42000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>56786E20-9306-4990-B7DB-AD199AED255E</gtr:id><gtr:outcomeId>QYMcCbVuoNq0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ICE Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>International Collaborative Effort for DMD</gtr:fundingOrg><gtr:id>E24EC408-3878-433A-822D-F18CDE2F9B21</gtr:id><gtr:outcomeId>dvcKFhb755Y0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>84000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>DF797285-A42F-4DE5-BA34-A860D89B3E2D</gtr:id><gtr:outcomeId>Ajy17m6FmqD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>4A549AF7-B07E-40A0-8F21-61DFEFDD3AB9</gtr:id><gtr:outcomeId>AKwa12kWPsd0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>133413</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Arthritis Research Campaign (ARC) - Project Grant</gtr:description><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>E20159D0-6D94-4D40-A27D-1408DFEDA1FC</gtr:id><gtr:outcomeId>48B9EDF40980</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200182</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sylvia Aitken Project Grant</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>The Sylvia Aitken Charitable Trust</gtr:fundingOrg><gtr:id>709426D4-9A04-42EB-AF61-13FE964DAE87</gtr:id><gtr:outcomeId>VrhV2zaNuZP0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67540</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CLRN Contingency Funding</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>8882034E-9291-4A3B-A7ED-143FA41C36EA</gtr:id><gtr:outcomeId>MUZEbdr8Adf0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>661363</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment Grant</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>90C34DA5-FAAF-471D-A0AD-606805AE12EA</gtr:id><gtr:outcomeId>ZeP3dub8MBj0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>497024</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>3D960228-C499-47C9-B71E-B0B9F3FBBAF3</gtr:id><gtr:outcomeId>SRDpubVprxF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1543444</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Project grant: A randomised controlled trial of efficacy of heat shock protein upregulation in IBM</gtr:description><gtr:fundingOrg>Food and Drug Administration (FDA)</gtr:fundingOrg><gtr:id>BC2B0378-EFF6-4244-ABAB-26CA218C63E9</gtr:id><gtr:outcomeId>58a457b293f2b9.22814157</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30007</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCLH Clinical Research and Development Fast Track Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>University College London Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>93C4C88F-E1AE-42DF-9913-4B7421DC5EBA</gtr:id><gtr:outcomeId>HMikYgCaYZh0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>Project Grant/UCL/UCLH Comprehensive Biomedical Research Centre</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>45769877-67BA-4995-AF59-965FA6F1DAF2</gtr:id><gtr:outcomeId>Z962WbxUiP60</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>ECBB966C-713E-4BE0-8F1C-545E4FF83EA3</gtr:id><gtr:outcomeId>b8JUqQdHpNH0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35500</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Jain Foundation</gtr:description><gtr:end>2008-11-02</gtr:end><gtr:fundingOrg>Jain Foundation</gtr:fundingOrg><gtr:id>F5D57F90-FA10-4D82-A82D-6F5A004631B1</gtr:id><gtr:outcomeId>euPPYXkGHAq0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124200</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Duchenne Parent Project France (DPPF)</gtr:fundingOrg><gtr:id>F5E7909F-F314-4B6C-AEAA-03740B98662D</gtr:id><gtr:outcomeId>XKhhLSc3Wdm0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80646</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Duchenne Ireland</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Action Duchenne</gtr:fundingOrg><gtr:id>832D07DB-4680-44FF-862F-F7C0DD8D15E9</gtr:id><gtr:outcomeId>T1mxJodQtq60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>160390</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>59283DF7-7D39-4CDB-83A5-B62F4925BE54</gtr:id><gtr:outcomeId>doTDHx4nNgV0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>78000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Collaboration Agreement</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>3C1FC06B-B881-4A23-915A-2366363B4CC4</gtr:id><gtr:outcomeId>h1sy1PAo3Uq0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>237000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Muscular Dystrophy Association (USA)</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy Association</gtr:fundingOrg><gtr:id>20772AB7-111E-4B93-BEB0-6590FD094371</gtr:id><gtr:outcomeId>cFBGUEDvtcF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>133790</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B704D4DF-BCEC-4DCE-B505-7806BBD5DE21</gtr:id><gtr:outcomeId>iBbwSn8gZuP0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>579316</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D83D3BBC-D5E1-4C6F-B0EF-C14D4EF67E0E</gtr:id><gtr:outcomeId>DDszHKVqqAJ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60372</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University College London &amp;amp; Private Donor Impact PhD studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>7830BFEE-E0B3-4C5D-B57D-DE89156DAD3A</gtr:id><gtr:outcomeId>HJV8X5oWD3h0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1357222</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TREAT-NMD Translational Research in Europe - Assessment and Treatment of Neuromuscular Diseases (10m euros across 27 participants)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>93C92D1B-8FD3-4E17-8290-8586F71C3800</gtr:id><gtr:outcomeId>NerxgWmL6uA0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>154658</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Technologies Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>96268544-94AD-4251-89CD-A595444BE915</gtr:id><gtr:outcomeId>3D6E44E1ED70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>154658</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Showcase Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>984A46BA-36A7-4CFB-BA11-8CDBFF9031D7</gtr:id><gtr:outcomeId>sjzDuXCLPf10</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>196896</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>081E0F7D-AE5F-40D0-A66A-3129B3CC46B4</gtr:id><gtr:outcomeId>RQbZR7aNXeV0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>69701</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industrial Collaboration (Pfizer)</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>777B12CF-8BF4-4A7E-A615-B0ABC01F6859</gtr:id><gtr:outcomeId>XDJuvCUivz70</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>155846</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT PhD Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>D1934945-DD54-4495-B786-683C50A1E101</gtr:id><gtr:outcomeId>LL5iUQEYq8u0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:id>DA4FB196-6F43-4B36-A791-A850F9C6E793</gtr:id><gtr:outcomeId>YbU3eGSyRua2</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Merck</gtr:fundingOrg><gtr:id>13F26612-DEFD-40DC-B626-A1382CB2A375</gtr:id><gtr:outcomeId>cizeRuv8UTw0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Motor Neurone Disease Association Fisher - PhD studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>695AFC59-20F2-40F2-A6CA-317F1C034CDB</gtr:id><gtr:outcomeId>WTNv18F79nj</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>339000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCL/UCLH CBRC Capital Bid</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>125FDE6C-F5F5-4307-B671-91D061E11E83</gtr:id><gtr:outcomeId>BEz6SEXRmb40</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>116759</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Muscular Dystrophy Association (USA) - Development Grant/Muscular Dystrophy Association (USA)</gtr:description><gtr:fundingOrg>Muscular Dystrophy Association</gtr:fundingOrg><gtr:id>7EC53A9D-3DC9-4CB5-9413-F2207E47B02D</gtr:id><gtr:outcomeId>752ECABA8C00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>29118</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AFM Project Grant</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>BF20357E-FD6A-47D0-9FB5-846768A09F43</gtr:id><gtr:outcomeId>b6xFee54RQv0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>850000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>7D199A2B-1DA5-41F6-A110-CCFB301EC782</gtr:id><gtr:outcomeId>SsNZuKo1CHY0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2468621</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>CC089D7F-9556-478B-BC57-31686872884D</gtr:id><gtr:outcomeId>PNp6vRynfTc0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>68000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Thierry Latran Foundation</gtr:fundingOrg><gtr:id>BCBA3BFC-F5E7-4F34-BD6E-05246ACBB78D</gtr:id><gtr:outcomeId>RTLbC2wqHQH0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCL CBRC Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>B8C61A4B-077F-4141-9EC0-2D92FBF1EB54</gtr:id><gtr:outcomeId>WWi1SPwx7go0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2550000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>51AB33D9-6164-4A44-AFDE-5973034C4B87</gtr:id><gtr:outcomeId>Y9AZGY8itJX0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>968683</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>907EF00F-CFCD-4F94-B909-5D0C93477584</gtr:id><gtr:outcomeId>ooCMM4KuAX50</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Post-doctoral Fellowship/Muscular Dystrophy Association (USA)</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy Association</gtr:fundingOrg><gtr:id>995D2F29-EFF7-4A49-A677-81DAF7812B17</gtr:id><gtr:outcomeId>c6Yfiw888360</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer's Research UK- Pilot Project Grant</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>75A89FBE-EB5A-41C7-8D6F-BDD5BB5C41E0</gtr:id><gtr:outcomeId>ZZ57RRWzgdb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCL/UCLH Comprehensive Biomedical Research Centre Researcher Salary</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0A463217-633B-4BE1-8197-3AA4E51AF14A</gtr:id><gtr:outcomeId>gW61Hv4pjbo0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48122</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Newcastle upon Tyne Hospitals NHS Charities</gtr:description><gtr:fundingOrg>Newcastle upon Tyne Hospitals NHS Charity</gtr:fundingOrg><gtr:id>D0903EAA-5564-42AC-901A-1D5AEBFFA83A</gtr:id><gtr:outcomeId>fhnt5NmqSNn0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>598527</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>1D0AC07A-51A9-4186-BC73-4D85B08F6987</gtr:id><gtr:outcomeId>T9JmiagETs80</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2471061</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT Senior Investigator Award</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>6275ADC0-97FC-4627-A373-F632F4372097</gtr:id><gtr:outcomeId>DFeX1GvwnaN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lily foundation Project Grant</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>The Lily Foundation</gtr:fundingOrg><gtr:id>E42229B7-EEBA-4CD8-AC9D-FF27A043D779</gtr:id><gtr:outcomeId>Sj3imY2or2M0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>320000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>- Using Next Generation Sequencing to investigate neuromuscular disorders</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E1EA5768-867A-4F7B-82D3-192FCB741E29</gtr:id><gtr:outcomeId>g8c4UvJqCmK</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>754000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC - Exercise training and assessment laboratory</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>AF3A1B11-3289-4757-A539-60967D256303</gtr:id><gtr:outcomeId>DE8B3318C2D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CA72ABC9-B157-4BEE-9414-4C1FBC29116C</gtr:id><gtr:outcomeId>kLMwfchWR8z0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>576521</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BIO-NMD Identifying and validating pre-clinical biomarkers for diagnostics and therapeutics of Neuromuscular Disorders (5.6m euros across 12 participants)</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>6A9C867E-74A3-4134-84DD-1ADEB2D270D1</gtr:id><gtr:outcomeId>eynvdDMjADW0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35157</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NHS Trust Project Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>E3ABB7C3-7F70-4584-9CC7-2CAA242CA500</gtr:id><gtr:outcomeId>CpYpFXwtHEv0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>130000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>07864E3E-872B-4827-A3F0-B8C4D2B8412E</gtr:id><gtr:outcomeId>c3EXtgB8j8N0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>117802</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Muscular Dystrophy Campaign Project Grant</gtr:description><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>12753F41-ED4A-4CDC-9E9C-90D71B5D7823</gtr:id><gtr:outcomeId>C27E4F71E180</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124359</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Heart Research UK</gtr:fundingOrg><gtr:id>F92DBD38-A6BA-42B1-8104-B2D4EE10F8EB</gtr:id><gtr:outcomeId>o6haDaNNNnr0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>247107</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Training Fellowship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D70CF3E4-F954-40A3-B0AC-B09508D37FEF</gtr:id><gtr:outcomeId>oJBXk8Fk8Nb0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>153502</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>BE45EDA8-46BD-48B4-A47F-CF7998C0B1B4</gtr:id><gtr:outcomeId>mfQ7wz9Jmf90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>33457</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>2B388247-DF58-43BB-AFCE-164ABE4C33F8</gtr:id><gtr:outcomeId>PxvQNow8Pj60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60372</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University College London &amp;amp; National Hospital Development Foundation Impact PhD studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>77C503E8-E035-4374-92D4-6010823AEEB5</gtr:id><gtr:outcomeId>dGxoeJavmda0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>111812</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>154931D9-AC21-45C9-BA85-E6F3ACCF228F</gtr:id><gtr:outcomeId>Q75TnRQpzDJ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>106363</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>4A3B188F-3873-41EB-817F-ED82F842D2F0</gtr:id><gtr:outcomeId>TtVKsuvvoXw0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1008392</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1CB707B2-1F7D-43CB-93DA-290CCAD2EDCC</gtr:id><gtr:outcomeId>ZmDhpyy2jhG0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>95000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>80B5343C-E2CB-47CA-BFB9-7AF99A45E70C</gtr:id><gtr:outcomeId>Pm1gkjzKD1C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53000</gtr:amountPounds><gtr:country>Denmark, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Lundbeck Foundation</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Lundbeck Foundation</gtr:fundingOrg><gtr:id>871F4673-F983-4969-891F-B07537CFCD58</gtr:id><gtr:outcomeId>jVLsAoWK1a10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>86019</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industrial Collaboration (AVI Biopharma)</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Sarepta Therapeutics Inc.</gtr:fundingOrg><gtr:id>9B7F7330-3485-468C-9A69-E0407A5BA14F</gtr:id><gtr:outcomeId>Yno9hKaB4gi0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>Refurbishment Grant/UCL/UCLH Comprehensive Biomedical Research Centre</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C4168871-8C5D-4033-8320-A47F585ADB0B</gtr:id><gtr:outcomeId>VhtkqdjXPpm0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99397</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Epilepsy Research UK</gtr:fundingOrg><gtr:id>515979ED-2AF9-4CC0-B14B-69965B2C1318</gtr:id><gtr:outcomeId>NVsEy9faeB90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60004</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CLRN Contingency Funding</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>6F4D6EFF-3145-4E75-BEDE-3A7C6BAA47DF</gtr:id><gtr:outcomeId>FovkecQiDot0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>47000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>1C4C856C-70C8-47E4-AF37-13E85BFBC719</gtr:id><gtr:outcomeId>gHEWYMCSnoN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>320000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C9203257-858C-407B-807E-BF04DD999123</gtr:id><gtr:outcomeId>eFfGR5z1uyp0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Facility</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>2957817A-BF24-47B3-AC89-4490F9ECC8A0</gtr:id><gtr:outcomeId>Qxwr79HfhNb0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>310000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 collaborative project</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>FD591EFE-DEF0-4287-9F6C-4A5BFF967589</gtr:id><gtr:outcomeId>Coy4H19DAMx0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25084</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Project Grant</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>779C4FC2-9F0A-4204-819A-D373AF554EEF</gtr:id><gtr:outcomeId>Txzk5gYXEp80</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4507000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>1D587B9E-481C-4D2D-8BA9-6F147EF39DB3</gtr:id><gtr:outcomeId>EE6WUV9wtmA0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>51D4058E-BB25-4CBD-A0D7-1E2085CBD608</gtr:id><gtr:outcomeId>YbU3eGSyRua3</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26106</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Brain Research Trust</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Brain Research Trust (BRT)</gtr:fundingOrg><gtr:id>9AEB4A22-0B12-4F04-8915-AC743F90C200</gtr:id><gtr:outcomeId>YMrzickTwPn0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>28367</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AFM Project Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>80FFE169-2DFF-4600-8D9F-CD62C7DDB102</gtr:id><gtr:outcomeId>EHf4eQd5XJ70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80429</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Heart Research UK</gtr:fundingOrg><gtr:id>11113F6A-D8C5-41B0-9DFC-371F2CD3E193</gtr:id><gtr:outcomeId>bJ8Eka6kTQe0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>6FB7786F-7BCD-43FE-B05E-C6BAF58CBE9C</gtr:id><gtr:outcomeId>YbU3eGSyRua1</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>166891</gtr:amountPounds><gtr:country>Italy, Italian Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Carlo Besta Neurological Institute</gtr:fundingOrg><gtr:id>CFCB2002-DC40-42A0-B953-99FD3A66208A</gtr:id><gtr:outcomeId>NWwNaueCx6W0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124200</gtr:amountPounds><gtr:country>Monaco, Principality of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Monaco Association against Duchenne Muscular Dystrophy</gtr:fundingOrg><gtr:id>DCE826F9-5D19-4A08-854B-2BEFFA73F9E7</gtr:id><gtr:outcomeId>XKhhLSc3Wdm1</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>275000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>3D296565-1443-415A-8EC5-9A092654AD67</gtr:id><gtr:outcomeId>reEiqJX6pKz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75173</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MDC PhD Studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>A84A65AF-FAB0-434E-82F3-9288F949B7CD</gtr:id><gtr:outcomeId>Egjx57gHeDH0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>31923</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>Action Duchenne</gtr:fundingOrg><gtr:id>EE1E78F0-BD85-49AC-9C0D-87CD24DBE325</gtr:id><gtr:outcomeId>kcBhP2oGjiN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>210601</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Muscular Dystrophy Campaign Project Grant</gtr:description><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>C1998BA8-36DE-4E6D-9CE0-E761B1F5F876</gtr:id><gtr:outcomeId>30BB18529EC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>269400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council - Patient Cohort</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>29781080-D02D-44CA-917D-3C33C038AECB</gtr:id><gtr:outcomeId>E31255F97C50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>996727</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant (Signals that control cell fate and plasticity in the Schwann cell lineage) Jessen and Mirsky</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>49A74F06-CEFC-409D-A3E9-E9981BFF13BD</gtr:id><gtr:outcomeId>PxWLDSPzn150</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2004-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>778157</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>5F166844-0398-43C0-87E1-20F71854E6E9</gtr:id><gtr:outcomeId>MpDmwBYwYwv0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1110785</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2B4F0476-9B33-4BCC-980E-F89EA0CC6D44</gtr:id><gtr:outcomeId>kW2cgUo5k6z0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>66641</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CLRN Contingency Funding</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>51351CC7-D263-4AE0-97FB-412D14142E70</gtr:id><gtr:outcomeId>bpimxb7LauE0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF - Clinical Trial Grant</gtr:description><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>F7DFC6B0-3284-43D4-9000-434B06C2D2CD</gtr:id><gtr:outcomeId>922DF7204000</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>790B2CC2-D21C-40B4-9A23-BC16ECCF643A</gtr:id><gtr:outcomeId>fxqapCmyrKB0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Associates x2</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>65457E5C-EF2D-4E24-8DBC-ED12CA530C0D</gtr:id><gtr:outcomeId>58a45808f2fbe0.26482064</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>333790</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR - Doctoral Research Training Fellowship</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>A9E9B9E7-2B75-4A5F-A0F0-042981FEF083</gtr:id><gtr:outcomeId>EDFDD7BA81E0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>428000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>C92A2652-8C09-4A5A-9742-CA4782D0963D</gtr:id><gtr:outcomeId>fS4fL7eUMU90</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>559676</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University Award</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Lewy Body Society (LBS)</gtr:fundingOrg><gtr:id>AED29B70-9EC2-495E-B3AF-19D9D2E093FD</gtr:id><gtr:outcomeId>RJkomg3MXeh0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Organon</gtr:description><gtr:fundingOrg>Merck</gtr:fundingOrg><gtr:id>B13758FF-06AE-4538-A2A6-8E0CFBFB6470</gtr:id><gtr:outcomeId>ZJScLhyKFx21</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>661363</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A next generation sequencer for the Institute of Neurology. Equipment Gran</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>B7CA15A8-B27C-45EC-8300-F47A0250C615</gtr:id><gtr:outcomeId>L5cobH2HokZ</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4761</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>World Muscle Society Conference Sponsorship/Muscular Dystrophy Association (USA)</gtr:description><gtr:fundingOrg>Muscular Dystrophy Association</gtr:fundingOrg><gtr:id>257611FD-82A5-4583-9A46-6165EE2A6BF1</gtr:id><gtr:outcomeId>MqmgT1PdkMF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>46000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>F5A59FF8-73D9-4F2D-A856-973A882FC141</gtr:id><gtr:outcomeId>LBagsm9GCQD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1189000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>856CD6F9-4718-4D03-98D8-146D23967A6E</gtr:id><gtr:outcomeId>jmnuq8hj8Wf0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228275</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>851601BC-6C35-45E6-BEAB-2FEB6C9326D9</gtr:id><gtr:outcomeId>WuCkyrfnbQw0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Patrick Bertoud Fellowship/Charities Aid Foundation</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Charities Aid Foundation</gtr:fundingOrg><gtr:id>CC73E4EE-F238-4B8D-9257-6811E1B18B9D</gtr:id><gtr:outcomeId>Yia5D9LTU1R0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60372</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University College London &amp;amp; Senexis Impact PhD studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>085CC3D5-8735-4F8E-A1B7-03D1803B95C9</gtr:id><gtr:outcomeId>X81CEDDsXha0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13640</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>F1D85B90-8AA9-481D-97D5-7B9E17337D76</gtr:id><gtr:outcomeId>TEfFH6zR7SJ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCLH National Hospital Development Foundation - Impact PhD studentship scheme</gtr:description><gtr:fundingOrg>University College London Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>9D55AEDF-1D1D-4F72-A09C-505CF9153F79</gtr:id><gtr:outcomeId>FF587B27D510</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>107667</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Jain Foundation Project Grant</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Jain Foundation</gtr:fundingOrg><gtr:id>CC44508D-2361-498C-8AC7-D15F7CE2785B</gtr:id><gtr:outcomeId>TBU945Qu3490</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Thierry Latran Foundation</gtr:fundingOrg><gtr:id>EEF0C4F2-C06A-430F-ACB2-F30677FE070E</gtr:id><gtr:outcomeId>MibAxq7N5Px0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>31000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>20683901-7196-440A-9C72-95D5CC060408</gtr:id><gtr:outcomeId>Puou7bnYcXJ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>144000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Partnership CASE Studentship</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>A4C65514-A29F-4DA1-899C-4B30510D3317</gtr:id><gtr:outcomeId>BVe9aYk3sTb0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5189294</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Institutes of Health (USA) - RDCRC Grant</gtr:description><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>8C136F54-94B6-4200-907C-DE5263371138</gtr:id><gtr:outcomeId>125543527DF0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship/Brain Research Trust</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Brain Research Trust (BRT)</gtr:fundingOrg><gtr:id>BF880817-E73E-4300-BF62-09FFBA7E5460</gtr:id><gtr:outcomeId>HLoQXnUCgzG0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>102B6660-6B80-4ED1-A098-7C20D4FBA7CB</gtr:id><gtr:outcomeId>VxkuchtFVZ70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>271911</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AFM Project Grant</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>C812104B-2CD7-4A12-B94B-887023908371</gtr:id><gtr:outcomeId>Sg8hdWpK9q90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>46785</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCL/UCLH CBRC Flexibility and Sustainability Funding</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>7043E3B4-4F10-474D-966A-D0A3C19188A9</gtr:id><gtr:outcomeId>dAxGTWLCqxC0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>126000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MDC Project Grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>56A3BD65-5819-4067-900F-354442D86AA0</gtr:id><gtr:outcomeId>BiJTJ9XpagF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1366109</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>065374/Z/01/Z London Pain Consortium (&amp;pound;5.4m across 4 participating centres)</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>065374/Z/01/Z</gtr:fundingRef><gtr:id>157A32A7-BCBA-4BD0-AA9A-AED5E9374444</gtr:id><gtr:outcomeId>LtUEFXcEccs0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>43770</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Trials Support Officer</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>853BD45A-DC7B-41A9-ADE6-D50405AF269F</gtr:id><gtr:outcomeId>FtEZvM1vUXw0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>353000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cooperative Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E3697260-D35F-4D6C-BA55-389949CE43B5</gtr:id><gtr:outcomeId>n4GW2ex6Euo0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Ipsen Fund</gtr:department><gtr:description>The Ipsen Fund - Clinical Research Training Fellowship</gtr:description><gtr:fundingOrg>Ipsen</gtr:fundingOrg><gtr:id>8F80319A-1734-47C0-8265-632BF1677A44</gtr:id><gtr:outcomeId>8C2CB5C3A810</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CMT UK - Impact PhD studentship scheme /CMT UK</gtr:description><gtr:fundingOrg>CMT United Kingdom</gtr:fundingOrg><gtr:id>EE4BEB40-940D-4DCD-8B7A-125AF1EE6770</gtr:id><gtr:outcomeId>C7FADBD19690</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4878800</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>DA937B34-FDBE-48B9-8D54-7C9445DCE3CA</gtr:id><gtr:outcomeId>cg4g1PCg9jn0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>339000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>A next generation sequencer for the Institute of Neurology. Capital bid</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>8FD54292-6099-429E-9DE4-24B93A505E57</gtr:id><gtr:outcomeId>mRMS3h3x16b</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>160000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Myasthenia Gravis Association</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Myaware</gtr:fundingOrg><gtr:id>6306709B-79C6-4460-96D1-B48177C35740</gtr:id><gtr:outcomeId>ZqdGKkboffz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>246000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Foreign and Commonwealth Office (FCO)</gtr:fundingOrg><gtr:id>3DEC3AF0-772A-449C-81D1-9B6B195452F1</gtr:id><gtr:outcomeId>VCEwoNFutku0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP7 Neuromics</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>F40A2CD4-4977-4DB1-A179-6E7F7FFD3A19</gtr:id><gtr:outcomeId>nEM5JqqGAP7</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1215192</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lentivirally-modified stem cells to treat Duchenne muscular dysrophy</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>45168C5B-4A5B-4212-97EB-DAC360A7FE83</gtr:id><gtr:outcomeId>bzJUdVpW821</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>96884</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>89B71423-AFF8-4BB5-B3C8-BA7DD9B652BA</gtr:id><gtr:outcomeId>ok6W1XaUBzg0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>D34F4010-01B1-4756-8DD7-5AAC14F921F2</gtr:id><gtr:outcomeId>gsyG7vjtCgE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22367</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/Department of Health - Health Innovation Challenge Fund</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>BACD41E3-2F9E-4097-B0DC-3EA3408D93C0</gtr:id><gtr:outcomeId>WX6YmKcNjMs0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24051</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Special Trustees, Newcastle Upon Tyne Hospitals NHS Foundation Trust</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>6B4E83DA-0055-44E3-AB0E-F70A5E9E091E</gtr:id><gtr:outcomeId>i1YFq1Z2g7q0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>229336</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT Project Grant</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>CB431183-C88D-45B2-A64D-848648969430</gtr:id><gtr:outcomeId>n8ctKFt32jd0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>138347</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC - Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>853AADCB-FC80-465C-904B-CE7790AEC689</gtr:id><gtr:outcomeId>8BFC765D0550</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>108000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CLRN Bridging Grant</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>DBBF417D-2F07-4854-9ECE-75FAB0FCC47E</gtr:id><gtr:outcomeId>RbrS1zkDLfC0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180267</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Research Training Fellowship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>ABE7B0B1-4A62-4FE4-8847-534491918FD6</gtr:id><gtr:outcomeId>383FB08BFF20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>A54B25F7-F618-4842-921D-2892E40E23EF</gtr:id><gtr:outcomeId>YbU3eGSyRua0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>320000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5AB5AF8A-A421-4031-B917-DDD8F63F8822</gtr:id><gtr:outcomeId>ikLQ8kDrAsp0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Vera Down Fellowship</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>British Medical Association (BMA)</gtr:fundingOrg><gtr:id>FCDBE898-F579-46CD-88E7-66454F258323</gtr:id><gtr:outcomeId>hHdceqbG1wy0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>65CC170F-9A07-4469-929D-8CDDD625980E</gtr:id><gtr:outcomeId>RTJTQwGbETN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93001</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCL/UCLH Comprehensive Biomedical Research Centre - Project Grant</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5B81FA40-3877-482D-BA56-2C138C3C934C</gtr:id><gtr:outcomeId>E258CE0D6C70</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pilot Grant/Brain Research Trust</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Brain Research Trust (BRT)</gtr:fundingOrg><gtr:id>0822DB36-13F3-4C93-9A64-76A9B29824FA</gtr:id><gtr:outcomeId>i31TNBkCBWW0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCL - CDRC Fast Track Grant/Sparker Enterprises</gtr:description><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>5EB2665C-8475-4E03-91F7-340E887D53AE</gtr:id><gtr:outcomeId>CE768E65F0C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>403876</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>115AD0E3-E37F-408A-B389-3C2555AEA888</gtr:id><gtr:outcomeId>CRR1uw18jMH0</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8434670</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Institutes of Health (USA) - Project Grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>878E91D7-3DB9-4258-88DB-CBD7AE456EA8</gtr:id><gtr:outcomeId>8A4B56042FB0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2468621</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>00B7551B-B37F-4311-9134-05CC595E6C28</gtr:id><gtr:outcomeId>U6J1Jq4eELv0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>103000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CLRN contingency funding</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>506BC327-6EF1-4071-93F5-6D2DB5708CAC</gtr:id><gtr:outcomeId>qgq8BYN2xCF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18938</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Federal Ministry of Education and Research</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>German Federal Ministry of Education and Research</gtr:fundingOrg><gtr:id>58382A7B-96C4-4169-B323-A57A991504BF</gtr:id><gtr:outcomeId>jAq46cSG2Vc0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>68000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>Thierry Latran Foundation</gtr:fundingOrg><gtr:id>FD09700E-5EF3-402D-BBEC-162EB1B0E689</gtr:id><gtr:outcomeId>sb9A7hSY4RF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>108000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Comprehensive Clinical Research Network (Coordinating Centre) ? NIHR</gtr:department><gtr:description>Support NIH RDCRC natural history stdy</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>B05A5B31-0F0C-49B4-BADA-A9E3679DD822</gtr:id><gtr:outcomeId>jx2CLsCp9LF</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1284915</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT Programme Grant</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>E0D26B00-2BCE-46FD-A395-7D68F238401E</gtr:id><gtr:outcomeId>nsWQFhsUuFD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Various citations in scientific clinical reviews</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>08F9FA4E-FBDB-4793-AD9D-6C72E28C7616</gtr:id><gtr:impact>Clinical reviews influence prescribing and practice of clinicians at all levels and raise awareness of the limitations of IVIG availability and use.</gtr:impact><gtr:outcomeId>nEpdaEQUNGV</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National IVIG guideline consultation</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>A7454CEE-A2BD-4F4B-A5EB-BC1D4FF95116</gtr:id><gtr:impact>Guideline consultation was national and included deputations from all major IVIG interested specialties and users. 

This influence retained appropriate use of IVIG for diseases where it is effective and maintains IVIG supply nationally.</gtr:impact><gtr:outcomeId>Uf3yftUJDjW</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Orphan drugs</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>A34417F2-7821-47C2-A311-35E0851797A9</gtr:id><gtr:impact>Professor Dimitri Kullmann contributed to an open letter to the Prime Minister raising awareness of an unexpected consequence of the European Union's regulations on orphan drugs, which has resulted in a 50-fold increase in the price of 3,4-diaminopyridine, used in the treatment of Lambert-Eaton Myasthenic Syndrome and Congenital Mysathenic Syndromes. Cited in BMJ 2010; 341:c6466.</gtr:impact><gtr:outcomeId>YjMs5ANNME9</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DoH Clinical Guidelines for Immunogloblin Use 1st and 2nd Editions, DoH Demand Management Plan for Immunoglobulins, DoH National IVIG Database</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>DC5FAB2C-C71C-4FC6-9214-734141D7A8A6</gtr:id><gtr:impact>Department of Health policy documents.</gtr:impact><gtr:outcomeId>Rbwh5tj1csi</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Clinical Guidelines for Immunoglobulin Use 1st and 2nd Editions</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:guidelineTitle>Clinical Guidelines for Immunoglobulin Use 1st and 2nd Editions, Demand Management Plan for Immunoglobulins and National IVIG Database</gtr:guidelineTitle><gtr:id>A25E13BE-E4EE-4D2D-8F38-F37EF9B5FFA4</gtr:id><gtr:impact>Evidence based clinical guidelines for the use of immunoglobulin in England and Wales which have influenced prescribing and use of valuable IVIG resource. 

The demand management plan has secured a supply of IVIG nationally and secured supply for those for whom it is crucial to survival in times of shortage.

The database has provided use and contracting/purchasing information to secure IVIG supply nationally. It is providing data on responsiveness of patients to IVIG in all indications.</gtr:impact><gtr:outcomeId>tforbc3Fe6X</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National IVIG prescribing and use guidelines and monitoring committtee and database monitoring committee</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>B747E653-452F-4E86-A6EF-62BB4C18092C</gtr:id><gtr:impact>Maintaining the database data and the clinical guidelines.</gtr:impact><gtr:outcomeId>K83PwYAeBC8</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New mouse models with mutations in genes known to be causative for neurogeneration in humans.</gtr:description><gtr:id>26421EE0-23F5-4025-8988-513C6C7B3155</gtr:id><gtr:impact>Presentations at meetings. Papers to follow.</gtr:impact><gtr:outcomeId>gyDcMek1T3U</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mutant Mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>cDNA clones encoding either dysferlin or ANO5 have been inserted in frame with protein tags (myc tab, EGFP etc) for expression in cell culture.</gtr:description><gtr:id>AD85FF15-C4EB-4703-9686-312E73DFE70E</gtr:id><gtr:impact>Material provided to other researchers in 2008, 2009, 2010 and 2011. 
Collaborative publications e.g. Hernandez-Deviez 2008 and Cacciottolo 2011.</gtr:impact><gtr:outcomeId>f5EMvRJpn5J</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dysferlin and ANO5 constructs</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>DNA samples from Inclusion Body Myositis patients</gtr:description><gtr:id>B680A082-8E10-47EA-B33C-715A38FD6C24</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>Lpx3bktFRC2</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>IBM DNA Bank</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Natural history data from IBM patients.</gtr:description><gtr:id>D2EAF28C-A93B-4C77-99B2-E2BB8BF5DBAA</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>Afb6oq5PWYg</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Inclusion Body Myositis cohort</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have derived myoblasts from control, mdx and SJL (dysferlin-deficient) mouse lines and characterised them in culture. These cells can be used for a variety of in vitro analyses.</gtr:description><gtr:id>A6CF4BB5-061C-4089-B111-7A72A3BF0EFB</gtr:id><gtr:impact>Publication in preparation.</gtr:impact><gtr:outcomeId>cbeKAWyU6MK</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Immorto-mouse myoblast cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>GM mice bred without RBPj in Schwann cells.</gtr:description><gtr:id>789156EC-63CD-4C50-A144-3495C98E5DCB</gtr:id><gtr:impact>This mouse model has enabled us to study transdifferentiation and regeneration in the peripheral nervous system.</gtr:impact><gtr:outcomeId>DPMHQZpn6zr</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>GM mice without RBPj in Schwann cells</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>QTRAC is the patented technique developed by Professor Hugh Bostock in the Centre for Neuromuscular disease which allows reliable clinical evaluation of peripheral nerve excitability - so called nerve excitability testing. This has been adopted in a number of clinical neurophysiology units worldwide. We have published on this work eg Tomlinson et al Nerve excitability testing in episodic ataxia Brain in press PMID 21106501.</gtr:description><gtr:id>C74C7144-84DF-426F-BC5E-A60C52609346</gtr:id><gtr:impact>PMIDs 21106501, 20095022, 19900504, 20715364.</gtr:impact><gtr:outcomeId>DK46mHc7F7o</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>QTRAC</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:url>http://europepmc.org/abstract/MED/21106501</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Myoblasts cell lines have been established on over 1000 patients as part of routine diagnostics in our centre. Patients are consented to provide this as a gift to research. Cell lines are used for basic research activity.</gtr:description><gtr:id>DA95C379-1EAA-4C7F-B5C6-FC03237F303C</gtr:id><gtr:impact>Joint publication in Journal of Biological chemistry 2007 investigating mtiochondrial dysfunction in patients with mitochondrial diseases.</gtr:impact><gtr:outcomeId>p2gTPJ4Mng5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Biobank myoblast muscle cell lines</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Techniques to assess the cardiac phenotype of mouse models of muscular dystrophy in vivo. This includes analysis of the heart structure and function using MRI and conductance catheter studies to define the pressure-volume relationship of the cardiac cycle in live animals.</gtr:description><gtr:id>047A3599-7A44-4E1A-BAF7-140AB5A6FEC1</gtr:id><gtr:impact>Recent publications: Bauer et al. 2009, Bauer et al. 2010.</gtr:impact><gtr:outcomeId>QArS22w39Vo</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Analysis of cardiac function in mouse models</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mangangese is a contrast agent in MRI which mimics calcium, and so shows increased contrast in muscular dystrophy where calcium is aberrantly elevated.</gtr:description><gtr:id>A0707EAF-452C-4881-A0B5-8A4F4CFF259C</gtr:id><gtr:impact>Not yet.</gtr:impact><gtr:outcomeId>ttnNmYT1Hkp</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Manganese-enhanced MRI (MEMRI)</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The 2005 CMT neuropathy score has been updated in 2010, and a paediatric version is also being produced. The scale is currently being validated.</gtr:description><gtr:id>A6908691-764C-4109-B45B-9C7D523AF079</gtr:id><gtr:impact>Reported in workshop report PMID 20850975.</gtr:impact><gtr:outcomeId>mhcFvSY3fxU</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Reliability and validity of the CMT neuropathy score as a measure of disability</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:url>http://europepmc.org/abstract/MED/20850975</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>GM mice bred without Notch1 in Schwann cells</gtr:description><gtr:id>37B10969-CB89-4E05-B85C-6D1E5CC04AE2</gtr:id><gtr:impact>This mouse model has enabled us to study transdifferentiation and regeneration in the peripheral nervous system.</gtr:impact><gtr:outcomeId>f45EefXKGge</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>GM mice without Notch1 in Schwann cells</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Natural history patient data</gtr:description><gtr:id>E4552E98-66A9-421A-85D0-57F56838127B</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>LWZgY2R6WuU</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CMT cohort</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Prospective data collection of natural history study of hundreds of children with Duchenne Muscular Dystrophy.</gtr:description><gtr:id>4F7918EE-ED11-4276-B7C7-0F48B8375D86</gtr:id><gtr:impact>Ongoing collection of data; growth of database.</gtr:impact><gtr:outcomeId>B2x17BtgEYD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>North-Star</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Assay for membrane stability. By placing cells in hypo-osmotic medium we have developed a method to define the degree of membrane stability conferred by a restored dystrophin molecule based on the release of enzymes into the medium.</gtr:description><gtr:id>C93B871A-040C-4FDE-B82B-122E3CBF1098</gtr:id><gtr:impact>Publication (Jorgensen et al. 2009) and further funding.</gtr:impact><gtr:outcomeId>EngfgPapik6</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Hypo-osmotic shock to measure membrane stability</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Produced a minimal dataset for a CMT international database.</gtr:description><gtr:id>1FCDF90B-9E59-4D9C-982B-1A219576CD6B</gtr:id><gtr:impact>Published as workshop report in Neuromuscular Disorders PMID 20850975.</gtr:impact><gtr:outcomeId>jMj73tK3EJt</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CMT International Database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://europepmc.org/abstract/MED/20850975</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>International database of CMT patient data housed in Florida at DMCC in association with TREAT-NMD.</gtr:description><gtr:id>8FB2D4BD-B94D-41CF-97A5-BCA6892A6D1B</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>VMzGsWFbdfn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>International CMT Database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>DNA samples from channelopathy patients</gtr:description><gtr:id>96B53F75-9607-40DE-9802-85B73E283D5A</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>ZBoVkwk4gUx</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Channelopathy DNA Bank</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Web-based database of patient information from IBM cohort.</gtr:description><gtr:id>98F614F3-CB77-40EB-911D-98E5AFE9BE5D</gtr:id><gtr:impact>Continued growth of database.</gtr:impact><gtr:outcomeId>VHD2HHcsySk</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IBM-Net</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Correlation of collagen VI immunofluorescence staining pattern with mutation and clinical presentation.</gtr:description><gtr:id>4ECF503E-F496-4E96-86A6-4839DA193BED</gtr:id><gtr:impact>Provided to other researchers in 200 and 2009.
Improvement in the diagnostic algorithm for Bethlem myopathy.</gtr:impact><gtr:outcomeId>hjhDLkae2n2</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Collagen VI fibroblast IF assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Natural history data from mitochondrial patients</gtr:description><gtr:id>15BE6ECF-14DD-44EF-83BA-3D825DCB13D6</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>MDyoqzYa8zB</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mitochondrial cohort</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Prospective data collection of natural history study of hundreds of children with Spinal Muscular Atrophy.</gtr:description><gtr:id>C942E10A-2ACA-4B94-9F82-BE511A03BC93</gtr:id><gtr:impact>Continued growth of database.</gtr:impact><gtr:outcomeId>AjoEBqb183t</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Smart-Net</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Database of CMT patient natural history data in collaboration with the RDCRC housed at Florida, USA.</gtr:description><gtr:id>87040B78-8B43-45C2-B189-B643996DE16D</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>Ax8cT1HN2dx</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CMT studies/Natural History Study database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Natural history data from channelopathy patients</gtr:description><gtr:id>A19BB826-C238-49E1-9D04-2A3A41CB5E95</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>dAkBbdqGeJg</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Channelopathy cohort</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have derived iPSC from a series of DMD patient fibroblast cultures with a disparate set of mutations, some of which could be targeted using AONs.</gtr:description><gtr:id>2C413CA5-20A9-4397-A3EA-4BBFCF8EF360</gtr:id><gtr:impact>Collaborative publications (Dick et al, 2010 and in preparation).</gtr:impact><gtr:outcomeId>qnqVoyCs3h8</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>iPSC cells derived from DMD patients</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>DNA samples from Charcot Marie Tooth patients</gtr:description><gtr:id>8C732B4E-5E0F-4904-BAFE-6DDBBC70784F</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>kLzD39kwiNg</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CMT DNA Bank</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>GM mice bred without c-Jun in Schwann cells</gtr:description><gtr:id>B47F760F-AC5C-413E-BC57-88C9E41B31E1</gtr:id><gtr:impact>This mouse model has enabled us to study transdifferentiation and regeneration in the peripheral nervous system.</gtr:impact><gtr:outcomeId>gzieMphbhUB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>GM mice without c-Jun in Schwann cells</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Prospective data collection for natural history study of hundreds of young adults with Duchenne Muscular Dystrophy; coordination of 18 centres.</gtr:description><gtr:id>52ACEEEC-D93D-43ED-852D-37FC412E8B6B</gtr:id><gtr:impact>Growth of national database.</gtr:impact><gtr:outcomeId>SPGRRpgSykJ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Adult North-Star Database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Established core techniques for behavioural assessment of mouse models of neuromuscular disease e.g.:
Global behaviour
Morphology
Nerve and muscle function
Nerve function
Organ function
Biochemistry
Cellular function
Molecular biolody</gtr:description><gtr:id>E69F719E-60B0-438E-8EBC-E8F11421A3B6</gtr:id><gtr:impact>Publications: PMID 19470612, 18495669, 19913415.</gtr:impact><gtr:outcomeId>Y4sdNyuzCGV</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Standard battery for investigation of animal models of neuromuscular disease</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19470612</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4662EC6E-8351-4E25-8141-CD6DBB62FEFA</gtr:id><gtr:title>C283Y mutation in the gamma-sarcoglycan gene in Greek Gypsies with severe limb girdle muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b21c7c507ea81bb7ffe13185bcf5c85"><gtr:id>7b21c7c507ea81bb7ffe13185bcf5c85</gtr:id><gtr:otherNames>Spengos K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>Do12gyKAzJW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D121237-6010-428A-85DE-6995EEF2A136</gtr:id><gtr:title>Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/378141bd5d0e9dda40dc02234cae0d5b"><gtr:id>378141bd5d0e9dda40dc02234cae0d5b</gtr:id><gtr:otherNames>Bonnen PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_12934_24_23993193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABE3872C-B048-42A1-AE5B-FBD0043C2729</gtr:id><gtr:title>Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e151e15164644c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02DFE93A-41A3-4820-9989-2A7965F5E1F7</gtr:id><gtr:title>Revised normative values for grip strength with the Jamar dynamometer.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9f23628f161ce7bf812289c275c58a7"><gtr:id>d9f23628f161ce7bf812289c275c58a7</gtr:id><gtr:otherNames>Peters MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>b6S7o4J4RYn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2606E130-DE70-4D24-AEEC-7424C45BAE53</gtr:id><gtr:title>POLG2 deficiency causes adult-onset syndromic sensory neuropathy, ataxia and parkinsonism.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/757713170620a18ded8c99a5dab0b0f1"><gtr:id>757713170620a18ded8c99a5dab0b0f1</gtr:id><gtr:otherNames>Van Maldergem L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>585d31501a2e23.45789432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E278583-29AE-4589-A611-E597A88331C0</gtr:id><gtr:title>GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatment.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cbb9749bf7e50639403044c4e70caa6"><gtr:id>9cbb9749bf7e50639403044c4e70caa6</gtr:id><gtr:otherNames>Michell AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>s4gjm3eUCnm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A363A2B5-864E-4775-858A-30E77F1CDA94</gtr:id><gtr:title>A case of necrotizing myopathy with proximal weakness and cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12934_24_22565568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3245AA79-94D8-496E-BD08-74058163A20F</gtr:id><gtr:title>Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdd956acf2cbdc15ced38e5429a2f68c"><gtr:id>fdd956acf2cbdc15ced38e5429a2f68c</gtr:id><gtr:otherNames>Forrest S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>sKsX1nKREWw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79D24E12-5DBD-40E4-96B8-C6439E635983</gtr:id><gtr:title>Sudden Cardiac Death Due to Deficiency of the Mitochondrial Inorganic Pyrophosphatase PPA2.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8649623a6122edf94d131e1380f65892"><gtr:id>8649623a6122edf94d131e1380f65892</gtr:id><gtr:otherNames>Kennedy H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>585d66755ade97.67958234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03D77F21-5299-4CA0-8FFA-1E656348F117</gtr:id><gtr:title>Excitability properties of motor axons in the maturing mouse.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ba4f1b2aba4251c1d3388c3bfec387"><gtr:id>c0ba4f1b2aba4251c1d3388c3bfec387</gtr:id><gtr:otherNames>Bo?rio D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>3D5FD14484C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC20F49F-BC47-434E-B4EF-4D9947B4807A</gtr:id><gtr:title>Impaired mitochondrial function abolishes gamma oscillations in the hippocampus through an effect on fast-spiking interneurons.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e87940e6460d8a108148a5e207bd528"><gtr:id>0e87940e6460d8a108148a5e207bd528</gtr:id><gtr:otherNames>Whittaker RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>agqEpn4gAQU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78CB2743-9FA9-491E-8BF9-B44D614F11FE</gtr:id><gtr:title>Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>ePw8ej4Qpt8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F04A8F3-5205-4FF5-BC71-E11F7BBBB27B</gtr:id><gtr:title>Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28628804526efe2b2fb3f23a2324943e"><gtr:id>28628804526efe2b2fb3f23a2324943e</gtr:id><gtr:otherNames>Kemp JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>hpGgURNy1KP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>739AC20D-7F74-4D07-8C36-ED668C11E47D</gtr:id><gtr:title>How to go about diagnosing and managing the limb-girdle muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Neurology India</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9055555dfa5493524f1a78a42db633"><gtr:id>ff9055555dfa5493524f1a78a42db633</gtr:id><gtr:otherNames>Guglieri M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3886</gtr:issn><gtr:outcomeId>AYqw9UdkY3f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3519B444-FA93-4861-9D4D-D2750328D04A</gtr:id><gtr:title>Attenuation of adverse cardiac effects in prednisolone-treated delta-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f678cf2dad2cd094a26a57da88e6f252"><gtr:id>f678cf2dad2cd094a26a57da88e6f252</gtr:id><gtr:otherNames>Bauer R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>cA5GRiVVznz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA355BF5-DFE8-46D0-A5C6-5E56E27E14A1</gtr:id><gtr:title>Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4de2a860f153838d0613290971dc2033"><gtr:id>4de2a860f153838d0613290971dc2033</gtr:id><gtr:otherNames>Ernst D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>doi_55f98498435a8dc8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A6A242E-A89D-484D-809A-13EF3F046CA2</gtr:id><gtr:title>SEPN1-related myopathies: clinical course in a large cohort of patients.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/002dc518113cfcd49df817b7f8935a46"><gtr:id>002dc518113cfcd49df817b7f8935a46</gtr:id><gtr:otherNames>Scoto M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>gmvRRyPE6ZA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F5F9CC6-4C81-4897-809C-E87AAE331F8B</gtr:id><gtr:title>OPA1 increases the risk of normal but not high tension glaucoma.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>M6zyxcM4FXV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AC21F5A-F9BF-416F-AE5B-0CDD4F848C46</gtr:id><gtr:title>158th ENMC international workshop on congenital muscular dystrophy (Xth international CMD workshop) 8th-10th February 2008 Naarden, The Netherlands.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d12a81c1a41c39038e9286100f8688e7"><gtr:id>d12a81c1a41c39038e9286100f8688e7</gtr:id><gtr:otherNames>Muntoni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>YnamrXVtV5a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17083B5A-4131-4A78-A79D-79A04876C21F</gtr:id><gtr:title>Assessment of the transformation of equine skin-derived fibroblasts to multinucleated skeletal myotubes following lentiviral-induced expression of equine myogenic differentiation 1.</gtr:title><gtr:parentPublicationTitle>American journal of veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88c97d6ebfa4c0932dde8dec53ddcebc"><gtr:id>88c97d6ebfa4c0932dde8dec53ddcebc</gtr:id><gtr:otherNames>Fernandez-Fuente M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9645</gtr:issn><gtr:outcomeId>VMzh8nDhqyz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58D35BEA-D578-42EF-86E3-480F6B9F502B</gtr:id><gtr:title>Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f678cf2dad2cd094a26a57da88e6f252"><gtr:id>f678cf2dad2cd094a26a57da88e6f252</gtr:id><gtr:otherNames>Bauer R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn><gtr:outcomeId>K411Jk59CHm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>751A1513-E90B-47B8-A0CD-8D20E9413404</gtr:id><gtr:title>Investigating the pathology of Emery-Dreifuss muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f5566bd69ae9c218c942f5d42996d30"><gtr:id>8f5566bd69ae9c218c942f5d42996d30</gtr:id><gtr:otherNames>Brown SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>UtpSNzroH9N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20F2C720-7B99-4B44-85B3-4879D24F461A</gtr:id><gtr:title>P93 MRI quantification of abnormal muscle water distribution in chronic neuromuscular diseases: a sensitive biomarker</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fa9fb2b1df9a7bdaf7630cdced7dc64"><gtr:id>9fa9fb2b1df9a7bdaf7630cdced7dc64</gtr:id><gtr:otherNames>Morrow J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>nLcyp3hb1i2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93AE680C-1AF4-42A5-AE24-680D0BA3BBD5</gtr:id><gtr:title>A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4ee0789f9f5930d9f44f57ed3ac8e64"><gtr:id>e4ee0789f9f5930d9f44f57ed3ac8e64</gtr:id><gtr:otherNames>Douglass C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>jmrjw3aimGu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF98EC26-4169-42F3-A382-190BD014C926</gtr:id><gtr:title>Uncoordinated transcription and compromised muscle function in the lmna-null mouse model of Emery- Emery-Dreyfuss muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c458e935294b9a81e76d9b1450594174"><gtr:id>c458e935294b9a81e76d9b1450594174</gtr:id><gtr:otherNames>Gnocchi VF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>foeMeHfqyC8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCB45983-B7D1-4334-B0D6-8DF2152CC436</gtr:id><gtr:title>Mutations in APOPT1, encoding a mitochondrial protein, cause cavitating leukoencephalopathy with cytochrome c oxidase deficiency.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99d8c6ccf94c3c67c4711ae04e433e07"><gtr:id>99d8c6ccf94c3c67c4711ae04e433e07</gtr:id><gtr:otherNames>Melchionda L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5460c9c36b0df6.87855078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4418A5-ECC3-4CC1-A049-44E8CE808622</gtr:id><gtr:title>Extreme-Depth Re-sequencing of Mitochondrial DNA Finds No Evidence of Paternal Transmission in Humans.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>5675e4758ff0c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A10C48BD-9463-4571-885D-95A8F59942CD</gtr:id><gtr:title>Stability and sensitivity of water Tobtained with IDEAL-CPMG in healthy and fat-infiltrated skeletal muscle.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18adbf2f970b6c0f00a18d236074c12d"><gtr:id>18adbf2f970b6c0f00a18d236074c12d</gtr:id><gtr:otherNames>Sinclair CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>5a35e2f7afa6c4.01230660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E8A68FF-9A80-4C36-90D4-9FCADAE7F37E</gtr:id><gtr:title>I(h)-mediated depolarization enhances the temporal precision of neuronal integration.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1dfdefb4f074acaad26adccba29954d"><gtr:id>b1dfdefb4f074acaad26adccba29954d</gtr:id><gtr:otherNames>Pavlov I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>krnumpBjJ1E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13B9DB45-DCBA-49F4-B8AD-E5D610DB2CA1</gtr:id><gtr:title>A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b7f1273a72660918c9c8cbbb04b2699"><gtr:id>2b7f1273a72660918c9c8cbbb04b2699</gtr:id><gtr:otherNames>Mestre TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>58a4551bd0e4c4.84588135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32F1142D-D546-4E83-99AA-E95D521ADE9F</gtr:id><gtr:title>In vivo assessment of muscle membrane properties in the sodium channel myotonias.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63da48f6092092665f886cfef88e3860"><gtr:id>63da48f6092092665f886cfef88e3860</gtr:id><gtr:otherNames>Tan SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>5a2fd5cfa71e71.42471242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BE0C704-C784-4C61-991F-537F3EDDF77E</gtr:id><gtr:title>Behavioral and other phenotypes in a cytoplasmic Dynein light intermediate chain 1 mutant mouse.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b340eec681d243ded9a96296147e0c6"><gtr:id>5b340eec681d243ded9a96296147e0c6</gtr:id><gtr:otherNames>Banks GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>HKE2HUBirA8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FBB7695-A9FB-4F93-A835-973B4AE70266</gtr:id><gtr:title>Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b01a7f0d06f28eeccfe862612551033"><gtr:id>3b01a7f0d06f28eeccfe862612551033</gtr:id><gtr:otherNames>Clarke NF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>Jd1qEE6b57G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6392ECC-739C-41EF-AB2E-109B31B030FE</gtr:id><gtr:title>Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fdd721e3b7dc01a85e725a2d862f396"><gtr:id>9fdd721e3b7dc01a85e725a2d862f396</gtr:id><gtr:otherNames>And?ng M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>RRApzB9GErf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9768EA65-ECA4-4EE7-8D2F-F7712B6CB82B</gtr:id><gtr:title>Roles of mitochondria in human disease.</gtr:title><gtr:parentPublicationTitle>Essays in biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df3b4dffb07770cf05bb699acad8cfc4"><gtr:id>df3b4dffb07770cf05bb699acad8cfc4</gtr:id><gtr:otherNames>Duchen MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0071-1365</gtr:issn><gtr:outcomeId>ZB7dHXn1xmj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4754F1A1-DCDA-46C4-A298-086BD4C0BF41</gtr:id><gtr:title>Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12934_24_22094484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC9F8472-CF54-4B62-8CDB-EFB7A5C6F67E</gtr:id><gtr:title>Conduction block and tonic pupils in Charcot-Marie-Tooth disease caused by a myelin protein zero p.Ile112Thr mutation.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>tQooVgNu6w2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>899EA09A-C9A0-45DC-9D77-D2D451EE3BDA</gtr:id><gtr:title>The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?</gtr:title><gtr:parentPublicationTitle>Health and quality of life outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a0807e96b153ba4e10e38f3a79a301a"><gtr:id>8a0807e96b153ba4e10e38f3a79a301a</gtr:id><gtr:otherNames>Cano SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1477-7525</gtr:issn><gtr:outcomeId>FhYCdYdtCXe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DAA517B-1063-4112-B938-ABE49E7C16B3</gtr:id><gtr:title>The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f950fd99d3923d0e32eb2c63f89184e9"><gtr:id>f950fd99d3923d0e32eb2c63f89184e9</gtr:id><gtr:otherNames>Fratter C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>aCYSHeaGXod</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6EA742D-C4E0-4EBF-9F53-FBA772731484</gtr:id><gtr:title>Defective i6A37 modification of mitochondrial and cytosolic tRNAs results from pathogenic mutations in TRIT1 and its substrate tRNA.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d934800bba4c6d737acf332a3f88b99e"><gtr:id>d934800bba4c6d737acf332a3f88b99e</gtr:id><gtr:otherNames>Yarham JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_540e151e15192c06c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9207E60-B74A-4A91-9083-13829D1D216C</gtr:id><gtr:title>Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75880868018d92d0b7d54e2c82d1b2bc"><gtr:id>75880868018d92d0b7d54e2c82d1b2bc</gtr:id><gtr:otherNames>Liu YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_540e151e1514bd255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>871824AB-8896-432A-96AE-1847F99662C6</gtr:id><gtr:title>Frequency of rare recessive mutations in unexplained late onset cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>5675e4847fbed</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4D9A237-1973-46B5-9FA2-306ABA56F40A</gtr:id><gtr:title>Hyperventilation during the EEG is safe in mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0793e339bc72df33ee6cf3ced77267b"><gtr:id>f0793e339bc72df33ee6cf3ced77267b</gtr:id><gtr:otherNames>Romaniuk L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1388-2457</gtr:issn><gtr:outcomeId>qg2ocFFk17X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FF88A21-3519-4C27-854E-2FE88F39AB92</gtr:id><gtr:title>Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>jx9QRggikEv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B564A92-449C-4CE8-B8F5-C5E095C70616</gtr:id><gtr:title>Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58a4551ceb4a92.15524150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6950CE97-4D65-4FB2-A333-86CE02D045B7</gtr:id><gtr:title>Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/face896ebc409efe4c4822fd442883ac"><gtr:id>face896ebc409efe4c4822fd442883ac</gtr:id><gtr:otherNames>Namavar Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>d7LpXyRxQsn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30C7066D-94A2-46DD-9446-750B86BF33D2</gtr:id><gtr:title>A 'sustain pedal' in the hippocampus?</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f13d4d30c5a901bebc5dc995df7dfd5b"><gtr:id>f13d4d30c5a901bebc5dc995df7dfd5b</gtr:id><gtr:otherNames>Walker MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>qw61SBCdemK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0B78C96-3116-4580-865C-2F6A7A4C4AF5</gtr:id><gtr:title>Multiphoton imaging of the functioning kidney.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebce6cf6481d3699fe4f10fc4e9b01c1"><gtr:id>ebce6cf6481d3699fe4f10fc4e9b01c1</gtr:id><gtr:otherNames>Hall AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>qUHtEU76aP9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E0E08FE-E82B-4552-B9BF-8D129D5F74A1</gtr:id><gtr:title>The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>k25hk5yjK3M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67E7926C-DE2B-4E77-8B5D-B4DB3E3E492F</gtr:id><gtr:title>Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0c3973aad9499627e1876989b0260e7"><gtr:id>c0c3973aad9499627e1876989b0260e7</gtr:id><gtr:otherNames>Bilsland LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>079C7C71CBD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4000677E-333F-4821-AA59-7D09B6F93FAA</gtr:id><gtr:title>Novel missense mutation p.A310P in the GNE gene in autosomal-recessive hereditary inclusion-body myopathy/distal myopathy with rimmed vacuoles in an Italian family.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f790d2c9fedb7818ced26287f0e135d0"><gtr:id>f790d2c9fedb7818ced26287f0e135d0</gtr:id><gtr:otherNames>Stober A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>64C992745F0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E6BB194-DA2F-473F-A314-A4C036A824E8</gtr:id><gtr:title>Interventions for muscular dystrophy: molecular medicines entering the clinic.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>oPX4M6astqM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F873B970-6D6F-4A0F-9E0C-908EEC0E41C7</gtr:id><gtr:title>BAG3 mutations: another cause of giant axonal neuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159c8c7cefbd596fac1d4f5555aa91ee"><gtr:id>159c8c7cefbd596fac1d4f5555aa91ee</gtr:id><gtr:otherNames>Jaffer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_12934_24_22734908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B882C7FF-D0F3-4522-A004-BA63050BD95D</gtr:id><gtr:title>Design principles for bifunctional targeted oligonucleotide enhancers of splicing.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/653339c52c16d8922680985cac4f2592"><gtr:id>653339c52c16d8922680985cac4f2592</gtr:id><gtr:otherNames>Owen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>GfLBMPjLQTu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D101B7CD-4B27-4B14-A028-94F5921F944B</gtr:id><gtr:title>Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3bc1e6261a073e8c97bb04481b8202a"><gtr:id>a3bc1e6261a073e8c97bb04481b8202a</gtr:id><gtr:otherNames>Taylor RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_540e151e1519d8057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AD5EC33-FC20-438D-92B2-0EE81BC80999</gtr:id><gtr:title>Congenital myasthenic syndromes in childhood: diagnostic and management challenges.</gtr:title><gtr:parentPublicationTitle>Journal of neuroimmunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4345298aa80f7aab384e189cb31b897"><gtr:id>f4345298aa80f7aab384e189cb31b897</gtr:id><gtr:otherNames>Kinali M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0165-5728</gtr:issn><gtr:outcomeId>j6aYNBTURFp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54404C74-6839-44B3-A09E-8F94D3959033</gtr:id><gtr:title>Daily salbutamol in young patients with SMA type II.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a07700458597bb17074c545f65ae73a"><gtr:id>9a07700458597bb17074c545f65ae73a</gtr:id><gtr:otherNames>Pane M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>RHaSNCPupxK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43B24010-4843-402B-9681-BF9D3A69C2DB</gtr:id><gtr:title>Enhanced excitation-coupled Ca(2+) entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd1a5f7ac289c3b81d1201ad7793dcd"><gtr:id>bbd1a5f7ac289c3b81d1201ad7793dcd</gtr:id><gtr:otherNames>Treves S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>s45eiH9NgjG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FE17995-35DB-44BC-9823-B6EB21545D97</gtr:id><gtr:title>Respiratory management of congenital myasthenic syndromes in childhood: Workshop 8th December 2009, UCL Institute of Neurology, London, UK.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1dbe5873652bd62ed0c8c7c781a347"><gtr:id>3c1dbe5873652bd62ed0c8c7c781a347</gtr:id><gtr:otherNames>Robb SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>cufruKkEQGk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A3947CB-218F-41A5-9D85-6C5222C1A057</gtr:id><gtr:title>166th ENMC International Workshop on Collagen type VI-related Myopathies, 22-24 May 2009, Naarden, The Netherlands.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f9794626372cba4e99e29be48340afc"><gtr:id>8f9794626372cba4e99e29be48340afc</gtr:id><gtr:otherNames>Allamand V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>PrmtMzKNUWg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4828B018-BC0F-421A-AD44-EFD19AE8A93F</gtr:id><gtr:title>Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>5a2fd5a29c7e78.25903341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAB48061-DC2F-42D4-9E77-D2FC47C9DCE9</gtr:id><gtr:title>Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e8bd4bdcad951e2a1cb090ab772f4b2"><gtr:id>9e8bd4bdcad951e2a1cb090ab772f4b2</gtr:id><gtr:otherNames>Pareyson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>swRxRznUVSr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D08B6735-3F38-452F-A223-E9BEC15C1321</gtr:id><gtr:title>Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/694f8cf95736b2802883926f906e6121"><gtr:id>694f8cf95736b2802883926f906e6121</gtr:id><gtr:otherNames>Stewart JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>hPP4Gq1a9cQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0A11B8E-8464-42E9-8D8D-CA54A3F34A53</gtr:id><gtr:title>Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594e37aab06f2613027f9a2e38d388c1"><gtr:id>594e37aab06f2613027f9a2e38d388c1</gtr:id><gtr:otherNames>Arbogast S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>dHjt4bvWgy4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>279A1774-37BC-41F6-A15A-C047443F23F4</gtr:id><gtr:title>Mitochondrial DNA sequence characteristics modulate the size of the genetic bottleneck.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99fcf07122666dd23e6cca7816fda75"><gtr:id>d99fcf07122666dd23e6cca7816fda75</gtr:id><gtr:otherNames>Wilson IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56c313ce097563.37577189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8133A185-4256-4CBA-B4C6-7C8A5CEFF5CA</gtr:id><gtr:title>Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dac81a37ee1b309119650fc33449ba80"><gtr:id>dac81a37ee1b309119650fc33449ba80</gtr:id><gtr:otherNames>Straub V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1878-7479</gtr:issn><gtr:outcomeId>KmVDW8Vsekm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41B83122-9395-4B42-BEE2-5565D6677FBD</gtr:id><gtr:title>RYR1 mutations are a common cause of congenital myopathies with central nuclei.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45127c22733a7131c6676eb173e87543"><gtr:id>45127c22733a7131c6676eb173e87543</gtr:id><gtr:otherNames>Wilmshurst JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>JzXthz5GcCz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AD463F5-8DC0-4640-836A-CB52F9A71177</gtr:id><gtr:title>Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd004fe7995fd24fab161f71a958a5af"><gtr:id>cd004fe7995fd24fab161f71a958a5af</gtr:id><gtr:otherNames>Gilbert GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>HL3N976Vd6X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC2850CB-4661-4360-A8A6-FD5209A1E4E8</gtr:id><gtr:title>Modifying the Medical Research Council grading system through Rasch analyses.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12cffd5a1b1a9a5423d7304520481af6"><gtr:id>12cffd5a1b1a9a5423d7304520481af6</gtr:id><gtr:otherNames>Vanhoutte EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12934_24_22189568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2D204C2-78F0-4C92-AE03-1AC3B38AD2EC</gtr:id><gtr:title>Quantitative magnetization transfer in in vivo healthy human skeletal muscle at 3 T.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18adbf2f970b6c0f00a18d236074c12d"><gtr:id>18adbf2f970b6c0f00a18d236074c12d</gtr:id><gtr:otherNames>Sinclair CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>H1MHaznBaF7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>351CD3B4-75C4-4371-8C3B-99DA773F648A</gtr:id><gtr:title>Mitochondrial DNA and disease.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>cp5mYAic78Z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9F246FA-190C-4435-B556-D63BB4DE0F5D</gtr:id><gtr:title>Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2b1c654f3f7c681d5144537db29b9b9"><gtr:id>c2b1c654f3f7c681d5144537db29b9b9</gtr:id><gtr:otherNames>Odgerel Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>htvvnk9yTne</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02395D93-95B9-434B-902D-FF71B06AED6D</gtr:id><gtr:title>Pathogenic mitochondrial mt-tRNA(Ala) variants are uniquely associated with isolated myopathy.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce0a0e0400ee574b2ff1f4f75d7e293"><gtr:id>1ce0a0e0400ee574b2ff1f4f75d7e293</gtr:id><gtr:otherNames>Lehmann D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>56c3232dd6da71.54117427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91632CFC-D8DF-49A9-8A3E-999D3B8B0325</gtr:id><gtr:title>KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d631037f5320d11a281f3a0b1b2d319"><gtr:id>5d631037f5320d11a281f3a0b1b2d319</gtr:id><gtr:otherNames>Rivi?re JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>SZKFm5FLd7L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD3FDF7D-71B3-4ADA-BA2D-2AB625369911</gtr:id><gtr:title>Collaborating to bring new therapies to the patient--the TREAT-NMD model.</gtr:title><gtr:parentPublicationTitle>Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1128-2460</gtr:issn><gtr:outcomeId>WkaF4MND4EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1ADC9BF-37E7-46BF-9F8B-44F866BBE69F</gtr:id><gtr:title>Mitochondria and cortical gamma oscillations: food for thought?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62432ff96e016de65fc113e394792328"><gtr:id>62432ff96e016de65fc113e394792328</gtr:id><gtr:otherNames>Cunningham MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>QwjDHcp6yFe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5145E254-AB11-48AD-BC04-5289624ECBA5</gtr:id><gtr:title>The m.5650G&amp;gt;A mitochondrial tRNAAla mutation is pathogenic and causes a phenotype of pure myopathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aceeebe176b2a13722db7069cd6fe796"><gtr:id>aceeebe176b2a13722db7069cd6fe796</gtr:id><gtr:otherNames>McFarland R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>Ay1CDqVz4eL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9ED39084-243F-42F5-B805-E1D92D446B70</gtr:id><gtr:title>Targeted next-generation sequencing of a 12.5 Mb homozygous region reveals ANO10 mutations in patients with autosomal-recessive cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb3aeff777d9f893ba2221a1dc254fb"><gtr:id>5bb3aeff777d9f893ba2221a1dc254fb</gtr:id><gtr:otherNames>Vermeer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>f35vTkV7RUo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1678BCE1-0A1B-462F-98B7-1E6F4E5F783B</gtr:id><gtr:title>157th ENMC International Workshop: patient registries for rare, inherited muscular disorders 25-27 January 2008 Naarden, The Netherlands.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f800e74a5990b1ef29862940fb3058e7"><gtr:id>f800e74a5990b1ef29862940fb3058e7</gtr:id><gtr:otherNames>S?rk?zy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>XUzimZkvRDa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F529A030-8125-46DF-8238-1D79895CD075</gtr:id><gtr:title>Upregulation of PKD1L2 provokes a complex neuromuscular disease in the mouse.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22531b9cd6444b8fbcae32050fb34a54"><gtr:id>22531b9cd6444b8fbcae32050fb34a54</gtr:id><gtr:otherNames>Mackenzie FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>E4FFBEC0A6F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E44E6DB-B48C-465D-AD9F-66E0AFA584D2</gtr:id><gtr:title>Consensus statement on standard of care for congenital muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Journal of child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa93aa452bfcd1b752d72dd489b66ab5"><gtr:id>aa93aa452bfcd1b752d72dd489b66ab5</gtr:id><gtr:otherNames>Wang CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0883-0738</gtr:issn><gtr:outcomeId>qVWTiEE7WWW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC6EABCD-8D81-4E1A-9D67-C56468F10EB0</gtr:id><gtr:title>Simultaneous T2 and lipid quantitation using IDEAL-CPMG.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf62af8fb7d57de44b4fa22da6ffb775"><gtr:id>bf62af8fb7d57de44b4fa22da6ffb775</gtr:id><gtr:otherNames>Janiczek RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>qPhKxMs5wGc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87EB81AE-F057-46FC-AF58-8F65C61753C0</gtr:id><gtr:title>Exome sequencing in undiagnosed inherited and sporadic ataxias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f9849843de5f9b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA48E02F-B86C-4224-9960-CF074C5EDB93</gtr:id><gtr:title>Infantile onset myofibrillar myopathy due to recessive CRYAB mutations.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/998164dc30c4abebdef572553f213880"><gtr:id>998164dc30c4abebdef572553f213880</gtr:id><gtr:otherNames>Forrest KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>BXKdWDpUfJ7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1E36A66-8840-47FC-A9EE-2B148A9CD72E</gtr:id><gtr:title>The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7ec87e85c3fbb76e8aa5998f77b9fce"><gtr:id>c7ec87e85c3fbb76e8aa5998f77b9fce</gtr:id><gtr:otherNames>Besse A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>doi_55f984984389db60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>860523F2-5778-4C82-80B8-D88842EF6A09</gtr:id><gtr:title>Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea6cf7f32ce5138c0346fdb7615e95bc"><gtr:id>ea6cf7f32ce5138c0346fdb7615e95bc</gtr:id><gtr:otherNames>Polke JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>fEZh3qAQdVU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C67440BD-2FC0-494E-B267-BE928EC42A97</gtr:id><gtr:title>The respiratory management of patients with duchenne muscular dystrophy: a DMD care considerations working group specialty article.</gtr:title><gtr:parentPublicationTitle>Pediatric pulmonology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8c5e955419e6abc90f5e0955d985d06"><gtr:id>b8c5e955419e6abc90f5e0955d985d06</gtr:id><gtr:otherNames>Birnkrant DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1099-0496</gtr:issn><gtr:outcomeId>YZnwTF8Uh3g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49EB8028-E25F-45D6-9B19-92BDB835919F</gtr:id><gtr:title>Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4d22202c99dba94354fdaf35fbc8d2b"><gtr:id>e4d22202c99dba94354fdaf35fbc8d2b</gtr:id><gtr:otherNames>Schessl J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>TZWueT78qog</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>121B6375-6AEF-4E2E-BE1E-812520D7501A</gtr:id><gtr:title>Clinical and pathological features of mitochondrial DNA deletion disease following antiretroviral treatment.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d5d618d31b1d170b90a2083007ae6c"><gtr:id>45d5d618d31b1d170b90a2083007ae6c</gtr:id><gtr:otherNames>Payne BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5675e430b48aa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B5AB3CC-06E3-4068-B04C-DCB2AA70FFAD</gtr:id><gtr:title>The endocannabinoid system in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0c3973aad9499627e1876989b0260e7"><gtr:id>c0c3973aad9499627e1876989b0260e7</gtr:id><gtr:otherNames>Bilsland LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>AFB74180B28</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D31B1BFC-DA18-4B26-9144-8355161632F7</gtr:id><gtr:title>De novo LMNA mutations cause a new form of congenital muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c89f747c976c795c585a3c85ea199"><gtr:id>697c89f747c976c795c585a3c85ea199</gtr:id><gtr:otherNames>Quijano-Roy S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>fhJZXRk5GVM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>254542E7-2B03-4F00-8676-48ABC1226BAD</gtr:id><gtr:title>Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fd3070e6d0ccb572d62a0bce33c62c4"><gtr:id>1fd3070e6d0ccb572d62a0bce33c62c4</gtr:id><gtr:otherNames>Schinkel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>pm_12934_24_22248393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2900C89F-F366-49E8-B83F-26FC59912E58</gtr:id><gtr:title>Channeling into the epilepsies.</gtr:title><gtr:parentPublicationTitle>Epilepsy currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1535-7511</gtr:issn><gtr:outcomeId>BXdhx6XbNpb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33C51B7B-9F86-46EA-98F8-3D48656C79E1</gtr:id><gtr:title>MRI shows increased sciatic nerve cross sectional area in inherited and inflammatory neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18adbf2f970b6c0f00a18d236074c12d"><gtr:id>18adbf2f970b6c0f00a18d236074c12d</gtr:id><gtr:otherNames>Sinclair CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>7955104E53D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5263FACB-7B58-4089-80CD-67891991B112</gtr:id><gtr:title>Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b20e3f5b91e8ee2bb487514c42ad91b"><gtr:id>1b20e3f5b91e8ee2bb487514c42ad91b</gtr:id><gtr:otherNames>Mihaylova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>613CD3DC2A8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A654DE17-AEB1-4D3A-988B-6D783638D24E</gtr:id><gtr:title>An observational study of asymmetry in CMT1A.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f0140cb8c5db66be0ae0e063f979b79"><gtr:id>5f0140cb8c5db66be0ae0e063f979b79</gtr:id><gtr:otherNames>Pelayo-Negro AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>585d595735c716.38320216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94ADD074-2B6D-48F6-9D1B-A9B14706C5A2</gtr:id><gtr:title>Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7d7dab9bcd362c812ec7147699561da"><gtr:id>d7d7dab9bcd362c812ec7147699561da</gtr:id><gtr:otherNames>Klein A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>KCvSeevQ1cA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6A03AC7-5036-46A5-9B4A-28258360E3F4</gtr:id><gtr:title>Perinatal dyskinesia as a presenting feature in Prader Willi syndrome.</gtr:title><gtr:parentPublicationTitle>European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/415013c73ed6adb2c33667ccbdd1ffda"><gtr:id>415013c73ed6adb2c33667ccbdd1ffda</gtr:id><gtr:otherNames>McSweeney N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1090-3798</gtr:issn><gtr:outcomeId>obWDLp4TJ6S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38F21118-F5AD-4212-8B44-D37F8E75357A</gtr:id><gtr:title>Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c4ec378124cc54f1c5190a52450e068"><gtr:id>4c4ec378124cc54f1c5190a52450e068</gtr:id><gtr:otherNames>Mirsky R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>FJZLPBw6LQo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE002948-EBE1-4097-87F8-D1B277B69C64</gtr:id><gtr:title>Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2596d3af9c0ecb02e3af1d191bf271ea"><gtr:id>2596d3af9c0ecb02e3af1d191bf271ea</gtr:id><gtr:otherNames>Gegg ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>EDS3UAV2DDC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB8349D0-E188-4089-9A92-9C7F7E84C489</gtr:id><gtr:title>Episodic Ataxia Type 1: Characterization of the Disease and Its Effect on Quality of Life (S12.005)</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1994ebc8696849581b1d4a0935232bd4"><gtr:id>1994ebc8696849581b1d4a0935232bd4</gtr:id><gtr:otherNames>Graves T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>p8bcG62Tf8R</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAF7D0C3-2E80-4726-BDE9-5CEF69EE8B56</gtr:id><gtr:title>A thorough assessment of benign genetic variability in GRN and MAPT.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f54cad0ab0877e543fc660186cd44ff0"><gtr:id>f54cad0ab0877e543fc660186cd44ff0</gtr:id><gtr:otherNames>Guerreiro RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>WxYju4ADk9b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>242B2A71-5C3E-4403-A8A9-3A76A1C14E37</gtr:id><gtr:title>Peripheral nerve damage associated with administration of taxanes in patients with cancer.</gtr:title><gtr:parentPublicationTitle>Critical reviews in oncology/hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4053e0d90ab1065255c670d4253de9e"><gtr:id>d4053e0d90ab1065255c670d4253de9e</gtr:id><gtr:otherNames>Argyriou AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1040-8428</gtr:issn><gtr:outcomeId>YG8ePUHmW8g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9180B2FB-FF76-4015-A38C-E9762F36E4F5</gtr:id><gtr:title>A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament &amp;quot;hook&amp;quot; effect.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe424690789fe3b498adf4ad55c8999b"><gtr:id>fe424690789fe3b498adf4ad55c8999b</gtr:id><gtr:otherNames>Lu CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>gZd6D2dWtX9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F850EB1-DE59-451C-A153-A170AABB7880</gtr:id><gtr:title>Human ataxias: a genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signaling.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7fccc55a62cf97212e1cfed26905242"><gtr:id>f7fccc55a62cf97212e1cfed26905242</gtr:id><gtr:otherNames>Schorge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>Rh2wtEQiUD5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5B64A3C-A6ED-48B5-A314-31566B7F27BE</gtr:id><gtr:title>Alternative splicing modulates inactivation of type 1 voltage-gated sodium channels by toggling an amino acid in the first S3-S4 linker.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2748097c5a93b216cbf5bf41ebdbb3ad"><gtr:id>2748097c5a93b216cbf5bf41ebdbb3ad</gtr:id><gtr:otherNames>Fletcher EV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>DFPNd9uLEwU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5827E3E2-A584-4F87-A3C9-64DAD8088011</gtr:id><gtr:title>Mitochondrial DNA mutations in ageing and disease: implications for HIV?</gtr:title><gtr:parentPublicationTitle>Antiviral therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d5d618d31b1d170b90a2083007ae6c"><gtr:id>45d5d618d31b1d170b90a2083007ae6c</gtr:id><gtr:otherNames>Payne BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-6535</gtr:issn><gtr:outcomeId>5458bda565d096.53964783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A675E94-DACD-4B04-A135-2EB712F0075E</gtr:id><gtr:title>Resistance training in patients with single, large-scale deletions of mitochondrial DNA.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9577563548c626dd95be27b3f1f57c9"><gtr:id>d9577563548c626dd95be27b3f1f57c9</gtr:id><gtr:otherNames>Murphy JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>HuiaDYk2Kc4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD7BC215-718D-4C62-8D12-C68F9018B8CE</gtr:id><gtr:title>Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baf93ecbab15b08ce52d70b1af9453dc"><gtr:id>baf93ecbab15b08ce52d70b1af9453dc</gtr:id><gtr:otherNames>Cirak S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>CX3E7tqs1qQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7DD50DD-3726-4C65-933A-FD586EFAEE14</gtr:id><gtr:title>Neurological picture. Spontaneous intracranial hypotension, hygromata and haematomata.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f59a922685f5199fdfb53d3100807996"><gtr:id>f59a922685f5199fdfb53d3100807996</gtr:id><gtr:otherNames>Healy DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>qg8cx2ZZfA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>266F7DB0-9461-47CD-B6B9-E9F4F1A706FF</gtr:id><gtr:title>A national perspective on prenatal testing for mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f5a64e763cce75d1f562606ee76e5bc"><gtr:id>7f5a64e763cce75d1f562606ee76e5bc</gtr:id><gtr:otherNames>Nesbitt V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>5460c33d22dc04.45858672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>721614E1-B637-49B1-BCA7-1ECED1DF2E7F</gtr:id><gtr:title>Habitual physical activity in mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12a5ca78b73495d62019f91594d56fa7"><gtr:id>12a5ca78b73495d62019f91594d56fa7</gtr:id><gtr:otherNames>Apabhai S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>f6zoJ6ZBxqD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A15FFFE2-F769-4FEA-9308-F28C78EA1AD4</gtr:id><gtr:title>Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cda1ffcc0400f51ae27e4b53b1fad06"><gtr:id>5cda1ffcc0400f51ae27e4b53b1fad06</gtr:id><gtr:otherNames>Harms MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12934_24_22459677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F577980F-F793-4642-B1F1-8247AC0EEC76</gtr:id><gtr:title>Interrater reliability and aspects of validity of the myositis damage index.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9668a367c055f13453b225c8562ab8d3"><gtr:id>9668a367c055f13453b225c8562ab8d3</gtr:id><gtr:otherNames>Sultan SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>pyNXfRuvLTb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D197CC18-0339-4287-B822-5AE287D23C16</gtr:id><gtr:title>A critical analysis of the combined usage of protein localization prediction methods: Increasing the number of independent data sets can reduce the accuracy of predicted mitochondrial localization.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5017c785efa7206a7f3f1e637c1afe0e"><gtr:id>5017c785efa7206a7f3f1e637c1afe0e</gtr:id><gtr:otherNames>Lythgow KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>aBtmE2Gfxv1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1365476-89B0-4D6D-9F39-0D030432FCF7</gtr:id><gtr:title>Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2ea971f41f8b71d54e54576d18e6ea4"><gtr:id>c2ea971f41f8b71d54e54576d18e6ea4</gtr:id><gtr:otherNames>Lee HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>XcNrrdUSkWj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B5CE2B3-B71D-48DF-9173-DFC8DF7B1AFF</gtr:id><gtr:title>Single deletions in mitochondrial DNA--molecular mechanisms and disease phenotypes in clinical practice.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>BQgHGFMoh1r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C51E0075-C47D-4298-82C0-A91C429DE498</gtr:id><gtr:title>Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>mNzQB4qzwrr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>368E912A-3E09-46C9-864B-8123E9330661</gtr:id><gtr:title>A practical approach to the genetic neuropathies.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>5675e2efba694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF75766A-BE5C-48B5-BCDA-BCB07055B38E</gtr:id><gtr:title>Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d6cd3c48df4ba250f8982f7b132101"><gtr:id>35d6cd3c48df4ba250f8982f7b132101</gtr:id><gtr:otherNames>Zimon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>duUJ4dzFv4K</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CE89D92-D9EE-4AF5-8BF8-F8AEA80A1E65</gtr:id><gtr:title>Mitochondrial dysfunction in aging: Much progress but many unresolved questions.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d5d618d31b1d170b90a2083007ae6c"><gtr:id>45d5d618d31b1d170b90a2083007ae6c</gtr:id><gtr:otherNames>Payne BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5675e603721d6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3044027F-833D-4221-997E-684581C042A9</gtr:id><gtr:title>Dose of dialysis based on body surface area is markedly less in younger children than in older adolescents.</gtr:title><gtr:parentPublicationTitle>Clinical journal of the American Society of Nephrology : CJASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efbebf974a31599a324aecc458feda42"><gtr:id>efbebf974a31599a324aecc458feda42</gtr:id><gtr:otherNames>Daugirdas JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1555-9041</gtr:issn><gtr:outcomeId>mjduaqLXoE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD37ED45-966A-40E0-B05C-07EF4D3418A7</gtr:id><gtr:title>The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/426814ae3d00276b2973974ab4eff106"><gtr:id>426814ae3d00276b2973974ab4eff106</gtr:id><gtr:otherNames>Reilich P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>FCLyfCV4Zdw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2325C138-3246-4ACC-A189-97C0B06A6980</gtr:id><gtr:title>173rd ENMC International Workshop: congenital muscular dystrophy outcome measures 5-7 March 2010, Naarden, The Netherlands.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c908c95680291cd2f6373931cd8bb337"><gtr:id>c908c95680291cd2f6373931cd8bb337</gtr:id><gtr:otherNames>B?nnemann CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>XTTdhngjmjV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF546D85-F4B6-46EA-ADD4-9BFC1ED2F553</gtr:id><gtr:title>Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ccd588457e2b396fae242688b972e96"><gtr:id>6ccd588457e2b396fae242688b972e96</gtr:id><gtr:otherNames>Hicks D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>ti88mqqYU9L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89DF6E76-9760-411C-8C69-2CB3FE6BB1CC</gtr:id><gtr:title>Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15009db960c68ecf31a441f546b1971d"><gtr:id>15009db960c68ecf31a441f546b1971d</gtr:id><gtr:otherNames>Thornhill P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>gV1HUAiYNxx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87461BF3-DD9B-48B3-8914-5856EB48571A</gtr:id><gtr:title>LTP and LTD in cortical GABAergic interneurons: emerging rules and roles.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>QvRkCPgts7f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4F2A40-D6E2-4338-8424-74636D19DE46</gtr:id><gtr:title>The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>HqSeDkbEEFB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F986217-8585-4958-8561-1D2F5576F23A</gtr:id><gtr:title>Maternal diet-induced obesity alters mitochondrial activity and redox status in mouse oocytes and zygotes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/340c874fc32cc04f0cae97a522cccd62"><gtr:id>340c874fc32cc04f0cae97a522cccd62</gtr:id><gtr:otherNames>Igosheva N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Wvsb4seexdG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FA3678D-66C9-4332-9ADB-2E15FAAF2E6C</gtr:id><gtr:title>Guidelines for preclinical animal research in ALS/MND: A consensus meeting.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73e47fb5b8a356fda565e40bc411804c"><gtr:id>73e47fb5b8a356fda565e40bc411804c</gtr:id><gtr:otherNames>Ludolph AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>5C48682CD89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20888A59-F6B5-4392-8CA1-74801EF31613</gtr:id><gtr:title>Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51fb847e6a36c4c4664cccb152cf38ba"><gtr:id>51fb847e6a36c4c4664cccb152cf38ba</gtr:id><gtr:otherNames>Kalmar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>9EC9B630E28</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F216A5F-F512-439A-A6F2-68B8468879C9</gtr:id><gtr:title>Mouse schwann cells need both NRG1 and cyclic AMP to myelinate.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f93ef8f37653debc9c8cbdb6c3c430f8"><gtr:id>f93ef8f37653debc9c8cbdb6c3c430f8</gtr:id><gtr:otherNames>Arthur-Farraj P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>orho7vyuKDo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E6ECB83-EA3D-42AF-8E65-A9E3C61EFD6D</gtr:id><gtr:title>Deficits in axonal transport precede ALS symptoms in vivo.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0c3973aad9499627e1876989b0260e7"><gtr:id>c0c3973aad9499627e1876989b0260e7</gtr:id><gtr:otherNames>Bilsland LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>YN6BenBzaye</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DF103D0-80F5-45E7-A834-201225B58106</gtr:id><gtr:title>Stem cells to treat muscular dystrophies - where are we?</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84e3707839d90302345838b73f672b7"><gtr:id>e84e3707839d90302345838b73f672b7</gtr:id><gtr:otherNames>Meng J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>MeuPZpsW2xu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22649DAE-2399-4EEE-BD0E-1F6DC9CBFD5B</gtr:id><gtr:title>Neuromuscular disorders and 2010: recent advances.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3594f340e4a1627490ba4eeba3e02389"><gtr:id>3594f340e4a1627490ba4eeba3e02389</gtr:id><gtr:otherNames>Sarkozy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>jDgmmnbXECY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD0C6103-2596-4570-A4C3-986A35D715BC</gtr:id><gtr:title>Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2c84b8517fcf40edbdb86bb7a02bba1"><gtr:id>a2c84b8517fcf40edbdb86bb7a02bba1</gtr:id><gtr:otherNames>Huang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>Dpn51PokFuN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FE14707-D6CC-4377-B1F9-2AA0692C571C</gtr:id><gtr:title>Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>Z4hGFrqDcdn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90E5F231-FED6-498A-8D17-D14C3C121540</gtr:id><gtr:title>NEFL-related Charcot-Marie-tooth disease: an unraveling story.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4732af7ef6ff3beb803fd47a10bc7e3f"><gtr:id>4732af7ef6ff3beb803fd47a10bc7e3f</gtr:id><gtr:otherNames>Reilly MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>NBGQ6xxRpdX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66F2A960-0685-44DC-9A01-20FDD79A6A22</gtr:id><gtr:title>Mutation in FAM134B causing severe hereditary sensory neuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>BDX2K1cmNJV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>880D92EC-9F26-4BDD-BF1F-0EC46834CCE8</gtr:id><gtr:title>Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b340eec681d243ded9a96296147e0c6"><gtr:id>5b340eec681d243ded9a96296147e0c6</gtr:id><gtr:otherNames>Banks GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5596A669DEC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A0E1ACB-F475-4F92-BFA0-5E71AB331237</gtr:id><gtr:title>Novel missense mutation in charged multivesicular body protein 2B in a patient with frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Alzheimer disease and associated disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0893-0341</gtr:issn><gtr:outcomeId>ev9DrPyrDrJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6604257-265A-4CDE-8397-F93D751B0F58</gtr:id><gtr:title>Reproducibility, and age, body-weight and gender dependency of candidate skeletal muscle MRI outcome measures in healthy volunteers.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81487feecd00f449b4f5dac70d19f178"><gtr:id>81487feecd00f449b4f5dac70d19f178</gtr:id><gtr:otherNames>Morrow JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>pm_540e151e1516f2f9f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>848ED3B4-5E86-4109-AAA6-93C9A763E457</gtr:id><gtr:title>Candidate screening of the TRPC3 gene in cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f34af4d2e8574f0b217df6dd39dd652"><gtr:id>3f34af4d2e8574f0b217df6dd39dd652</gtr:id><gtr:otherNames>Becker EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>G5P4DU9Nmsa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>397C072A-7603-4ADF-9D8B-D761218F8697</gtr:id><gtr:title>Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89783a5fcb17bacf0fca3ef2fd51289d"><gtr:id>89783a5fcb17bacf0fca3ef2fd51289d</gtr:id><gtr:otherNames>Boldrin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>s5W53AjJdZT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>296977B6-F0D2-460C-AB54-57AA3FB87490</gtr:id><gtr:title>Mitochondrial Causes of Epilepsy: Evaluation, Diagnosis, and Treatment.</gtr:title><gtr:parentPublicationTitle>Seminars in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a619845b5cc71248eec5a3b2a35994cb"><gtr:id>a619845b5cc71248eec5a3b2a35994cb</gtr:id><gtr:otherNames>Steele HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-8235</gtr:issn><gtr:outcomeId>5675e6374e495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFFBED41-FCD6-4A2C-A752-F8B6E3C40384</gtr:id><gtr:title>Fukutin-related protein alters the deposition of laminin in the eye and brain.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37d446106b9e0c96a9a817a5bd2c77d7"><gtr:id>37d446106b9e0c96a9a817a5bd2c77d7</gtr:id><gtr:otherNames>Ackroyd MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>oHA64VwnBpP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ABA9A85-B7FB-46BE-940F-15413660FF1A</gtr:id><gtr:title>Diagnosis and new treatment in muscle channelopathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a9f60a4f55c55b41eef3570b7eacea6"><gtr:id>3a9f60a4f55c55b41eef3570b7eacea6</gtr:id><gtr:otherNames>Meola G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>tbLkZdynAVK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39B06D7F-408F-4126-9493-4AE769DAD2B2</gtr:id><gtr:title>Localization and subcellular distribution of prolyl oligopeptidase in the mouse placenta.</gtr:title><gtr:parentPublicationTitle>Journal of molecular histology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/457e1ec108eb5f8a9a95b905dcf97b0c"><gtr:id>457e1ec108eb5f8a9a95b905dcf97b0c</gtr:id><gtr:otherNames>Matsubara S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1567-2379</gtr:issn><gtr:outcomeId>ZAD1SXri5qL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D825DF6-CA18-4FF9-8A83-9FDF668CEC20</gtr:id><gtr:title>Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51b5a4ac4301cb06c0c4aca329635896"><gtr:id>51b5a4ac4301cb06c0c4aca329635896</gtr:id><gtr:otherNames>Abeti R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>o4CNvNRmunG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ADA78F3-B53A-4A22-9452-B6297FF6F99C</gtr:id><gtr:title>Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycan-deficient mouse model for dilated cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f678cf2dad2cd094a26a57da88e6f252"><gtr:id>f678cf2dad2cd094a26a57da88e6f252</gtr:id><gtr:otherNames>Bauer R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>MJndXX1Lw3K</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>294D0042-FFFD-488B-B125-EC2CB1F24F66</gtr:id><gtr:title>Aggressive CNS lupus vasculitis in the absence of systemic disease activity.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a2120c0ff4a9d24112d293975ce431d"><gtr:id>5a2120c0ff4a9d24112d293975ce431d</gtr:id><gtr:otherNames>Everett CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>TZopCvwrpk7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>942F9EAD-5EF7-4DA9-AF59-8C275B26E8FB</gtr:id><gtr:title>Excitability properties of mouse motor axons in the mutant SOD1(G93A) model of amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ba4f1b2aba4251c1d3388c3bfec387"><gtr:id>c0ba4f1b2aba4251c1d3388c3bfec387</gtr:id><gtr:otherNames>Bo?rio D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>159B9BCF49E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9799C76-087B-4196-BA29-E75015F87D9A</gtr:id><gtr:title>Neuropathy in a human without the PMP22 gene.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d9688a8fadf7d02556545a5638eb428"><gtr:id>4d9688a8fadf7d02556545a5638eb428</gtr:id><gtr:otherNames>Saporta MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>XGcpGvcwJAv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>979A266A-7B85-422A-94E6-ACD9CF492994</gtr:id><gtr:title>Mitochondrial myopathies: developments in treatment.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17c4bf40a30c5caae9a86eb4cdafa86d"><gtr:id>17c4bf40a30c5caae9a86eb4cdafa86d</gtr:id><gtr:otherNames>Hassani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>PMwcoeVfFvg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA223A10-F440-4F8B-A440-6AFF704769BC</gtr:id><gtr:title>Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>jePNA4toj4E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77AB4C43-43B5-4DF1-BA58-A66F97FD0888</gtr:id><gtr:title>Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/530590beeddef08f0b21d586fd53b853"><gtr:id>530590beeddef08f0b21d586fd53b853</gtr:id><gtr:otherNames>Floyd BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>585d667b71f622.79936000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CEE9410-BEB9-4A8A-9591-AD7208580815</gtr:id><gtr:title>Lifeline. An interview of Kate Bushby.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>ErvN3SZddrY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14C6B35E-9EC0-41DB-A26E-11DD6C1487A7</gtr:id><gtr:title>Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/631e7e221a0beb9853f27bcc706f1ea9"><gtr:id>631e7e221a0beb9853f27bcc706f1ea9</gtr:id><gtr:otherNames>Cantley J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>hwK2S18fhwu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BF78A32-3E39-4E16-81F0-82033790A145</gtr:id><gtr:title>Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5102bb3f1793a25975bc5ab48754ce24"><gtr:id>5102bb3f1793a25975bc5ab48754ce24</gtr:id><gtr:otherNames>Sejerson T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>La6VPLuLSzo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51120469-2186-4FE7-A980-E890881AEA38</gtr:id><gtr:title>A painful right leg.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5320bba7f2766a860341f917c99dc58"><gtr:id>b5320bba7f2766a860341f917c99dc58</gtr:id><gtr:otherNames>Smith LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>SSEqfHwGju4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0ACB1C3-400D-4F8E-ADD4-CA799786E034</gtr:id><gtr:title>Evidence of severe mitochondrial oxidative stress and a protective effect of low oxygen in mouse models of inherited photoreceptor degeneration.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6834a729dc1a104204ce07b0daf736f6"><gtr:id>6834a729dc1a104204ce07b0daf736f6</gtr:id><gtr:otherNames>Vlachantoni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pCHmTU1qmqN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53DF5D0A-3423-40A0-941F-CCDA16C589E7</gtr:id><gtr:title>Siblings of young people with Duchenne muscular dystrophy--a qualitative study of impact and coping.</gtr:title><gtr:parentPublicationTitle>European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40c1d1c4009ad9d9e5fceff1d9ec2f1"><gtr:id>f40c1d1c4009ad9d9e5fceff1d9ec2f1</gtr:id><gtr:otherNames>Read J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-3798</gtr:issn><gtr:outcomeId>sE8xtNZfNMM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01111967-B127-481D-8B9C-5D248EC57BB8</gtr:id><gtr:title>Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8f2b4697a97df486f15c696bd4449ff"><gtr:id>f8f2b4697a97df486f15c696bd4449ff</gtr:id><gtr:otherNames>Nadarajah VD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>gWwbm79TTxg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC779A30-7B28-4F01-B919-F8C1EC8AC6F9</gtr:id><gtr:title>Membrane cholesterol content plays a key role in the neurotoxicity of ?-amyloid: implications for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Aging cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2312f559dcfb3144a0b4c3c4b307152"><gtr:id>a2312f559dcfb3144a0b4c3c4b307152</gtr:id><gtr:otherNames>Abramov AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-9718</gtr:issn><gtr:outcomeId>sPcBNSUjLtb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0291378A-2889-41EB-A7E4-BAE5A5BC9EA0</gtr:id><gtr:title>Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95c5583b627c162ed22d4038ba7ebb73"><gtr:id>95c5583b627c162ed22d4038ba7ebb73</gtr:id><gtr:otherNames>Kopajtich R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>doi_55f984984380af81</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF58389F-C8E7-48BC-A4A5-DC1982445A09</gtr:id><gtr:title>P36 Progesterone reduces and shifts the voltage dependence of the skeletal muscle chloride conductance</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c422d35d3cdb2c9dbcabd6ca6e921d"><gtr:id>31c422d35d3cdb2c9dbcabd6ca6e921d</gtr:id><gtr:otherNames>Burge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>NqC6fN3otCY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD959889-DC9D-481E-8010-1D5CBD2A5350</gtr:id><gtr:title>Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94720badb8d3af043a4399befc5bec26"><gtr:id>94720badb8d3af043a4399befc5bec26</gtr:id><gtr:otherNames>M?ller JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>A1jiTDqdaPL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9DF1CBC-4D5F-4141-93C4-E6A7B7D411AE</gtr:id><gtr:title>Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c91f13481ecffef6f93e85f05e3620a"><gtr:id>4c91f13481ecffef6f93e85f05e3620a</gtr:id><gtr:otherNames>Anagnostou ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>585d3990527044.21598463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>316DEC30-374E-4969-8C21-08296737AA49</gtr:id><gtr:title>New aspects on patients affected by dysferlin deficient muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6155c86941d23091b9154fe86c5089e"><gtr:id>c6155c86941d23091b9154fe86c5089e</gtr:id><gtr:otherNames>Klinge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>hpwydqjSuYs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E6913A5-A323-4612-BE12-42480739349D</gtr:id><gtr:title>Clonal expansion of early to mid-life mitochondrial DNA point mutations drives mitochondrial dysfunction during human ageing.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>doi_55f98498441da4f0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F7B5F01-B53A-4A3D-8088-A6EAD1DBE4BA</gtr:id><gtr:title>A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>5675e521eb0f1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6832E374-6C6C-4E59-AE25-96BC0C710662</gtr:id><gtr:title>Whole genome expression as a quantitative trait.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>eDZ4J3XtuhP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD843A16-83AA-4E8D-90F2-64DCCE7C5076</gtr:id><gtr:title>Intolerance to &amp;szlig;-blockade in a mouse model of d-sarcoglycan-deficient muscular dystrophy cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f678cf2dad2cd094a26a57da88e6f252"><gtr:id>f678cf2dad2cd094a26a57da88e6f252</gtr:id><gtr:otherNames>Bauer R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn><gtr:outcomeId>tT2PhEgvGQB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BED62EC-BB38-49CD-9329-6E9DBE848F29</gtr:id><gtr:title>Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62557012b4513ba68159a8dd855f6149"><gtr:id>62557012b4513ba68159a8dd855f6149</gtr:id><gtr:otherNames>Clement EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>iT3ZyVtD9KQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45012B35-873C-4C99-82C1-EA0D6B9102BE</gtr:id><gtr:title>Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900f2596778f7b8a20c902800109b43b"><gtr:id>900f2596778f7b8a20c902800109b43b</gtr:id><gtr:otherNames>Spiegel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>585d55975f2471.83530675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA3016BB-A69E-449E-A9A4-E59F6E96CC7F</gtr:id><gtr:title>Adenovirus-based targeting in myoblasts is hampered by nonhomologous vector integration.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ac446b10f390ba7d73955695ebf6230"><gtr:id>4ac446b10f390ba7d73955695ebf6230</gtr:id><gtr:otherNames>Isman O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>323EE4519C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24CF1F1A-59EC-46CD-A778-E8D9DC2EC0C7</gtr:id><gtr:title>Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80d90ee46f35a4a33c5823afc4f87b66"><gtr:id>80d90ee46f35a4a33c5823afc4f87b66</gtr:id><gtr:otherNames>Van Deerlin VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>SVwExH79Bi8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1A59CAF-38DB-4901-89C3-125249BD5984</gtr:id><gtr:title>1700 MRI quantification of lower limb muscle fatty atrophy: a potential outcome measure in chronic neuromuscular diseases</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fa9fb2b1df9a7bdaf7630cdced7dc64"><gtr:id>9fa9fb2b1df9a7bdaf7630cdced7dc64</gtr:id><gtr:otherNames>Morrow J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>TGrAJrt8WXA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F249511C-9400-4678-98F2-5D18C305B9B8</gtr:id><gtr:title>IF(1): setting the pace of the F(1)F(o)-ATP synthase.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>dMVfFbiNnCT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D2898EF-8700-4648-88AD-3BD9E2A06D61</gtr:id><gtr:title>Lack of oxygen deactivates mitochondrial complex I: implications for ischemic injury?</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f376d441a3e486dedaf3d49c673e0282"><gtr:id>f376d441a3e486dedaf3d49c673e0282</gtr:id><gtr:otherNames>Galkin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>TFvsQTvaPJp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FE0F172-9B31-451C-8847-44041B34A48E</gtr:id><gtr:title>Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5458bda6110c11.97445729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3B15AFF-D9DE-40EA-B989-CBBD019A2413</gtr:id><gtr:title>TRP vanilloid 2 knock-out mice are susceptible to perinatal lethality but display normal thermal and mechanical nociception.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d89eb753e4f726acd71066421eb951d"><gtr:id>9d89eb753e4f726acd71066421eb951d</gtr:id><gtr:otherNames>Park U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>DfkSjUwbT3B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F0CFD70-E5D2-4E86-AAD0-3A39B8FCEF6D</gtr:id><gtr:title>THAP1 mutations (DYT6) are an additional cause of early-onset dystonia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>Fc6yLd1qoCG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62BF86EE-E6BC-4A67-8F43-D64A2E71FCA4</gtr:id><gtr:title>Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f9849843d57423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46AAC389-4932-4CDC-B647-D7ED80855322</gtr:id><gtr:title>Correcting radiofrequency inhomogeneity effects in skeletal muscle magnetisation transfer maps.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18adbf2f970b6c0f00a18d236074c12d"><gtr:id>18adbf2f970b6c0f00a18d236074c12d</gtr:id><gtr:otherNames>Sinclair CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>CxnsSA5KJ4b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53E97379-5DF3-44E0-A74E-67E1C4239B25</gtr:id><gtr:title>New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>nquqP1FeNfA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D862E00-AD60-42B2-82A1-18A3B6552970</gtr:id><gtr:title>X inactivation in females with X-linked Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12934_24_22483671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A1A9FEA-0378-4B58-A7A0-703D4F43DA5B</gtr:id><gtr:title>Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d77f4a974d7dca691474e7790a715fd2"><gtr:id>d77f4a974d7dca691474e7790a715fd2</gtr:id><gtr:otherNames>Walter MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>2CBDC0E9AAD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>078A6266-FD70-431B-BD79-598A18E2501D</gtr:id><gtr:title>Dynein-dynactin complex subunits are differentially localized in brain and spinal cord, with selective involvement in pathological features of neurodegenerative disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4a54e7510f59f2cd19e061051e11c63"><gtr:id>a4a54e7510f59f2cd19e061051e11c63</gtr:id><gtr:otherNames>Ateh DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>8FE0091C14D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3885F50-E7EB-453C-8774-7F12E12C61BD</gtr:id><gtr:title>An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e78549a28b33ad69cc45ce2d814a8585"><gtr:id>e78549a28b33ad69cc45ce2d814a8585</gtr:id><gtr:otherNames>Achilli F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>CyAsWXqA2qh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9668793C-4DB2-4FC1-A37B-F128C897C30E</gtr:id><gtr:title>Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9424d7e37ca3a2d7f9ecbaa8e24e2c06"><gtr:id>9424d7e37ca3a2d7f9ecbaa8e24e2c06</gtr:id><gtr:otherNames>Guergueltcheva V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>YxbGriT9VvS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D6C052B-920C-4F57-B53A-AC3A277D5E9C</gtr:id><gtr:title>Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for neuroprotective and neurotoxic effects.</gtr:title><gtr:parentPublicationTitle>Cellular &amp; molecular biology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51fb847e6a36c4c4664cccb152cf38ba"><gtr:id>51fb847e6a36c4c4664cccb152cf38ba</gtr:id><gtr:otherNames>Kalmar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1425-8153</gtr:issn><gtr:outcomeId>9D10F93AA08</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61DA56B2-3849-4953-8500-9CCF5A5C6EF5</gtr:id><gtr:title>Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6155c86941d23091b9154fe86c5089e"><gtr:id>c6155c86941d23091b9154fe86c5089e</gtr:id><gtr:otherNames>Klinge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>RNvByiZCfRP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49FE0077-959E-4089-86D3-52057D2D6AE9</gtr:id><gtr:title>MRC sum-score in the ICU: good reliability does not necessarily reflect &amp;quot;true reliability&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12cffd5a1b1a9a5423d7304520481af6"><gtr:id>12cffd5a1b1a9a5423d7304520481af6</gtr:id><gtr:otherNames>Vanhoutte EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>pm_12934_24_22499112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF8D4267-A73C-413B-AA30-9B8F33AD0C73</gtr:id><gtr:title>Human neurotrophin receptor p75NTR defines differentiation-oriented skeletal muscle precursor cells: implications for muscle regeneration.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b4764a44bb44894a1a3ec393dab140a"><gtr:id>5b4764a44bb44894a1a3ec393dab140a</gtr:id><gtr:otherNames>Colombo E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>m7tF3VaePSy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC1B4366-9E56-4F14-B8A7-E3850D2F6E05</gtr:id><gtr:title>A recurrent mitochondrial p.Trp22Arg NDUFB3 variant causes a distinctive facial appearance, short stature and a mild biochemical and clinical phenotype.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>585d3b5db1ff28.50164267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>825933FA-78D6-4D31-91D9-69BC635A25DD</gtr:id><gtr:title>What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>TAsZhaKcnKL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFDAE26E-7D30-4A81-9056-4976E6CBD732</gtr:id><gtr:title>Reproducibility of fMRI in the clinical setting: implications for trial designs.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2280a1794b8091e10a369ebac8e9989"><gtr:id>a2280a1794b8091e10a369ebac8e9989</gtr:id><gtr:otherNames>Bosnell R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>kWxqyAwHAYn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6563A9D0-2B58-40A0-BE9B-F2D1411983DD</gtr:id><gtr:title>Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37d446106b9e0c96a9a817a5bd2c77d7"><gtr:id>37d446106b9e0c96a9a817a5bd2c77d7</gtr:id><gtr:otherNames>Ackroyd MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>GURMLBJakV6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66180981-3110-4ED3-A1EC-9C714B2ED91C</gtr:id><gtr:title>Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f9849843e7b77c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39890394-E51A-4C2E-B8C4-47D91E15B1C1</gtr:id><gtr:title>Reverse protein arrays as novel approach for protein quantification in muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cf4a337a53f1dc57fc3110c6b08a1f0"><gtr:id>0cf4a337a53f1dc57fc3110c6b08a1f0</gtr:id><gtr:otherNames>Escher C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>8EECA5E6D6B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A57C3A5-D045-4EBE-A87D-5907F3941594</gtr:id><gtr:title>Inherited mtDNA variations are not strong risk factors in human prion disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5675e9bebbe5b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC2A6C1-68A9-42BA-AB5A-6521D8AE6836</gtr:id><gtr:title>Caveolinopathy--new mutations and additional symptoms.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aebe657a83f3bef4407d42ba54fd136d"><gtr:id>aebe657a83f3bef4407d42ba54fd136d</gtr:id><gtr:otherNames>Aboumousa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>SxtfEAk8yyD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBE74BFD-13C5-425D-8579-AEADB0B3B9CD</gtr:id><gtr:title>Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6654a0b045199634457f99036cfedeff"><gtr:id>6654a0b045199634457f99036cfedeff</gtr:id><gtr:otherNames>Collins CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>7B57E07F0C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDEE8E27-B736-40E6-89A0-5A7C1BF5186C</gtr:id><gtr:title>Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>aVf5qKjgqPt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74A4F223-F54D-42A5-B924-6D3D50DB23B8</gtr:id><gtr:title>In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12934_24_23065794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>190A1A85-190B-4F6A-9640-214D37907A88</gtr:id><gtr:title>A recessive ryanodine receptor 1 mutation in a CCD patient increases channel activity.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5793c8f752c0f91eebd5af75bc724f27"><gtr:id>5793c8f752c0f91eebd5af75bc724f27</gtr:id><gtr:otherNames>Ghassemi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>kHpLh29cPSh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D09E5B1-924E-4484-8A69-2350E7DE7232</gtr:id><gtr:title>Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3047b66658c89d193e22961bca635735"><gtr:id>3047b66658c89d193e22961bca635735</gtr:id><gtr:otherNames>Garrood P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>VuKEJdLwoSN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52E561DE-AEB0-427B-B53D-9C605D78D7FA</gtr:id><gtr:title>1154 Skeletal muscle chloride channel gene (CLCN1) copy number variation can cause myotonia congenita</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f5c0e5506c2caa2b25922e10de34484"><gtr:id>1f5c0e5506c2caa2b25922e10de34484</gtr:id><gtr:otherNames>Rayan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>iyWS5t1nDud</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77CC9E5A-CC0C-4BEE-BD23-C0FF737B93CD</gtr:id><gtr:title>A leaky splicing mutation in NFU1 is associated with a particular biochemical phenotype. Consequences for the diagnosis.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/945a8a6bc560b4c57b90454e50083ec5"><gtr:id>945a8a6bc560b4c57b90454e50083ec5</gtr:id><gtr:otherNames>Ferrer-Cort?s X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>56c31f147a6b31.21833431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1240E21-1369-487B-A6D0-834B77427207</gtr:id><gtr:title>Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673eb3a354040dbcb56dbe98ec677ebe"><gtr:id>673eb3a354040dbcb56dbe98ec677ebe</gtr:id><gtr:otherNames>van de Leemput J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>MaxAMKVyX45</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D0070EB-9E37-4374-AFA3-AD5E6C86EF5B</gtr:id><gtr:title>The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/543588421047beef3a75683dc167b9fa"><gtr:id>543588421047beef3a75683dc167b9fa</gtr:id><gtr:otherNames>Lu QL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>teDHvj6bX4k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1627532C-4E66-4FBA-85F0-1FE87EAF2D1D</gtr:id><gtr:title>CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58a4551c6bd2d7.49455852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30B6DF4D-306C-49D2-BFAF-11E8C49830EB</gtr:id><gtr:title>Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71d949c1c28cb9d2a95b1c179c02764b"><gtr:id>71d949c1c28cb9d2a95b1c179c02764b</gtr:id><gtr:otherNames>Senderek J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>otm2NTpsQLb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CB3BA3F-5F53-44DB-9840-01601F546FF9</gtr:id><gtr:title>CLIC1 function is required for beta-amyloid-induced generation of reactive oxygen species by microglia.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38a3b975d6998f6edb37d74a3302d5e6"><gtr:id>38a3b975d6998f6edb37d74a3302d5e6</gtr:id><gtr:otherNames>Milton RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>MoC8WrHNE4i</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>998D3261-3B56-4E8B-8278-CCEA645105A2</gtr:id><gtr:title>Rituximab responsive multiple radiculopathies and cranial nerve palsies in association with chronic lymphocytic leukaemia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81487feecd00f449b4f5dac70d19f178"><gtr:id>81487feecd00f449b4f5dac70d19f178</gtr:id><gtr:otherNames>Morrow JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>f2zokN5sAHK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>924AAB9F-0076-4414-A7AD-65141E46F499</gtr:id><gtr:title>A motor-driven mechanism for cell-length sensing.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a068ee28f50767617003e549e2b63703"><gtr:id>a068ee28f50767617003e549e2b63703</gtr:id><gtr:otherNames>Rishal I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_12934_24_22773964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>742BC772-4A07-4F0A-B054-EA894294E87A</gtr:id><gtr:title>Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e5ec211da0dca15b5656a9a543849cd"><gtr:id>5e5ec211da0dca15b5656a9a543849cd</gtr:id><gtr:otherNames>Rahman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>CDThfZTwecq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>625C12DE-7940-4837-A224-2EB362B8B2C9</gtr:id><gtr:title>Dystrophin and the brain.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d8f3bb060500a5be403ba0bef3f0811"><gtr:id>9d8f3bb060500a5be403ba0bef3f0811</gtr:id><gtr:otherNames>Ricotti V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>qHXDF1cPJTy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDBF1AD4-6A5C-4B82-8C27-89D2805427F5</gtr:id><gtr:title>Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_12934_24_22249839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B7321D8-71BB-410D-A8D6-FBE0E2F3E85D</gtr:id><gtr:title>Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4345298aa80f7aab384e189cb31b897"><gtr:id>f4345298aa80f7aab384e189cb31b897</gtr:id><gtr:otherNames>Kinali M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>qHtcCJCnETZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16336153-BABC-4319-8195-F9D25B65DCB8</gtr:id><gtr:title>Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84e3707839d90302345838b73f672b7"><gtr:id>e84e3707839d90302345838b73f672b7</gtr:id><gtr:otherNames>Meng J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>LUm3cum529U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CE69C5F-ADE7-4F46-A9B1-C1AFD699DFF7</gtr:id><gtr:title>A dystroglycan mutation associated with limb-girdle muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34e0cd9e75aa5b8647e80cfaebe5d36c"><gtr:id>34e0cd9e75aa5b8647e80cfaebe5d36c</gtr:id><gtr:otherNames>Hara Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>dB6RW8b3vfh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C951BB15-123A-494D-B442-4BAEA7F5383C</gtr:id><gtr:title>Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255f14bfe5038a10c88615ffcedb9000"><gtr:id>255f14bfe5038a10c88615ffcedb9000</gtr:id><gtr:otherNames>Gr?newald A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>mcYhhH79qHT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E57A0F05-11A5-4A78-A7ED-769E32E0D6C9</gtr:id><gtr:title>Caveolin regulates endocytosis of the muscle repair protein, dysferlin.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a91969245d8a4b1585bcf26307930977"><gtr:id>a91969245d8a4b1585bcf26307930977</gtr:id><gtr:otherNames>Hern?ndez-Deviez DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>dqMPoV8BiBT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F01EA9F8-8B2F-454C-9F96-5DC40DB0723E</gtr:id><gtr:title>Novel insights into the pathomechanisms of skeletal muscle channelopathies.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7c3b73138c4b8f4b2def0fdd8adbddd"><gtr:id>a7c3b73138c4b8f4b2def0fdd8adbddd</gtr:id><gtr:otherNames>Burge JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn><gtr:outcomeId>pm_12934_24_22083238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71F80EEA-ACF1-440D-9DBE-00A98AD9CAFD</gtr:id><gtr:title>014 Prevalence study of skeletal muscle channelopathies in England</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>i4pgPdvS7KG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BA6892D-5599-45EB-A589-610AB68C339F</gtr:id><gtr:title>Mitochondrial deficits and abnormal mitochondrial retrograde axonal transport play a role in the pathogenesis of mutant Hsp27-induced Charcot Marie Tooth Disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51fb847e6a36c4c4664cccb152cf38ba"><gtr:id>51fb847e6a36c4c4664cccb152cf38ba</gtr:id><gtr:otherNames>Kalmar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a34ebee776d11.37134825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77449490-B6C3-49B8-8A25-AFD312F199C6</gtr:id><gtr:title>Sarcoidosis presenting as acute inflammatory demyelinating polyradiculoneuropathy.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f175735d8ce083c048d9ac312841f7d2"><gtr:id>f175735d8ce083c048d9ac312841f7d2</gtr:id><gtr:otherNames>Saifee TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>VG51goKENaP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB5A1B03-ED6F-417C-86FF-DA7039987A95</gtr:id><gtr:title>A new prion disease: relationship with central and peripheral amyloidoses.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>doi_55f9849843b13961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF6B7138-0B90-475C-9467-8087780B0B2D</gtr:id><gtr:title>Diagnosis and new treatments in muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Postgraduate medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d50688715ad7ab95d124bc2a14807f07"><gtr:id>d50688715ad7ab95d124bc2a14807f07</gtr:id><gtr:otherNames>Manzur AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0032-5473</gtr:issn><gtr:outcomeId>SPuLdEnzhyp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD48EC0F-69AB-4B2D-BFDE-7B402E99CD48</gtr:id><gtr:title>Eye movement recordings to investigate a supranuclear component in chronic progressive external ophthalmoplegia: a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ed6845e9d6209ade25e493e58cbec69"><gtr:id>0ed6845e9d6209ade25e493e58cbec69</gtr:id><gtr:otherNames>Ritchie AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>FmKWm4oZhLm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E3E24AD-CD60-4F89-AF11-F992572C3A8F</gtr:id><gtr:title>Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63da48f6092092665f886cfef88e3860"><gtr:id>63da48f6092092665f886cfef88e3860</gtr:id><gtr:otherNames>Tan SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>Dq4u8KEBTmc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>990F5A42-424E-41C6-8293-9D655F6BEEA5</gtr:id><gtr:title>The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4767d613694b160a2224099a0d07c0e9"><gtr:id>4767d613694b160a2224099a0d07c0e9</gtr:id><gtr:otherNames>Ng YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>5a35e4a0e9d5b1.76120375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35FE82A0-6E58-4884-933A-1119F85A40CF</gtr:id><gtr:title>Defects in multiple complexes of the respiratory chain are present in ageing human colonic crypts.</gtr:title><gtr:parentPublicationTitle>Experimental gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0531-5565</gtr:issn><gtr:outcomeId>NN6TaXEMLro</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D2D5BB5-B0B1-4AD1-A71F-5F23585794A1</gtr:id><gtr:title>Twelve-Month Change of IBMFRS in the Arimocolomol Inclusion Body Myositis Pilot Study</gtr:title><gtr:parentPublicationTitle>NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d56a035ef5a8c4f15c0d101bfb5a49cd"><gtr:id>d56a035ef5a8c4f15c0d101bfb5a49cd</gtr:id><gtr:otherNames>Wang Yunxia</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>MkV3Tm8TntP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50FE1433-B346-4E89-828B-C90DFF4BDE63</gtr:id><gtr:title>Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers.</gtr:title><gtr:parentPublicationTitle>European heart journal cardiovascular Imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de9c23bb73c8bb50f291bc66e670e46c"><gtr:id>de9c23bb73c8bb50f291bc66e670e46c</gtr:id><gtr:otherNames>Bates MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2047-2404</gtr:issn><gtr:outcomeId>5458f56e5e21c3.89307241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>186DD122-97E2-4C7B-A20C-7DEB943EB5AA</gtr:id><gtr:title>The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87deb417af4dec6e3e33e4caf151a305"><gtr:id>87deb417af4dec6e3e33e4caf151a305</gtr:id><gtr:otherNames>Stewart JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn><gtr:outcomeId>5675ea62f210a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2A39939-CAC6-4509-ADE8-5BF91070E462</gtr:id><gtr:title>Long-term survival of neonatal mitochondrial complex III deficiency associated with a novel BCS1L gene mutation.</gtr:title><gtr:parentPublicationTitle>Molecular genetics and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe9015226fe85aa441230a01ec3c9484"><gtr:id>fe9015226fe85aa441230a01ec3c9484</gtr:id><gtr:otherNames>Tuppen HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1096-7192</gtr:issn><gtr:outcomeId>C845C2E7785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF3DFAF0-E27B-4185-AB03-1B6191FFE473</gtr:id><gtr:title>Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>ebkaZx1rZvf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CF37E51-37D0-477C-8A8F-4075C9992816</gtr:id><gtr:title>Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78a0d7fbf3fd3bf8b000674d4ef44ad7"><gtr:id>78a0d7fbf3fd3bf8b000674d4ef44ad7</gtr:id><gtr:otherNames>Munot P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>VdMnJ4kwYNq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CBCC891-8278-4F39-A5B0-8C48BFBF9F35</gtr:id><gtr:title>c-Jun is a negative regulator of myelination.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc816796602ee03da55d2213d9badebb"><gtr:id>fc816796602ee03da55d2213d9badebb</gtr:id><gtr:otherNames>Parkinson DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>DbCZou6F16p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B48588CE-4B87-429B-9761-972C5ADB9CFE</gtr:id><gtr:title>Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular muscles.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>BPydNaK3crn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED82B7F5-D093-4A0A-A6CB-34B70F847AB3</gtr:id><gtr:title>015 Identifying the cause of phenotypic variability in a family with non-dystrophic myotonia</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40b7db4536ce53cc6c850cb524c32bab"><gtr:id>40b7db4536ce53cc6c850cb524c32bab</gtr:id><gtr:otherNames>Raja Rayan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>URiEuk46c7k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F06D8BA8-62E4-42E5-872A-FBBD0AA14416</gtr:id><gtr:title>Emerging therapies for mitochondrial disorders.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856a4d55b01d92abca12d16202621560"><gtr:id>856a4d55b01d92abca12d16202621560</gtr:id><gtr:otherNames>Nightingale H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>585d668197e377.09163283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA474EC3-BD3A-4A49-9E78-23623B99EC66</gtr:id><gtr:title>1130 Clinical features and clinical course of sporadic inclusion body myositis (IBM): a prospective cohort study: IBM-net</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b3b1f101fc39803c11f89c7209db490"><gtr:id>8b3b1f101fc39803c11f89c7209db490</gtr:id><gtr:otherNames>Cortese A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>AV3KbDqE8JC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D22A68E-9BB0-4298-A749-2EC60B66ADE7</gtr:id><gtr:title>Calpainopathy presenting as foot drop in a 41 year old.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4825c06e28e3e36da21434ee220cd097"><gtr:id>4825c06e28e3e36da21434ee220cd097</gtr:id><gtr:otherNames>Burke G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>qGQmFaM41qz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A044D965-DAC3-4BC9-85F1-1A55046EA22F</gtr:id><gtr:title>Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90aeac0c513710f3f3a92514fb49b9c5"><gtr:id>90aeac0c513710f3f3a92514fb49b9c5</gtr:id><gtr:otherNames>Ono Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>03403E664A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63633573-78E7-4F05-9DA4-F1105685119F</gtr:id><gtr:title>Mitochondrial disease in adults: what's old and what's new?</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe1f4b7c0cf2741f213eff19fe22e37f"><gtr:id>fe1f4b7c0cf2741f213eff19fe22e37f</gtr:id><gtr:otherNames>Chinnery PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>56d470e7974619.96900236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4F356EA-DB2E-48AD-8C83-1B99FBDCBF36</gtr:id><gtr:title>Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/742eb8a5ad4f031cd2f66c982ba3692e"><gtr:id>742eb8a5ad4f031cd2f66c982ba3692e</gtr:id><gtr:otherNames>Schoeman EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>5a6d9d1ae08149.54342595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1E1E4B8-E479-4BB7-9508-69570F8C6276</gtr:id><gtr:title>Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/956904144d85dfa48c9d4c729970301d"><gtr:id>956904144d85dfa48c9d4c729970301d</gtr:id><gtr:otherNames>Rohkamm B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>MnQtMxg3i27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F0DCCBB-D225-449B-8F9A-66C2F2EED7D4</gtr:id><gtr:title>Prevalence study of genetically defined skeletal muscle channelopathies in England.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>doi_55f98498440ba726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44A3F650-A5BA-4546-AE05-72DD1305E84F</gtr:id><gtr:title>Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f541a42cba1539f06b619564772e9d9d"><gtr:id>f541a42cba1539f06b619564772e9d9d</gtr:id><gtr:otherNames>Craven L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12934_24_20393463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD3B93E3-7018-48F3-9D5B-045F59FDB2E1</gtr:id><gtr:title>Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec2f27c03967b99bcc42479fd6b4820a"><gtr:id>ec2f27c03967b99bcc42479fd6b4820a</gtr:id><gtr:otherNames>Mercuri E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>deKMiGxit6K</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29FF122C-6466-4C95-8505-0D3C678A36BF</gtr:id><gtr:title>Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c733d70b218462c7abdc86627d4cb"><gtr:id>496c733d70b218462c7abdc86627d4cb</gtr:id><gtr:otherNames>Malik B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f9849843c35afd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>775F667B-4E29-4895-BEC3-8413A21D23A0</gtr:id><gtr:title>NONGENETIC FACTORS INFLUENCE SEVERITY OF EPISODIC ATAXIA TYPE 1 IN MONOZYGOTIC TWINS</gtr:title><gtr:parentPublicationTitle>NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6436138bf0b09fb013df7c2d82e1148c"><gtr:id>6436138bf0b09fb013df7c2d82e1148c</gtr:id><gtr:otherNames>Graves Tracey D.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5a3608ec1ee101.18924181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58E9E730-576A-498A-A756-A51568807179</gtr:id><gtr:title>Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>doi_55f98498432df77b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59CBD8D8-1F17-49D9-A8A7-5A69B08AA213</gtr:id><gtr:title>Schwann cell precursors transplanted into the injured spinal cord multiply, integrate and are permissive for axon growth.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f5aac7210ae37e9a6f644891b0b8111"><gtr:id>8f5aac7210ae37e9a6f644891b0b8111</gtr:id><gtr:otherNames>Agudo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>ckvT2E7PoQr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B963A064-9FD2-4C17-9CDD-84FD34527ACE</gtr:id><gtr:title>P73 The natural history of sporadic inclusion body myositis: data from the IBM-Net prospective cohort study</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b3b1f101fc39803c11f89c7209db490"><gtr:id>8b3b1f101fc39803c11f89c7209db490</gtr:id><gtr:otherNames>Cortese A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>KNRxE2zTVTr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F76701F-4770-46D4-B0C1-09983EF4F323</gtr:id><gtr:title>Pathological ribonuclease H1 causes R-loop depletion and aberrant DNA segregation in mitochondria.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0868462ff4eec27e8eea7f7c7c64375"><gtr:id>d0868462ff4eec27e8eea7f7c7c64375</gtr:id><gtr:otherNames>Akman G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58a4551b949302.28396865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7429D1A7-F5D5-4523-B4DC-E90B0E95F1B9</gtr:id><gtr:title>Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ba297a1edd6970078cb545704ad890"><gtr:id>79ba297a1edd6970078cb545704ad890</gtr:id><gtr:otherNames>Foley AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e151e15158fb3f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B38E04EF-3CF3-42B2-8BEC-10AA67D5453F</gtr:id><gtr:title>Mitochondrial DNA Heteroplasmy and Purifying Selection in the Mammalian Female Germ Line.</gtr:title><gtr:parentPublicationTitle>Development, growth &amp; differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fbc4ca8ba5003117f7675215adb2c25"><gtr:id>7fbc4ca8ba5003117f7675215adb2c25</gtr:id><gtr:otherNames>Burr SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0012-1592</gtr:issn><gtr:outcomeId>5a995ec02e4156.89404419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A69F309-7AC4-4FD6-815A-46289CDF8CE6</gtr:id><gtr:title>A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f3576e57cf946276ff405f0b00e328b"><gtr:id>6f3576e57cf946276ff405f0b00e328b</gtr:id><gtr:otherNames>Wagner KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>U9MpCr3kHN6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7760E169-DC7F-41E5-9DB4-5EDC9707DC38</gtr:id><gtr:title>Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th--13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June--1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular dis</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec2f27c03967b99bcc42479fd6b4820a"><gtr:id>ec2f27c03967b99bcc42479fd6b4820a</gtr:id><gtr:otherNames>Mercuri E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>ebqaxRtNWAG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FF76F4A-50E0-4901-A83D-0227B65EA689</gtr:id><gtr:title>Induction of heat shock proteins for protection against oxidative stress.</gtr:title><gtr:parentPublicationTitle>Advanced drug delivery reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51fb847e6a36c4c4664cccb152cf38ba"><gtr:id>51fb847e6a36c4c4664cccb152cf38ba</gtr:id><gtr:otherNames>Kalmar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0169-409X</gtr:issn><gtr:outcomeId>260EFFB430D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A01EF86D-1A10-4D78-9B5E-B43364944D7B</gtr:id><gtr:title>Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b64e804e8b83c486d28249333879c2f"><gtr:id>8b64e804e8b83c486d28249333879c2f</gtr:id><gtr:otherNames>Durmus H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>QRrSLmrCqm7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A0B392A-16FB-4D13-8322-28F776F08E02</gtr:id><gtr:title>Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/504251fb9f77e909097edc11a8ec2e6f"><gtr:id>504251fb9f77e909097edc11a8ec2e6f</gtr:id><gtr:otherNames>Penno A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>Trq81vLHuAp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C286A645-1B5F-4DBE-894C-9099B3D89820</gtr:id><gtr:title>CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barr&amp;eacute; syndrome.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64c5cb13cfda226b9b9221708cf27f87"><gtr:id>64c5cb13cfda226b9b9221708cf27f87</gtr:id><gtr:otherNames>Petzold A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>S3guHpr7tB2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6D1929B-D226-476A-A20C-187B57DFBA0A</gtr:id><gtr:title>The satellite cell in male and female, developing and adult mouse muscle: distinct stem cells for growth and regeneration.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b01e49b7307068f94897d76de9c47070"><gtr:id>b01e49b7307068f94897d76de9c47070</gtr:id><gtr:otherNames>Neal A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>qRFXbbzFKkS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E5435DE-5D08-4232-8964-4F2F755159EA</gtr:id><gtr:title>Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>hAhYLeANm7J</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09156BC9-2C8F-4768-BC7A-CE58A4FD1AB0</gtr:id><gtr:title>Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2312f559dcfb3144a0b4c3c4b307152"><gtr:id>a2312f559dcfb3144a0b4c3c4b307152</gtr:id><gtr:otherNames>Abramov AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>PWmUmxBJcRF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A4FD2BC-3A0A-406E-A316-B0009D890ACC</gtr:id><gtr:title>Mitochondria mediated cell death in diabetes.</gtr:title><gtr:parentPublicationTitle>Apoptosis : an international journal on programmed cell death</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/771a518c0ce4e6dbc1cd83e5c9c7fde9"><gtr:id>771a518c0ce4e6dbc1cd83e5c9c7fde9</gtr:id><gtr:otherNames>Szabadkai G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1360-8185</gtr:issn><gtr:outcomeId>M1viPYSLbQa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F9BCBEC-C8FC-45F2-81EE-DFFEE4AAB81E</gtr:id><gtr:title>Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3edc2144895ea1217098953b44b7e7f"><gtr:id>e3edc2144895ea1217098953b44b7e7f</gtr:id><gtr:otherNames>Moisoi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>DwEGBnzVMFr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D0FAAAF-0A13-4C5F-8663-14D7A4E15AC5</gtr:id><gtr:title>Congenital myopathies.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a3c0657fd1d6eb0111e2f92c5ed8dcd"><gtr:id>3a3c0657fd1d6eb0111e2f92c5ed8dcd</gtr:id><gtr:otherNames>Sewry CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>kZTivCQwtdV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2192BF4D-3AE4-4843-8414-3F1DFF56A14E</gtr:id><gtr:title>Late onset in dysferlinopathy widens the clinical spectrum.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6155c86941d23091b9154fe86c5089e"><gtr:id>c6155c86941d23091b9154fe86c5089e</gtr:id><gtr:otherNames>Klinge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>Bk1m7sXbbmh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0494EA2F-2F70-4591-83BF-2993D2162B65</gtr:id><gtr:title>Limb-girdle muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9055555dfa5493524f1a78a42db633"><gtr:id>ff9055555dfa5493524f1a78a42db633</gtr:id><gtr:otherNames>Guglieri M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>iTaZvYkHSfx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A412E3FF-A937-40DC-ABB5-FB2F11F85FE6</gtr:id><gtr:title>A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5703e5b71ddfea213fe1caef5141549"><gtr:id>a5703e5b71ddfea213fe1caef5141549</gtr:id><gtr:otherNames>Jimenez-Mallebrera C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>MTgwGBzPLnB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>848CD84A-30FD-4ED6-B43B-3381CAC6611E</gtr:id><gtr:title>Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1bc530dea0f047a0508cb343a8ec2de"><gtr:id>c1bc530dea0f047a0508cb343a8ec2de</gtr:id><gtr:otherNames>Kasperaviciute D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>QyWPVyN48zY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42B36DB8-AB94-4045-B8C2-48C3B9D18AEF</gtr:id><gtr:title>Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0f279786d09f909b2444464d0ac92f0"><gtr:id>d0f279786d09f909b2444464d0ac92f0</gtr:id><gtr:otherNames>Taanman JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>772CACAA3A2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>364575F2-7CAC-421C-9DD9-1BB662AD42A3</gtr:id><gtr:title>MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b275411489d2e326e8859ee3bae6f17"><gtr:id>4b275411489d2e326e8859ee3bae6f17</gtr:id><gtr:otherNames>Turner C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12934_24_24054840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBE8E513-A8A5-4CAC-A1ED-FF55173C0B9B</gtr:id><gtr:title>P63 The medical research council neuromuscular centre for translational research mitochondrial disease patient cohort study UK: from conceptualisation to utilisation</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f5a64e763cce75d1f562606ee76e5bc"><gtr:id>7f5a64e763cce75d1f562606ee76e5bc</gtr:id><gtr:otherNames>Nesbitt V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pzW7HrmEWFa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3442219-601C-46B1-AF0A-F7AF0C5D9B1B</gtr:id><gtr:title>Stiffness as a presenting symptom of an odd clinical condition caused by multiple sclerosis and myotonia congenita.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e8b42aebb2524f57d3833c5641664e8"><gtr:id>4e8b42aebb2524f57d3833c5641664e8</gtr:id><gtr:otherNames>Portaro S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12934_24_22921319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63DFD84C-3426-4026-9EB5-13AFACA0C177</gtr:id><gtr:title>Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>ggJBWEciDLH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6249A254-4013-4963-B7C4-6DBD012B617E</gtr:id><gtr:title>Voxel-based analysis in neuroferritinopathy expands the phenotype and determines radiological correlates of disease severity.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56b4b3c72759e8.99212661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46FB933D-7706-4BA5-8789-25D1033C2F4D</gtr:id><gtr:title>Neuropathologic Characterization of Pontocerebellar Hypoplasia Type 6 Associated With Cardiomyopathy and Hydrops Fetalis and Severe Multisystem Respiratory Chain Deficiency due to Novel RARS2 Mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49556e9fdf0c03f1e42f752a9d5ca04e"><gtr:id>49556e9fdf0c03f1e42f752a9d5ca04e</gtr:id><gtr:otherNames>Lax NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>5675e6b9f3a71</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>186684C0-D99D-4B79-85C6-9D45B5453D62</gtr:id><gtr:title>What's wrong with the amygdala in temporal lobe epilepsy?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>B4vDUuBT4Sr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81E2651E-4582-48A8-ABA3-87C56F32E29D</gtr:id><gtr:title>Differences in the accumulation of mitochondrial defects with age in mice and humans.</gtr:title><gtr:parentPublicationTitle>Mechanisms of ageing and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0047-6374</gtr:issn><gtr:outcomeId>WoKT1ZtfdP2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0882CF59-1614-43BD-9AEB-F791EF0B9F19</gtr:id><gtr:title>Neuropathology of primary adult-onset dystonia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74690dc73db578be92f84c36af352cb1"><gtr:id>74690dc73db578be92f84c36af352cb1</gtr:id><gtr:otherNames>Holton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>Nd7UDCijutv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7989B6F-C242-4BDE-97D8-4162ECA59D9B</gtr:id><gtr:title>Spike-timing dependent plasticity in inhibitory circuits.</gtr:title><gtr:parentPublicationTitle>Frontiers in synaptic neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/771dec6e39674e34ffad5286ff5cef53"><gtr:id>771dec6e39674e34ffad5286ff5cef53</gtr:id><gtr:otherNames>Lamsa KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1663-3563</gtr:issn><gtr:outcomeId>Y5XZP7jSvbh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF10B54F-8936-4423-8202-F41B95F3CE21</gtr:id><gtr:title>Central nervous system histoplasmosis in an immunocompetent patient.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb0a8b16aa776f53413c2aa9f59b14c3"><gtr:id>fb0a8b16aa776f53413c2aa9f59b14c3</gtr:id><gtr:otherNames>Tai YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>0445A3A1F12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF89C7D8-3730-4329-895B-DEA0D24F1C73</gtr:id><gtr:title>Respiratory chain complex I deficiency caused by mitochondrial DNA mutations.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13308921a9c6ca555cf90db4e0652d17"><gtr:id>13308921a9c6ca555cf90db4e0652d17</gtr:id><gtr:otherNames>Swalwell H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>XJ67KnTjAwp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19162E66-B1C8-4B6A-8FC8-D03BD10D5644</gtr:id><gtr:title>Use of microcalorimetry to determine the costs and benefits to Pseudomonas putida strain KT2440 of harboring cadmium efflux genes.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bedeae9787c1fcfdae9d5d9abdbf8bbf"><gtr:id>bedeae9787c1fcfdae9d5d9abdbf8bbf</gtr:id><gtr:otherNames>Gibbons SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>CCyaosKp5ah</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AEE9308-BD3E-4B2D-BC09-AA39702CF67F</gtr:id><gtr:title>The value of collaboration in improving knowledge on rare diseases.</gtr:title><gtr:parentPublicationTitle>The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0317-1671</gtr:issn><gtr:outcomeId>gW91oTWJ2L2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3334AB25-A24C-4AA3-A9A4-EB79C7A53CDD</gtr:id><gtr:title>Mitochondrial DNA mutations in neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5675e541c9b40</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6201020A-71C7-468B-8C9B-10C53176128F</gtr:id><gtr:title>Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>GVB8zKAZ92L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DECDDAE-1D8C-49B3-8C43-790082A3F6D7</gtr:id><gtr:title>A novel mutation in the FGD4 gene causing Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b036df9e2c95f6c71e728f0b065f6a9b"><gtr:id>b036df9e2c95f6c71e728f0b065f6a9b</gtr:id><gtr:otherNames>Zis P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>5a2fd888a71635.17714910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56C6D6C4-EDAA-4001-8749-8731DCA3EC00</gtr:id><gtr:title>Genetic treatments in muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d12a81c1a41c39038e9286100f8688e7"><gtr:id>d12a81c1a41c39038e9286100f8688e7</gtr:id><gtr:otherNames>Muntoni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>e53wNYY8sWp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B5E49C9-789A-42DC-BF51-663C275D66EB</gtr:id><gtr:title>Cardiac involvement in hereditary myopathy with early respiratory failure: A cohort study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a619845b5cc71248eec5a3b2a35994cb"><gtr:id>a619845b5cc71248eec5a3b2a35994cb</gtr:id><gtr:otherNames>Steele HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>585d668d0ab6d6.40761905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8CCC9EE-39D8-4771-8016-DBDDB6CD72F1</gtr:id><gtr:title>A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A).</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/426814ae3d00276b2973974ab4eff106"><gtr:id>426814ae3d00276b2973974ab4eff106</gtr:id><gtr:otherNames>Reilich P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>EWdQD9bXsXp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>656665DF-0AD4-4B33-8BB9-A91E1890C765</gtr:id><gtr:title>Group I mGluR agonist-evoked long-term potentiation in hippocampal oriens interneurons.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f1f054a23850a0fa11dfd04fb4f1335"><gtr:id>3f1f054a23850a0fa11dfd04fb4f1335</gtr:id><gtr:otherNames>Le Duigou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>diRgbiKKMhi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69E5B708-77FC-4D06-804B-93AF5F37EFE4</gtr:id><gtr:title>Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>oaSWFtvXjpZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CEAEE3C-A93A-4F58-BC67-61B68D77F35C</gtr:id><gtr:title>Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c62104d32c93b365f8738fc859b36bc4"><gtr:id>c62104d32c93b365f8738fc859b36bc4</gtr:id><gtr:otherNames>Echave P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>JJKkzWSYX9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1467462F-A395-4649-83C9-5C22F05665EB</gtr:id><gtr:title>The patient's experience of being a human subject.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society of Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4ac73ef45476ce8d9f1c02f95b68318"><gtr:id>e4ac73ef45476ce8d9f1c02f95b68318</gtr:id><gtr:otherNames>Kerrison S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0141-0768</gtr:issn><gtr:outcomeId>BxHJHyxNitX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>055BE4E0-65A2-4BCE-AC8C-50C21441C0E1</gtr:id><gtr:title>Bmi1 enhances skeletal muscle regeneration through MT1-mediated oxidative stress protection in a mouse model of dystrophinopathy.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/864644aa5b12b4d031b0305f549d041b"><gtr:id>864644aa5b12b4d031b0305f549d041b</gtr:id><gtr:otherNames>Di Foggia V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>doi_55f9849843b972c9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B753C33F-E8D7-4E70-9E86-BA67CCC4F4F1</gtr:id><gtr:title>P69 Investigating the effects of pharmacological up-regulation of the heat shock response in an in-vitro model of sporadic inclusion body myositis</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af0707d338e2c1c3c05688ae01f64aed"><gtr:id>af0707d338e2c1c3c05688ae01f64aed</gtr:id><gtr:otherNames>Ahmed M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>EUooG4zr6xi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9541DD5B-AC3C-41F9-9422-BFEA1D4C479B</gtr:id><gtr:title>Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d8b06617486d4669e1ef29358e24b5c"><gtr:id>6d8b06617486d4669e1ef29358e24b5c</gtr:id><gtr:otherNames>Patel P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>aSXEmEftKuJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>880BBC9A-189D-4968-903C-320DD3FC9F97</gtr:id><gtr:title>Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d06a2a15508f201c8ab9db40db7a5ea"><gtr:id>2d06a2a15508f201c8ab9db40db7a5ea</gtr:id><gtr:otherNames>Guelly C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>D9rrUhCJiQe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13051EAD-57BB-44DD-B7F2-70C69B20FB03</gtr:id><gtr:title>The bare essentials: muscle disease.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6311cf52d0c12bf83784b619117c1ba1"><gtr:id>6311cf52d0c12bf83784b619117c1ba1</gtr:id><gtr:otherNames>Merrison AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>iGso7ThnoLd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>547AC0E5-A15D-48DE-83D0-F48AFFFE3230</gtr:id><gtr:title>Pupil abnormalities in 131 cases of genetically defined inherited peripheral neuropathy.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>AqKTNNCwi1C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97028887-12D1-4B7A-B75F-E9EC9A6C9159</gtr:id><gtr:title>Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease.</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e2d81b8ea001d9cb0929e98392bea50"><gtr:id>6e2d81b8ea001d9cb0929e98392bea50</gtr:id><gtr:otherNames>Limongelli G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn><gtr:outcomeId>YkPJjD9eQ8g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EA59A9B-0397-4740-B6C4-476ECDDB42B8</gtr:id><gtr:title>Maternally inherited mitochondrial DNA disease in consanguineous families.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>Q48igwqZZzp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82D74BD7-C825-46EB-8C2F-E435D1630772</gtr:id><gtr:title>Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbf0dbec4918649bc8adba66e1c5a888"><gtr:id>dbf0dbec4918649bc8adba66e1c5a888</gtr:id><gtr:otherNames>Roberts RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>g8MMzfaUrfW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A30F5B0-433C-4D1E-A879-1D1BEE3B1A18</gtr:id><gtr:title>P85 Frequency and circumstances of falls in people with Inclusion Body Myositis</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/160705410ecce130708496fab5e137f2"><gtr:id>160705410ecce130708496fab5e137f2</gtr:id><gtr:otherNames>Hiscock A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>VEGojihWU7N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8265E73-AFA6-45E1-A2A5-C44E6015A289</gtr:id><gtr:title>Muscle weakness, palpitations and a small chin: the Andersen-Tawil syndrome.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>jj95GJz9aa8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71F941D6-6BF0-4406-9BB2-D3D893D8FBC1</gtr:id><gtr:title>Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12934_24_23349320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA82E14B-C3EA-43EB-9A06-BAC0CB4D57BF</gtr:id><gtr:title>Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>International journal of pediatric otorhinolaryngology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/448a153a3accd12a1ab5896d1553e0c7"><gtr:id>448a153a3accd12a1ab5896d1553e0c7</gtr:id><gtr:otherNames>Jephson CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0165-5876</gtr:issn><gtr:outcomeId>bsBJJQSvdJe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B961A75-CF54-48AE-9BCC-AFBF23DFD140</gtr:id><gtr:title>Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1dbe5873652bd62ed0c8c7c781a347"><gtr:id>3c1dbe5873652bd62ed0c8c7c781a347</gtr:id><gtr:otherNames>Robb SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>FqYiMYxxg8g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B665A13C-27CF-4B86-90C4-BEF3BF7551BB</gtr:id><gtr:title>PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fe26393ce1a826c37d2c03b54270978"><gtr:id>7fe26393ce1a826c37d2c03b54270978</gtr:id><gtr:otherNames>Gandhi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>C1YkeDktTtQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51B7FBCC-8E59-4FC9-9EDB-B98CC232C688</gtr:id><gtr:title>The presence of highly disruptive 16S rRNA mutations in clinical samples indicates a wider role for mutations of the mitochondrial ribosome in human disease.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19cd9eac194029b31fc778c6567229da"><gtr:id>19cd9eac194029b31fc778c6567229da</gtr:id><gtr:otherNames>Elson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>56c3208e6a7d23.47099939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>208DFE69-52AB-404E-946C-73A20FE0D64F</gtr:id><gtr:title>Chloride channels in myotonia congenita assessed by velocity recovery cycles.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63da48f6092092665f886cfef88e3860"><gtr:id>63da48f6092092665f886cfef88e3860</gtr:id><gtr:otherNames>Tan SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>pm_12934_24_24037712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63B6E9C5-0A24-41A5-BFF9-DF1B917B5A70</gtr:id><gtr:title>Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ba1bb31dc3adc9eddf6a5a6486279c1"><gtr:id>1ba1bb31dc3adc9eddf6a5a6486279c1</gtr:id><gtr:otherNames>Fialho D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>txi5hWLsrYH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8A73426-FD83-4D0E-8E66-C50DC727BF91</gtr:id><gtr:title>IF1, the endogenous regulator of the F(1)F(o)-ATPsynthase, defines mitochondrial volume fraction in HeLa cells by regulating autophagy.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>UgNgWeeuwUe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>626453B0-ADB4-4A1A-B148-BAFF6F9E17FC</gtr:id><gtr:title>Transgenic overexpression of LARGE induces a-dystroglycan hyperglycosylation in skeletal and cardiac muscle.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4947de2d8e7351716246dd2e2b612052"><gtr:id>4947de2d8e7351716246dd2e2b612052</gtr:id><gtr:otherNames>Brockington M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>GkijZ2647vQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20684DD4-D9F7-4311-B5E1-4020E45F7B8E</gtr:id><gtr:title>Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>RtfMJKVnjjV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39FB1F78-E252-419F-81E2-0285CBCEC853</gtr:id><gtr:title>Long-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscle.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba067adbaad3e4dc66ebb75666ec6970"><gtr:id>ba067adbaad3e4dc66ebb75666ec6970</gtr:id><gtr:otherNames>J?rgensen LH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>ftjiUZb5BKC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52F19877-5C8F-48C3-B5B2-0D1E72A56820</gtr:id><gtr:title>Neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb527c8f47b11cfd2bb90849f52723e8"><gtr:id>fb527c8f47b11cfd2bb90849f52723e8</gtr:id><gtr:otherNames>McNeill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>GFnuvsToPtS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AC91C2F-7B93-49BC-9D08-049C1F5931A0</gtr:id><gtr:title>Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69e3f082879e03ebe932776c512e0bfa"><gtr:id>69e3f082879e03ebe932776c512e0bfa</gtr:id><gtr:otherNames>Trender-Gerhard I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>nEgns5P4VW8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36168E61-9ABD-4826-BC67-3F2E43B1C6B7</gtr:id><gtr:title>An unusual gait following the discovery of a new disease.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>gKsQ6bsvjBw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>789D57A4-65BB-4A6F-84E6-EC68963073F2</gtr:id><gtr:title>In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2408812a9d6aa79cb920c86fdae47f"><gtr:id>de2408812a9d6aa79cb920c86fdae47f</gtr:id><gtr:otherNames>Shatunov A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>XaDLn1Cho61</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C5B3841-AD15-4B69-ACE0-E44F99FC7694</gtr:id><gtr:title>A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56dd6300c01ca9.94490384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E2CCAAF-31C8-4D0B-B225-D7817C8CD73B</gtr:id><gtr:title>P20 Targeting the endogenous stress response in a mouse model of SBMA</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f516dd0f5d3b9fb06a2aa733c8ecdd2b"><gtr:id>f516dd0f5d3b9fb06a2aa733c8ecdd2b</gtr:id><gtr:otherNames>Gray A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>JXRbyCKhqPG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B25AC8D-3503-4A37-8299-139AD5F35128</gtr:id><gtr:title>Interneurons go plastic.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>MzohxsMVfKj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D96015A4-9B38-4047-93F1-7F2B9B26A507</gtr:id><gtr:title>Neuromuscular diseases: milestones in development of treatments.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>Qm56bNZxqA2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12FC7591-83F3-4465-9922-57F0CB9A14EE</gtr:id><gtr:title>The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.</gtr:title><gtr:parentPublicationTitle>Ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0161-6420</gtr:issn><gtr:outcomeId>F1DBF2F7692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3937678C-3BA9-4161-AE36-75C3CED98787</gtr:id><gtr:title>Professor P. K. Thomas: clinician, investigator, editor and leader--a retrospective appreciation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c7a1409dc0d040a7d6016cb7296db7"><gtr:id>24c7a1409dc0d040a7d6016cb7296db7</gtr:id><gtr:otherNames>Asbury AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>R3e9p785F5c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37BD32DD-BCED-4E23-899D-92C44A97A71E</gtr:id><gtr:title>Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b3b1f101fc39803c11f89c7209db490"><gtr:id>8b3b1f101fc39803c11f89c7209db490</gtr:id><gtr:otherNames>Cortese A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12934_24_23489664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC3719BF-A22C-453B-BEBA-12F9C8C54FB7</gtr:id><gtr:title>Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f290ce49002164ad6a7d750e1563a856"><gtr:id>f290ce49002164ad6a7d750e1563a856</gtr:id><gtr:otherNames>Zhou H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>K2qX593bAVc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97E8F571-9A20-48A4-B72B-1E7533C4AFA0</gtr:id><gtr:title>Copper deficiency as a treatable cause of poor balance.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f3448b53cd01a1b60a66c2f94ca21c3"><gtr:id>9f3448b53cd01a1b60a66c2f94ca21c3</gtr:id><gtr:otherNames>Khaleeli Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>H9y2oXcvxkh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7F8BE76-0222-4884-BCE1-BD1946BC3E24</gtr:id><gtr:title>Audit of unplanned admissions in neuromuscular patients</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fb3ec285342edce49d99ce29f4fff57"><gtr:id>4fb3ec285342edce49d99ce29f4fff57</gtr:id><gtr:otherNames>Korkodios, M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>TPmwZLDJ4Do</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D17E168-568F-44E4-A52B-99CF8D019991</gtr:id><gtr:title>Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cffc962b932447a7204bc4603ea0b0cd"><gtr:id>cffc962b932447a7204bc4603ea0b0cd</gtr:id><gtr:otherNames>Uusimaa J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>Jz28RUFYSJM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD555C02-B515-4181-960B-93156107E145</gtr:id><gtr:title>Negative regulation of myelination: relevance for development, injury, and demyelinating disease.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bb985e362c786826aef0181c859abca"><gtr:id>9bb985e362c786826aef0181c859abca</gtr:id><gtr:otherNames>Jessen KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>FoWJjwNhGt2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E186BEC-FA90-4B23-9B03-A1A3FFD123E7</gtr:id><gtr:title>Presynaptic GABAA receptors enhance transmission and LTP induction at hippocampal mossy fiber synapses.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c038419a225a2c0964dbe5a40ee0af2e"><gtr:id>c038419a225a2c0964dbe5a40ee0af2e</gtr:id><gtr:otherNames>Ruiz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>C69D8BF849A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F168799-6DFF-4602-9FB1-72AAF78F12DA</gtr:id><gtr:title>A novel FTL insertion causing neuroferritinopathy.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c839b5fe5fc925fb105bb56ce6aea2db"><gtr:id>c839b5fe5fc925fb105bb56ce6aea2db</gtr:id><gtr:otherNames>Batey S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>A5FJxHJyd6k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE75D90A-B5F3-45EC-8BF9-A4A482CD0A1E</gtr:id><gtr:title>Targeting RNA to treat neuromuscular disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d12a81c1a41c39038e9286100f8688e7"><gtr:id>d12a81c1a41c39038e9286100f8688e7</gtr:id><gtr:otherNames>Muntoni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-1776</gtr:issn><gtr:outcomeId>DESm7HCy8Wt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ECCF9BD-BB29-4222-AEB4-4B7AF6C2FE44</gtr:id><gtr:title>Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/788ebf92ec2952daae53cdf7cb654f89"><gtr:id>788ebf92ec2952daae53cdf7cb654f89</gtr:id><gtr:otherNames>Marsh EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>CXChiydvT7X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68335419-5C3B-420B-8BE1-49B919A05E99</gtr:id><gtr:title>Plasma neurofilament heavy chain is not a useful biomarker in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>585d666c240484.69125771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04079717-65B7-472E-A623-FDCFCBD3FBA6</gtr:id><gtr:title>Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>585d353db85940.58584910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A1BBA77-0DA0-40C0-98DA-AFF8A6F7D350</gtr:id><gtr:title>149th ENMC International Workshop and 1st TREAT-NMD Workshop on: &amp;quot;planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d12a81c1a41c39038e9286100f8688e7"><gtr:id>d12a81c1a41c39038e9286100f8688e7</gtr:id><gtr:otherNames>Muntoni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>rLzr7QrKfDy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8E6748F-29D7-4773-AAEE-59E81786629B</gtr:id><gtr:title>Uneventful administration of vincristine in Charcot-Marie-Tooth disease type 1X.</gtr:title><gtr:parentPublicationTitle>Pediatric blood &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7761669456e8f87107b46b3332f7fedd"><gtr:id>7761669456e8f87107b46b3332f7fedd</gtr:id><gtr:otherNames>Ajitsaria R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>FddcjNm6bPm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E0F2B0A-E880-4081-AAC3-E8BB44725D3C</gtr:id><gtr:title>Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255f14bfe5038a10c88615ffcedb9000"><gtr:id>255f14bfe5038a10c88615ffcedb9000</gtr:id><gtr:otherNames>Gr?newald A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>cM5M9Zm2x1x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14E09929-13C0-4615-B084-85411239DF1D</gtr:id><gtr:title>Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b7a98fbe56cf9ec53af8ad582eedbd6"><gtr:id>7b7a98fbe56cf9ec53af8ad582eedbd6</gtr:id><gtr:otherNames>Burns J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_12934_24_22522479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD5A9405-8099-4125-8BC6-8214CFBD6868</gtr:id><gtr:title>Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2A.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/777c90a575208b6507d2a45513645fa7"><gtr:id>777c90a575208b6507d2a45513645fa7</gtr:id><gtr:otherNames>Charlton R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>iZBY9ocJ49n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E1A93F9-3D03-4C18-A6C3-F876C6CB5E5A</gtr:id><gtr:title>Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6155c86941d23091b9154fe86c5089e"><gtr:id>c6155c86941d23091b9154fe86c5089e</gtr:id><gtr:otherNames>Klinge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>dLHbcnqJVVV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54D9413C-D260-481C-BB51-7C74A1016425</gtr:id><gtr:title>Oscillations and filtering networks support flexible routing of information.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/484faf6aa308846b45079c332380ce6e"><gtr:id>484faf6aa308846b45079c332380ce6e</gtr:id><gtr:otherNames>Akam T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>8614530FBC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDB4A1E9-A9E6-4E3C-9B1B-BEA15E928D36</gtr:id><gtr:title>Kearns-Sayre syndrome caused by defective R1/p53R2 assembly.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>dUdck6RiD7b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B53E185-0BAB-4368-9212-1BF4BF56B688</gtr:id><gtr:title>Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0f279786d09f909b2444464d0ac92f0"><gtr:id>d0f279786d09f909b2444464d0ac92f0</gtr:id><gtr:otherNames>Taanman JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>CF46B22F02F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52E0F44C-BEFE-4139-92BE-FA8355F09F5D</gtr:id><gtr:title>Diagnosis and new treatments in genetic neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4732af7ef6ff3beb803fd47a10bc7e3f"><gtr:id>4732af7ef6ff3beb803fd47a10bc7e3f</gtr:id><gtr:otherNames>Reilly MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>CftSS3RKQjs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5796243D-F9A7-4EC6-AB19-43F8BCF8488A</gtr:id><gtr:title>Chronic immune sensory polyradiculopathy with cranial and peripheral nerve involvement.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8f32c4fbc954a0618769c4233e158d0"><gtr:id>f8f32c4fbc954a0618769c4233e158d0</gtr:id><gtr:otherNames>Trip SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12934_24_22124665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B1D2160-E4EA-40CA-B7AE-E3EA12EC4D05</gtr:id><gtr:title>Membrane dysfunction in Andersen-Tawil syndrome assessed by velocity recovery cycles.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63da48f6092092665f886cfef88e3860"><gtr:id>63da48f6092092665f886cfef88e3860</gtr:id><gtr:otherNames>Tan SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>nNEGST5fima</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8805CDD4-6037-42DF-9FA6-5627BBC62371</gtr:id><gtr:title>A novel m.7539C&amp;gt;T point mutation in the mt-tRNA(Asp) gene associated with multisystemic mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce0a0e0400ee574b2ff1f4f75d7e293"><gtr:id>1ce0a0e0400ee574b2ff1f4f75d7e293</gtr:id><gtr:otherNames>Lehmann D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>doi_55f984984392c6b6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AF4DF75-1599-4DCE-A065-95D4BBB0A3F8</gtr:id><gtr:title>Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95a8882d6b6ca14f034fcc78604f6a4a"><gtr:id>95a8882d6b6ca14f034fcc78604f6a4a</gtr:id><gtr:otherNames>Heeroma JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>KX4B9GsviYB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A56ECB1-0068-4F8B-A940-A21EF3D16C4C</gtr:id><gtr:title>A de novo dominant mutation in KIF1A associated with axonal neuropathy, spasticity and autism spectrum disorder.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32eced6165160ce76ae4eaa88f46e3d0"><gtr:id>32eced6165160ce76ae4eaa88f46e3d0</gtr:id><gtr:otherNames>Tomaselli PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>5a2fdc4f2cc709.47051755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>441B6D74-CD6F-4CDB-BD07-7137CF2136D1</gtr:id><gtr:title>Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12934_24_22933740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A8E005F-7BFC-415B-992E-E553CD3484E7</gtr:id><gtr:title>Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fdd2d9ceb1801f517f5761be92ef9cd"><gtr:id>8fdd2d9ceb1801f517f5761be92ef9cd</gtr:id><gtr:otherNames>Mayhew A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>BbQzTXuCeHJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>791A3CDA-AAEF-4A10-B149-122343DA3668</gtr:id><gtr:title>Episodic ataxia: SLC1A3 and CACNB4 do not explain the apparent genetic heterogeneity.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>cE6nAdcTSQV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4B78C45-9CCC-417D-90AD-3A8D46646A09</gtr:id><gtr:title>d-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.</gtr:title><gtr:parentPublicationTitle>Skeletal muscle</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9d500eb6414ab3cf12e1887a7027e58"><gtr:id>d9d500eb6414ab3cf12e1887a7027e58</gtr:id><gtr:otherNames>Blain AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2044-5040</gtr:issn><gtr:outcomeId>YtmMXc5WApj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0545FCF-089A-4C25-9403-9497F1C908EA</gtr:id><gtr:title>PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af3137ae30d800bbf896d7631ffa4d13"><gtr:id>af3137ae30d800bbf896d7631ffa4d13</gtr:id><gtr:otherNames>Wood-Kaczmar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>oD5tUYNjdFk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5475D917-FBEA-4E47-91F6-3E6172A97A4E</gtr:id><gtr:title>A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58cdb4a8130aa13e41ef654e326a54cd"><gtr:id>58cdb4a8130aa13e41ef654e326a54cd</gtr:id><gtr:otherNames>Walmsley GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>imABv7nvYqP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B936567F-5BEB-473B-BB6B-C3F34BBE3C75</gtr:id><gtr:title>A novel mutation in the nerve-specific 5'UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>oFmhHMCpPz4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8240E61-DAB0-48B9-A637-0568F7FC324D</gtr:id><gtr:title>Effect sizes can be misleading: is it time to change the way we measure change?</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b3dd5b02797e9636e0b6438340cc37b"><gtr:id>7b3dd5b02797e9636e0b6438340cc37b</gtr:id><gtr:otherNames>Hobart JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>BFbmx1zkjRD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F700BD10-6074-4799-8D2F-8B8B97304CB1</gtr:id><gtr:title>Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de9c23bb73c8bb50f291bc66e670e46c"><gtr:id>de9c23bb73c8bb50f291bc66e670e46c</gtr:id><gtr:otherNames>Bates MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>doi_55f9849843fa6d8f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>730F4F4B-0081-47E3-9916-32370B10B019</gtr:id><gtr:title>Recessive Mutations in TRMT10C Cause Defects in Mitochondrial RNA Processing and Multiple Respiratory Chain Deficiencies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159c01ed9a89d84a069fa5d561d3e52e"><gtr:id>159c01ed9a89d84a069fa5d561d3e52e</gtr:id><gtr:otherNames>Metodiev MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>585d666f031fa4.28411862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>309B52FE-82E9-4F01-98EE-211D9BB59C16</gtr:id><gtr:title>Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, alpha-MSH, and beta-endorphin.</gtr:title><gtr:parentPublicationTitle>Endocrine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbfdafc685cdde4f7305e2aa2e8e62f3"><gtr:id>fbfdafc685cdde4f7305e2aa2e8e62f3</gtr:id><gtr:otherNames>Hook V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1355-008X</gtr:issn><gtr:outcomeId>BHrLY8M3vG6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F314A78-4A57-4E1C-B62E-B9157DC8218F</gtr:id><gtr:title>Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b543b06313b787c174fd8fee9da7b7f5"><gtr:id>b543b06313b787c174fd8fee9da7b7f5</gtr:id><gtr:otherNames>Arechavala-Gomeza V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>KfenZJuF94Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06B7EFD1-DB7E-4079-A8BA-79FCFF9B9BA1</gtr:id><gtr:title>An intragenic duplication in guanosine triphosphate cyclohydrolase-1 gene in a dopa-responsive dystonia family.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>d1VZQsNMKd6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB267048-1792-4C11-9512-6C702C990F7C</gtr:id><gtr:title>Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8559af596fbf0adcac08d0a7ed5faff6"><gtr:id>8559af596fbf0adcac08d0a7ed5faff6</gtr:id><gtr:otherNames>Otto A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>UoWR1LeYbXV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84ACC397-C25F-441C-817A-46478B005B1B</gtr:id><gtr:title>Ataxia in a young patient.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bef6f03e1cdc8eff88441b13925befab"><gtr:id>bef6f03e1cdc8eff88441b13925befab</gtr:id><gtr:otherNames>Stevens J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>XhxWsYmDLKu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6228C3F3-4CE8-40AF-871E-9D5E52CF8BD9</gtr:id><gtr:title>Initial development and validation of a mitochondrial disease quality of life scale.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19cd9eac194029b31fc778c6567229da"><gtr:id>19cd9eac194029b31fc778c6567229da</gtr:id><gtr:otherNames>Elson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>5458f56e3237d5.30723704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6526029B-4907-416B-8CAE-DDA495AED553</gtr:id><gtr:title>A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d0c58f3e65f2f0c33dd5d66cc31fb81"><gtr:id>7d0c58f3e65f2f0c33dd5d66cc31fb81</gtr:id><gtr:otherNames>Acevedo-Arozena A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>PCe2XiXA45s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CE7CAF9-60C0-46C1-96D1-74D80A50DB18</gtr:id><gtr:title>A patient with episodic ataxia and paramyotonia congenita due to mutations in KCNA1 and SCN4A.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>Zr6Rbv66gZZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6594DE0-A44D-452A-8722-2D1C3880E3E3</gtr:id><gtr:title>Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2312f559dcfb3144a0b4c3c4b307152"><gtr:id>a2312f559dcfb3144a0b4c3c4b307152</gtr:id><gtr:otherNames>Abramov AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>mpMM8iWwiwu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9BA6368-E28A-4CD2-9C3E-5FDBDB2EE73C</gtr:id><gtr:title>Refinement of the locus for distal hereditary motor neuronopathy VII (dHMN-VII) and exclusion of candidate genes.</gtr:title><gtr:parentPublicationTitle>Genome</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43cb277fec855d5d6a95643036c5dae8"><gtr:id>43cb277fec855d5d6a95643036c5dae8</gtr:id><gtr:otherNames>Dick KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0831-2796</gtr:issn><gtr:outcomeId>UqaQG6iSjbJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8946A5C-97A1-45A7-AE0B-951B7B23544D</gtr:id><gtr:title>Mutation in BAG3 causes severe dominant childhood muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5b71265bc1a671cbde93ec4c55990ae"><gtr:id>a5b71265bc1a671cbde93ec4c55990ae</gtr:id><gtr:otherNames>Selcen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>cEYhacUCGdM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67FC7DD5-9DB6-4020-87C4-DCE314681085</gtr:id><gtr:title>Mitochondria: the hub of cellular Ca2+ signaling.</gtr:title><gtr:parentPublicationTitle>Physiology (Bethesda, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/771a518c0ce4e6dbc1cd83e5c9c7fde9"><gtr:id>771a518c0ce4e6dbc1cd83e5c9c7fde9</gtr:id><gtr:otherNames>Szabadkai G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1548-9221</gtr:issn><gtr:outcomeId>CvUMqox7gUZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA95639B-2772-4166-9E56-853F22531ED1</gtr:id><gtr:title>Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>doi_55f9849843378d88</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8866F3E0-B7C6-4293-8FFD-FCC6A854BB1F</gtr:id><gtr:title>Mitochondrial DNA disease: new options for prevention.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f541a42cba1539f06b619564772e9d9d"><gtr:id>f541a42cba1539f06b619564772e9d9d</gtr:id><gtr:otherNames>Craven L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12934_24_21852248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BD32402-A477-43F0-BFD2-AE0D21261292</gtr:id><gtr:title>Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b45d673a363e77d4c816abe04b27b0d"><gtr:id>2b45d673a363e77d4c816abe04b27b0d</gtr:id><gtr:otherNames>Woodhoo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>EzjL23pqacB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A26C9F7-B892-471B-8251-B241F2746A19</gtr:id><gtr:title>Clinical and pathological heterogeneity in late-onset partial merosin deficiency.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>doi_55f984984342339e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB98BFDB-1D14-4547-9476-9B4E5D84EA70</gtr:id><gtr:title>N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32d68ec8aec7672f0b88995be79ce83f"><gtr:id>32d68ec8aec7672f0b88995be79ce83f</gtr:id><gtr:otherNames>Irani SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>765068ED73F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F2595F3-FC9B-4237-A1B9-36DE123744D4</gtr:id><gtr:title>Hand weakness in Charcot-Marie-Tooth disease 1X.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/831351235fc5dea438844dc6bb8cf032"><gtr:id>831351235fc5dea438844dc6bb8cf032</gtr:id><gtr:otherNames>Arthur-Farraj PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12934_24_22464564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C0104DE-A3A1-4B8C-879D-7DAA604AC9C1</gtr:id><gtr:title>Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>p9e7TnNwW6d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0A1719A-5C8C-4475-A1DF-55D03632C9AE</gtr:id><gtr:title>P34 Muscle degeneration in ion channel dysfunction</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b0807916a1dc95eab6992d79a662b51"><gtr:id>8b0807916a1dc95eab6992d79a662b51</gtr:id><gtr:otherNames>Baruch N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>BeQ72oEKFxy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F01F00EA-D436-4229-BD52-F4218627748A</gtr:id><gtr:title>Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bcc897cd3fe11bd0256fc0c4650d290"><gtr:id>5bcc897cd3fe11bd0256fc0c4650d290</gtr:id><gtr:otherNames>Lampe AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>Jvpjty92HQq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6D65E34-79B1-4730-8D8A-C643FD57E3FC</gtr:id><gtr:title>Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ea350d6353cf47f8fb301ed34cd3f5b"><gtr:id>3ea350d6353cf47f8fb301ed34cd3f5b</gtr:id><gtr:otherNames>Wood AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>RVeaR9qgzyU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58F0DBE6-03F7-406C-B30C-8201EBB62A27</gtr:id><gtr:title>Symmetry of foot alignment and ankle flexibility in paediatric Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Clinical biomechanics (Bristol, Avon)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b7a98fbe56cf9ec53af8ad582eedbd6"><gtr:id>7b7a98fbe56cf9ec53af8ad582eedbd6</gtr:id><gtr:otherNames>Burns J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0268-0033</gtr:issn><gtr:outcomeId>QiNCwr5XuRV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF653984-A9ED-4E58-9014-2AFE3D00056B</gtr:id><gtr:title>Muscular dystrophies due to glycosylation defects.</gtr:title><gtr:parentPublicationTitle>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d12a81c1a41c39038e9286100f8688e7"><gtr:id>d12a81c1a41c39038e9286100f8688e7</gtr:id><gtr:otherNames>Muntoni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1878-7479</gtr:issn><gtr:outcomeId>V4pBUAtsomL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A234118-B656-47CD-A9C3-4C14CC2A280C</gtr:id><gtr:title>FUS is not dysregulated by the spinal bulbar muscular atrophy androgen receptor polyglutamine repeat expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>WRqiTFq4TMi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6284BFD4-A59B-4D5C-87FE-592B15DC5F4D</gtr:id><gtr:title>AMACR mutations cause late-onset autosomal recessive cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa58864b5a96cc3b19b28e2632005722"><gtr:id>fa58864b5a96cc3b19b28e2632005722</gtr:id><gtr:otherNames>Dick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>qQDXhDzknsU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C600852-9D02-4148-AE0D-9A705C8F30DF</gtr:id><gtr:title>P94 Novel muscle fat-fraction MRI metrics for quantifying neuromuscular pathology</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ddd9c520b71fe0ea8e81914b8df9ea2"><gtr:id>7ddd9c520b71fe0ea8e81914b8df9ea2</gtr:id><gtr:otherNames>Sinclair C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>TXC26y1wCcL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46C7761F-A761-4B1B-B983-7C02D7ED7E3E</gtr:id><gtr:title>A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61f2b8d084c5bbf0ac37b413cbcc29b8"><gtr:id>61f2b8d084c5bbf0ac37b413cbcc29b8</gtr:id><gtr:otherNames>Raja Rayan DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12934_24_22649220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21E242F5-0938-4909-8F0E-144045D1464D</gtr:id><gtr:title>LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94c1ca48f4413263ba39dba7b5e978ca"><gtr:id>94c1ca48f4413263ba39dba7b5e978ca</gtr:id><gtr:otherNames>Michot C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>X4bjt7wL5Xk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DB00187-09E3-4BBA-B22F-AA701998DF33</gtr:id><gtr:title>Cryptic Amyloidogenic Elements in the 3' UTRs of Neurofilament Genes Trigger Axonal Neuropathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c42c663e0f22036e78de1c30a1c181"><gtr:id>86c42c663e0f22036e78de1c30a1c181</gtr:id><gtr:otherNames>Rebelo AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>585d5158959379.20430524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DB9743D-196F-4A31-9A82-0928AC602E46</gtr:id><gtr:title>BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90aeac0c513710f3f3a92514fb49b9c5"><gtr:id>90aeac0c513710f3f3a92514fb49b9c5</gtr:id><gtr:otherNames>Ono Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>oCumdMFU4se</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F4A0482-66BE-46FA-9DE7-8AA958889B92</gtr:id><gtr:title>Resveratrol attenuates oxidative stress in mitochondrial Complex I deficiency: Involvement of SIRT3.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c8ccd1aab50b58f437e89a67ec52c4d"><gtr:id>2c8ccd1aab50b58f437e89a67ec52c4d</gtr:id><gtr:otherNames>Mathieu L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>585d6678817b45.47486791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA8191F7-A179-419F-A91D-3EA1AA8F10BF</gtr:id><gtr:title>In vivo assessment of muscle membrane properties in myotonic dystrophy.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63da48f6092092665f886cfef88e3860"><gtr:id>63da48f6092092665f886cfef88e3860</gtr:id><gtr:otherNames>Tan SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>56dd630114c150.80428892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3261180-2781-4FA7-A23C-25CCF5FF891D</gtr:id><gtr:title>ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1e57250802060d632a12b14befdbf43"><gtr:id>b1e57250802060d632a12b14befdbf43</gtr:id><gtr:otherNames>Schmalhofer WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>ZHeCE67KPvB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C137CEC5-97D3-4094-86CE-58A7BC8F19C3</gtr:id><gtr:title>Reply: Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56d470e80f1870.60487081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>797E17E8-5E28-40B6-9568-F5712CD13209</gtr:id><gtr:title>The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/232e4c4b4c77e68b3df501ddf461d544"><gtr:id>232e4c4b4c77e68b3df501ddf461d544</gtr:id><gtr:otherNames>Bennett DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>bGBZxv49KeW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D5FCA0F-BC7E-445F-AC10-7B38DD10E4BA</gtr:id><gtr:title>Mitochondrial dysfunction in neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Neurochemical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cc8cb977e2c5fdf8f260800585282d4"><gtr:id>6cc8cb977e2c5fdf8f260800585282d4</gtr:id><gtr:otherNames>Schapira AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0364-3190</gtr:issn><gtr:outcomeId>DcsfWdHKB6f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6FB3466-FBC0-4237-A20D-0E45778C742A</gtr:id><gtr:title>Assessing upper limb function in nonambulant SMA patients: development of a new module.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d06cafa9846d93795ff1a2d7d7ee1b3c"><gtr:id>d06cafa9846d93795ff1a2d7d7ee1b3c</gtr:id><gtr:otherNames>Mazzone E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>LW9gZED1yUt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6018B25-780F-42EA-ABAE-CEE2624FB780</gtr:id><gtr:title>Accurate mitochondrial DNA sequencing using off-target reads provides a single test to identify pathogenic point mutations.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17b1972d3507f836480ade3288e49dc0"><gtr:id>17b1972d3507f836480ade3288e49dc0</gtr:id><gtr:otherNames>Griffin HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>5458bb0c0ec679.81163669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97255C00-9611-414F-80E0-AFFB59D94B20</gtr:id><gtr:title>Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41aa6e8b6d083ffbb51660e93463fbb2"><gtr:id>41aa6e8b6d083ffbb51660e93463fbb2</gtr:id><gtr:otherNames>Norwood FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>ahs79dgtUfb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17FE4CF0-709D-4C14-8934-DFEFC50F51C9</gtr:id><gtr:title>Are human and mouse satellite cells really the same?</gtr:title><gtr:parentPublicationTitle>The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89783a5fcb17bacf0fca3ef2fd51289d"><gtr:id>89783a5fcb17bacf0fca3ef2fd51289d</gtr:id><gtr:otherNames>Boldrin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1554</gtr:issn><gtr:outcomeId>TJfb68gmXzq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC0D74F7-300A-42BD-9844-F250932D9D15</gtr:id><gtr:title>Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c733d70b218462c7abdc86627d4cb"><gtr:id>496c733d70b218462c7abdc86627d4cb</gtr:id><gtr:otherNames>Malik B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>QDQntHGxj8r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>546D4C59-AF3C-4D48-B25E-015C461DE02B</gtr:id><gtr:title>EEG Abnormalities in the Episodic Ataxias (P05.029)</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1994ebc8696849581b1d4a0935232bd4"><gtr:id>1994ebc8696849581b1d4a0935232bd4</gtr:id><gtr:otherNames>Graves T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>XjymQ1yGn6M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3878F8AE-0B49-4580-B754-AD95C17F35DF</gtr:id><gtr:title>COX10 mutations resulting in complex multisystem mitochondrial disease that remains stable into adulthood.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_12934_24_24100867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>326EF058-3BD4-48F1-9F7F-928A44C6C91A</gtr:id><gtr:title>Sodium channel mutations and epilepsy: association and causation.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7fccc55a62cf97212e1cfed26905242"><gtr:id>f7fccc55a62cf97212e1cfed26905242</gtr:id><gtr:otherNames>Schorge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>KWB8zQJbDp1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E4167F9-7A14-4313-846A-DAA8534D00ED</gtr:id><gtr:title>A new extensively characterised conditionally immortal muscle cell-line for investigating therapeutic strategies in muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c41a7e3030af9fa9048c0df24cce3a2"><gtr:id>4c41a7e3030af9fa9048c0df24cce3a2</gtr:id><gtr:otherNames>Muses S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>KaeFEhr5txE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF142F55-F9B1-469C-9065-837A30286BBA</gtr:id><gtr:title>A refined diagnostic algorithm for Bethlem myopathy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ccd588457e2b396fae242688b972e96"><gtr:id>6ccd588457e2b396fae242688b972e96</gtr:id><gtr:otherNames>Hicks D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>RRRbFYxXkEM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD3558E0-5DCD-4476-A25D-EC97F25D74FA</gtr:id><gtr:title>Mitochondria and calcium in health and disease.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df3b4dffb07770cf05bb699acad8cfc4"><gtr:id>df3b4dffb07770cf05bb699acad8cfc4</gtr:id><gtr:otherNames>Duchen MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>jbhHgW7WXsR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46987E44-1D40-4FD4-B5C1-80BB24F0D42D</gtr:id><gtr:title>RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f950fd99d3923d0e32eb2c63f89184e9"><gtr:id>f950fd99d3923d0e32eb2c63f89184e9</gtr:id><gtr:otherNames>Fratter C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>GFsHEoEWv3c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00312B74-4EAA-4E76-9646-AF35BD15B1B5</gtr:id><gtr:title>Biobanking in rare disorders.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e066b01550c96ebd55c22ce477282b8"><gtr:id>3e066b01550c96ebd55c22ce477282b8</gtr:id><gtr:otherNames>Lochm?ller H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>jnAybcV1EFh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78B7601D-9703-4790-879F-5789D7753965</gtr:id><gtr:title>Genetic analysis of FIG4 in patients with CMT</gtr:title><gtr:parentPublicationTitle>NEUROMUSCULAR DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e034571de4928afe9ed92c931e7330f"><gtr:id>9e034571de4928afe9ed92c931e7330f</gtr:id><gtr:otherNames>Cottenie E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>LZ2pt8Roaav</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B7C839D-6DA9-43BD-AF63-FA8D330657FA</gtr:id><gtr:title>Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>cjwVcrJdsn2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7824A86A-D1FE-4B63-B833-3F5422EB68FB</gtr:id><gtr:title>Natural history of Charcot-Marie-Tooth disease during childhood.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8169c1b2998376d54e46e1d79bd276cb"><gtr:id>8169c1b2998376d54e46e1d79bd276cb</gtr:id><gtr:otherNames>Cornett KMD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>5a2fd5b9c959d0.54839708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D1164EE-A179-4FEA-B262-150685B1A271</gtr:id><gtr:title>SCP2 mutations and neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56b4b3c6bed127.57784865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>897B3126-9F70-4EE6-9694-873C21135C7D</gtr:id><gtr:title>The size of the treatment effect: do patients and proxies agree?</gtr:title><gtr:parentPublicationTitle>BMC neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d76f18f61691cde137cf84808669554"><gtr:id>9d76f18f61691cde137cf84808669554</gtr:id><gtr:otherNames>van der Linden FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2377</gtr:issn><gtr:outcomeId>MqwSUWBDr6i</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE975CD5-2587-49C6-ACC8-87014F59AAED</gtr:id><gtr:title>The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67850162a1b7fefe9245641a6e9ad020"><gtr:id>67850162a1b7fefe9245641a6e9ad020</gtr:id><gtr:otherNames>El-Kadi AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>AFD4331ED48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA53E413-82B5-4E3E-86E3-EFD1A6FEF368</gtr:id><gtr:title>A neurological perspective on mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aceeebe176b2a13722db7069cd6fe796"><gtr:id>aceeebe176b2a13722db7069cd6fe796</gtr:id><gtr:otherNames>McFarland R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>0E7EB117B64</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EA270CB-ACDB-4871-9F3D-A79B1CBD1901</gtr:id><gtr:title>Skin changes in Ullrich congenital muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89a1c36287fb77df7b0a69754cf87977"><gtr:id>89a1c36287fb77df7b0a69754cf87977</gtr:id><gtr:otherNames>Nadeau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>FK2E74u1mDN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA90C546-7598-4EB3-B344-7E18E06B450B</gtr:id><gtr:title>Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure.</gtr:title><gtr:parentPublicationTitle>Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dbf87eabd5322a64bd366c8e3b553b9"><gtr:id>9dbf87eabd5322a64bd366c8e3b553b9</gtr:id><gtr:otherNames>Pisano A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1054-8807</gtr:issn><gtr:outcomeId>56c31f13d52665.80048266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>329D2C08-3B06-4072-BA78-9D64B18BACB7</gtr:id><gtr:title>Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18adbf2f970b6c0f00a18d236074c12d"><gtr:id>18adbf2f970b6c0f00a18d236074c12d</gtr:id><gtr:otherNames>Sinclair CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>ETJ5R3i28so</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9871627B-CE1C-4740-9533-A7A0106CBC4F</gtr:id><gtr:title>Mitochondrial function and redox state in mammalian embryos.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f36129be651699c68200ab0bec4782c"><gtr:id>5f36129be651699c68200ab0bec4782c</gtr:id><gtr:otherNames>Dumollard R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>DjY49pDdXJm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62D07E65-F888-4F48-BCE7-B87112CC9A35</gtr:id><gtr:title>Eosinophilic infiltration related to CAPN3 mutations: a pathophysiological component of primary calpainopathy?</gtr:title><gtr:parentPublicationTitle>Clinical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1a18afcbec7fa24746f7eaacb8b0a94"><gtr:id>b1a18afcbec7fa24746f7eaacb8b0a94</gtr:id><gtr:otherNames>Krahn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-9163</gtr:issn><gtr:outcomeId>FCaMkEVNpqg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9B69E2A-0C57-4DB8-AF70-8D7920FEB2DC</gtr:id><gtr:title>Mitochondrial disorders: disease mechanisms and therapeutic approaches.</gtr:title><gtr:parentPublicationTitle>Discovery medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26500bfd7d1fca1c1e02bc26eba7c99a"><gtr:id>26500bfd7d1fca1c1e02bc26eba7c99a</gtr:id><gtr:otherNames>Poole OV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1539-6509</gtr:issn><gtr:outcomeId>56dd62ffde7581.55789543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AB798E8-03DD-46A7-BE64-B6CAF42183AD</gtr:id><gtr:title>Divergent molecular effects of desmin mutations on protein assembly in myofibrillar myopathy.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84cf6af6839fdf1c8075a9c891d21a95"><gtr:id>84cf6af6839fdf1c8075a9c891d21a95</gtr:id><gtr:otherNames>Levin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>BB3D5EBA5E9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A36B0A19-6254-4BB4-98C9-99D0B521F12A</gtr:id><gtr:title>Neurological channelopathies: new insights into disease mechanisms and ion channel function.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>WWhdxt1uBz7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA28439F-2E7A-4BD3-81F0-94FEE71B158B</gtr:id><gtr:title>Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b222eb2887308b18e862b45fbb62c88b"><gtr:id>b222eb2887308b18e862b45fbb62c88b</gtr:id><gtr:otherNames>Geranmayeh F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>iL7G6fxPXBn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B336C9F3-82D0-4AB7-821F-EC5EE6DB046D</gtr:id><gtr:title>Sodium and chloride channelopathies with myositis: coincidence or connection?</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>cyWHkWrnapb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EF9AE8C-9EA3-48A5-B469-69754371EC2D</gtr:id><gtr:title>DOK7 mutations presenting as a proximal myopathy in French Canadians.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d393f19289b76d3e389bd803da3804a"><gtr:id>6d393f19289b76d3e389bd803da3804a</gtr:id><gtr:otherNames>Srour M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>3F4B95E3B89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55D0E00E-A946-44E7-A7E1-77CFE673547C</gtr:id><gtr:title>Stridor as a neonatal presentation of skeletal muscle sodium channelopathy.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>Y7XxFFLyDVi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EA52BA0-1BF9-4075-8E1F-E0131876F6A1</gtr:id><gtr:title>Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6b32d6f0cdd600701fbe330b244d231"><gtr:id>f6b32d6f0cdd600701fbe330b244d231</gtr:id><gtr:otherNames>Schoenmakers E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>PwUt3tY4SFF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>007E65A6-B7F0-4BC8-9D83-288CC0245C3F</gtr:id><gtr:title>A novel mechanism causing imbalance of mitochondrial fusion and fission in human myopathies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bdc173cc903af2b23be1f55ff257851"><gtr:id>1bdc173cc903af2b23be1f55ff257851</gtr:id><gtr:otherNames>Bartsakoulia M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a995f240ca672.90445045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7601582C-68B0-494C-8D23-3FF0EC965A81</gtr:id><gtr:title>Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Physiotherapy research international : the journal for researchers and clinicians in physical therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef6f6e51efdc2a2fcec4a9e4519c773c"><gtr:id>ef6f6e51efdc2a2fcec4a9e4519c773c</gtr:id><gtr:otherNames>Scott E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1358-2267</gtr:issn><gtr:outcomeId>AYAXYZUePPW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A82D0BA8-35E3-4793-A692-1D4DF2CC02F5</gtr:id><gtr:title>Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2408812a9d6aa79cb920c86fdae47f"><gtr:id>de2408812a9d6aa79cb920c86fdae47f</gtr:id><gtr:otherNames>Shatunov A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>Gdfq7BCaLot</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25FEE422-8CC9-46FB-87E2-95A130911118</gtr:id><gtr:title>Prevalence of neurogenetic disorders in the North of England.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c967a786847e7e5db1d802a30f49fbb9"><gtr:id>c967a786847e7e5db1d802a30f49fbb9</gtr:id><gtr:otherNames>Bargiela D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5675eb1cd6224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63A92956-875F-413B-9D12-BACCD3FCA47F</gtr:id><gtr:title>Knee bobbing in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>nCRzVR8Ubex</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DAB078D-878C-4C31-A719-7B5D019893C0</gtr:id><gtr:title>Targeting protein homeostasis in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af0707d338e2c1c3c05688ae01f64aed"><gtr:id>af0707d338e2c1c3c05688ae01f64aed</gtr:id><gtr:otherNames>Ahmed M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>585d5261421019.24007777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3EFDDCF-9C8C-4CC0-AE0B-235AFEC4B953</gtr:id><gtr:title>Sporadic inclusion body myositis: an unsolved mystery.</gtr:title><gtr:parentPublicationTitle>Acta reumatologica portuguesa</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ec459bbc79239f24d8fa0c4e80ceb2e"><gtr:id>4ec459bbc79239f24d8fa0c4e80ceb2e</gtr:id><gtr:otherNames>Machado P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0303-464X</gtr:issn><gtr:outcomeId>FLKRpdf2RY2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7924D87-999E-493E-9868-C4D5470F5C5C</gtr:id><gtr:title>Deletion of chromosome 12q21 affecting KCNC2 and ATXN7L3B in a family with neurodevelopmental delay and ataxia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12934_24_23475819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1290A466-0F76-4435-AFB0-C71316DC284A</gtr:id><gtr:title>Severe Dejerine-Sottas disease with respiratory failure and dysmorphic features in association with a PMP22 point mutation and a 3q23 microdeletion.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ac050b4cbcf59e748973d74c7628ed4"><gtr:id>8ac050b4cbcf59e748973d74c7628ed4</gtr:id><gtr:otherNames>Voermans NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_12934_24_22734911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F541ED82-B8C1-4105-A5FC-36D0D68AE3EE</gtr:id><gtr:title>MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81487feecd00f449b4f5dac70d19f178"><gtr:id>81487feecd00f449b4f5dac70d19f178</gtr:id><gtr:otherNames>Morrow JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5697a9064eaf42.04677813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E0E19FD-DBA6-41C4-97DA-CD8ED9745DDB</gtr:id><gtr:title>P60 Expanding the phenotypic and genotypic spectrum of adult RRM2B-related mitochondrial disease</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0f83e7d74b3f88e1c1cc321912f9be3"><gtr:id>c0f83e7d74b3f88e1c1cc321912f9be3</gtr:id><gtr:otherNames>Piceathly R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>gHcXLpWyKQT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C37107E0-F2AE-412E-A5D6-67221FF7A19D</gtr:id><gtr:title>Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3d700fecb67b99136b863c2ea912693"><gtr:id>d3d700fecb67b99136b863c2ea912693</gtr:id><gtr:otherNames>Labrum RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>a6PYjY5TShP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C649E5DB-9349-40C4-A514-4606FDA1FECF</gtr:id><gtr:title>SPG7 mutations are a common cause of undiagnosed ataxia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5675dfc0ae115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3DB8FAB-32A5-48F3-991A-6062538163EF</gtr:id><gtr:title>Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c2eb16c8df8cdb1a9bb2c1f5925e5e4"><gtr:id>8c2eb16c8df8cdb1a9bb2c1f5925e5e4</gtr:id><gtr:otherNames>Kirchhof P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>iTymu6HfxPd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CFC2AAE-98C2-47EC-BA02-03A99D320E88</gtr:id><gtr:title>Biallelic Mutations in TMEM126B Cause Severe Complex I Deficiency with a Variable Clinical Phenotype.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>585d6672078072.22190309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5008803F-634D-47E4-9178-CAF342482866</gtr:id><gtr:title>Mature adult dystrophic mouse muscle environment does not impede efficient engrafted satellite cell regeneration and self-renewal.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89783a5fcb17bacf0fca3ef2fd51289d"><gtr:id>89783a5fcb17bacf0fca3ef2fd51289d</gtr:id><gtr:otherNames>Boldrin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>iM4GENkM1tX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB0E5F12-B764-4ED4-8211-C369DCF6880E</gtr:id><gtr:title>Nuclear-mitochondrial proteins: too much to process?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5675e53c7c79c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47CD16AD-2AED-4BAE-A91D-61C225F57F3E</gtr:id><gtr:title>Sarcoglycanopathies.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08b871d671c6958d5c69d83130ec1b88"><gtr:id>08b871d671c6958d5c69d83130ec1b88</gtr:id><gtr:otherNames>Kirschner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>neUy8A3emoM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD9E0F4F-769F-4080-94D7-389E53C1B04E</gtr:id><gtr:title>Diagnosis and management of the limb girdle muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>pEgvt8EpZzG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99BFF536-E744-4B9E-BE8E-5BDBA5C2F9EA</gtr:id><gtr:title>Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cfe3367645d225c21a352c13d7fb7e7"><gtr:id>8cfe3367645d225c21a352c13d7fb7e7</gtr:id><gtr:otherNames>Jungbluth H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>b9zur2ro933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47C96CC6-E7EA-4A11-BEFE-D3128401C828</gtr:id><gtr:title>No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f0da5205014189b24ef547ea463228b"><gtr:id>0f0da5205014189b24ef547ea463228b</gtr:id><gtr:otherNames>Bertolin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>58a4551c35c9f7.93923471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B09018B3-2A34-4EAF-9691-5D4E26AE4C11</gtr:id><gtr:title>Dysfunction of the Ca(V)2.1 calcium channel in cerebellar ataxias.</gtr:title><gtr:parentPublicationTitle>F1000 biology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-594X</gtr:issn><gtr:outcomeId>nJFfNBxGdJ3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9676DF1-F2CC-4977-9D6E-805F0C4684EB</gtr:id><gtr:title>TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cddd2bef272a98bf3ef76e946616c4a"><gtr:id>5cddd2bef272a98bf3ef76e946616c4a</gtr:id><gtr:otherNames>Powell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5675e8cd25a5f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61457014-9C4C-485D-BD6E-29BC3AD2E3CA</gtr:id><gtr:title>Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>XjJqU9Xv92d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDDDF263-D2EE-4552-B06B-2F639E4F5A33</gtr:id><gtr:title>Dystroglycanopathies: coming into focus.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c0247455a00e50e0d2f8876b067d92"><gtr:id>90c0247455a00e50e0d2f8876b067d92</gtr:id><gtr:otherNames>Godfrey C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>HSReSyUyc3G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B2ED39A-C042-48BC-8761-0781B3D2CCED</gtr:id><gtr:title>Rational design of antisense oligomers to induce dystrophin exon skipping.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc407e71218096589121f3b1463eb434"><gtr:id>cc407e71218096589121f3b1463eb434</gtr:id><gtr:otherNames>Mitrpant C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>VXJveEoNfBn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A5C178A-A858-4B80-ADFA-24CC5A0099A7</gtr:id><gtr:title>Is there post-natal muscle growth in amyoplasia? A sequential MRI study.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec2f27c03967b99bcc42479fd6b4820a"><gtr:id>ec2f27c03967b99bcc42479fd6b4820a</gtr:id><gtr:otherNames>Mercuri E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>gWktbcTQJq8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84FDD7BB-A853-4669-A15E-0C0C08F5A95C</gtr:id><gtr:title>Classification and diagnosis of the inherited neuropathies.</gtr:title><gtr:parentPublicationTitle>Annals of Indian Academy of Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4732af7ef6ff3beb803fd47a10bc7e3f"><gtr:id>4732af7ef6ff3beb803fd47a10bc7e3f</gtr:id><gtr:otherNames>Reilly MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0972-2327</gtr:issn><gtr:outcomeId>RWg23BYKFKi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0E41626-20D6-4E8A-AC7A-D5CF55878975</gtr:id><gtr:title>097 Valosin Containing Protein (VCP) and Myofibrillar Myopathies (MFM) genes' mutations are not associated with sporadic Inclusion Body Myositis (sIBM)</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ec459bbc79239f24d8fa0c4e80ceb2e"><gtr:id>4ec459bbc79239f24d8fa0c4e80ceb2e</gtr:id><gtr:otherNames>Machado P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>KjcykKXDBqA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4044583F-1BED-4454-AFF2-9D8B667389BC</gtr:id><gtr:title>Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4d22202c99dba94354fdaf35fbc8d2b"><gtr:id>e4d22202c99dba94354fdaf35fbc8d2b</gtr:id><gtr:otherNames>Schessl J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>mdfu44aeve5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>051069E9-A6DB-4DD8-8DFA-25E236B2FC66</gtr:id><gtr:title>Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12934_24_23107649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E23CDBC-18BF-4631-8DED-EF677F05DAD8</gtr:id><gtr:title>Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ceef2a90e46a0e4368653e63abe06ba"><gtr:id>7ceef2a90e46a0e4368653e63abe06ba</gtr:id><gtr:otherNames>Malerba A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>DYvnjJanGrt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FA86D4F-2AF7-4CA8-98AB-567D49CCC63C</gtr:id><gtr:title>Exome sequencing identifies a REEP1 mutation involved in distal hereditary motor neuropathy type V.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36cadd68ece387a2d9e18ebd6f8d0b4c"><gtr:id>36cadd68ece387a2d9e18ebd6f8d0b4c</gtr:id><gtr:otherNames>Beetz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>QurKWUJNCaW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D366DF47-50A0-469E-9B16-72B277E4B56F</gtr:id><gtr:title>Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7ada31cae13180e506c25d1cec7fe06"><gtr:id>e7ada31cae13180e506c25d1cec7fe06</gtr:id><gtr:otherNames>Hilton-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>BAWBH4dpF3Z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70B6DC64-8247-4E95-BBEE-DC9496875AC1</gtr:id><gtr:title>Recent advances in the genetic neuropathies.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>585d668886a411.58542127</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC977FA9-9CAA-48D9-8087-759BF7C2942F</gtr:id><gtr:title>A novel p.Gln175X [corrected] premature stop mutation in the C-terminal end of HSP27 is a cause of CMT2.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_12934_24_22734906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FD1F265-C751-4751-BDEE-BDA7AAF6CA9A</gtr:id><gtr:title>P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment.</gtr:title><gtr:parentPublicationTitle>Journal of cellular and molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e00f22aa6cc2a90a23ec866c6c4d051"><gtr:id>1e00f22aa6cc2a90a23ec866c6c4d051</gtr:id><gtr:otherNames>Young CN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1582-1838</gtr:issn><gtr:outcomeId>pm_12934_24_21794079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>784F54AD-8AB1-421C-8AB9-C3970A528E93</gtr:id><gtr:title>A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1161dceb49b9031cc5693146e0b920cb"><gtr:id>1161dceb49b9031cc5693146e0b920cb</gtr:id><gtr:otherNames>Lunn MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>5697a906c44509.92964387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3296267D-1247-475A-BDC9-3438B85C3AE5</gtr:id><gtr:title>An interactive voice response diary for patients with non-dystrophic myotonia.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/298bb180e38e48cf69bf03d814af75c8"><gtr:id>298bb180e38e48cf69bf03d814af75c8</gtr:id><gtr:otherNames>Statland JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>QsPsxCbiK1H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27C29DC0-443F-4380-A5B8-92EC0475DB69</gtr:id><gtr:title>Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3594f340e4a1627490ba4eeba3e02389"><gtr:id>3594f340e4a1627490ba4eeba3e02389</gtr:id><gtr:otherNames>Sarkozy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>UgSRRHzcnqh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A697B2D-ECDD-4DED-9462-2EE062A51ACA</gtr:id><gtr:title>The multiple phenotypes of arthrogryposis multiplex congenita with reference to the neurogenic variant.</gtr:title><gtr:parentPublicationTitle>European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01ef84e7496042b08277bed7b59599c5"><gtr:id>01ef84e7496042b08277bed7b59599c5</gtr:id><gtr:otherNames>Ambegaonkar G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-3798</gtr:issn><gtr:outcomeId>JJSSGk9FKrW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19774EA4-CF98-4CCA-8521-53D508CC1332</gtr:id><gtr:title>1142 Mexiletine is an effective treatment in non-dystrophic myotonia</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f5c0e5506c2caa2b25922e10de34484"><gtr:id>1f5c0e5506c2caa2b25922e10de34484</gtr:id><gtr:otherNames>Rayan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>YbwGzeGZ54x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D8A1392-9C93-4119-8AE4-A3C886CAB85F</gtr:id><gtr:title>Mitochondrial disease: mimics and chameleons.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd55d049dbcc0d328614887ca48f1222"><gtr:id>fd55d049dbcc0d328614887ca48f1222</gtr:id><gtr:otherNames>Martikainen MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>56d470e8dfdc27.41786757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E3AF2BB-500F-4546-9C97-EE947FBC3890</gtr:id><gtr:title>Defining cardiac adaptations and safety of endurance training in patients with m.3243A&amp;gt;G-related mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de9c23bb73c8bb50f291bc66e670e46c"><gtr:id>de9c23bb73c8bb50f291bc66e670e46c</gtr:id><gtr:otherNames>Bates MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn><gtr:outcomeId>pm_12934_24_23742928</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61C894A7-EEDA-492E-A5F6-948185A2A300</gtr:id><gtr:title>Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc757b667cdddeb6122acd3074900504"><gtr:id>dc757b667cdddeb6122acd3074900504</gtr:id><gtr:otherNames>Lo HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>MDFcXHQbcPD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07E07106-907D-44A9-8B6D-49D85FFA0226</gtr:id><gtr:title>Clinical and neuropathological findings in patients with TACO1 mutations.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbfd8bc55ead66da66f56298557be2a2"><gtr:id>cbfd8bc55ead66da66f56298557be2a2</gtr:id><gtr:otherNames>Seeger J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>NjxvurSf9xp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D3A62B8-A6B0-4F47-B250-792212D1AFF7</gtr:id><gtr:title>Neurological channelopathies.</gtr:title><gtr:parentPublicationTitle>Annual review of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0147-006X</gtr:issn><gtr:outcomeId>AkFz3XPyRvA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C646E967-47DD-48E6-A10F-F74C074BF38D</gtr:id><gtr:title>Genetic and phenotypic characterization of complex hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>585d6685308e29.72870209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60575A0E-10F6-48E3-ADD8-39DCE1B1AC6C</gtr:id><gtr:title>Albumin uptake in OK cells exposed to rotenone: a model for studying the effects of mitochondrial dysfunction on endocytosis in the proximal tubule?</gtr:title><gtr:parentPublicationTitle>Nephron. Physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebce6cf6481d3699fe4f10fc4e9b01c1"><gtr:id>ebce6cf6481d3699fe4f10fc4e9b01c1</gtr:id><gtr:otherNames>Hall AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1660-2137</gtr:issn><gtr:outcomeId>A7QfJP8uAVk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76A50996-78F6-41AF-BF72-4108201FCC1A</gtr:id><gtr:title>Altered primary and secondary myogenesis in the myostatin-null mouse.</gtr:title><gtr:parentPublicationTitle>Rejuvenation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1d3cdc5770d45d575ad6504e903abcc"><gtr:id>f1d3cdc5770d45d575ad6504e903abcc</gtr:id><gtr:otherNames>Matsakas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1549-1684</gtr:issn><gtr:outcomeId>ZrQYiNh16bU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9289B385-61C8-4260-8E55-0B08DAF77070</gtr:id><gtr:title>Discrete gait characteristics are associated with m.3243A&amp;gt;G and m.8344A&amp;gt;G variants of mitochondrial disease and its pathological consequences.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8894fd431814e7b0d5213d0aae4975a7"><gtr:id>8894fd431814e7b0d5213d0aae4975a7</gtr:id><gtr:otherNames>Galna B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12934_24_24150688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B32D789-0920-42D9-BC11-DE9B6A69FFA7</gtr:id><gtr:title>Multipotent Basal Stem Cells, Maintained in Localized Proximal Niches, Support Directed Long-Ranging Epithelial Flows in Human Prostates.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dc907cd5e9284df572879baedd5e328"><gtr:id>9dc907cd5e9284df572879baedd5e328</gtr:id><gtr:otherNames>Moad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fd5be0ebde2.77673278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F123D0E-6567-43C5-922B-288E31A09348</gtr:id><gtr:title>A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/451873139f8353b8218f5a0a97348507"><gtr:id>451873139f8353b8218f5a0a97348507</gtr:id><gtr:otherNames>Bovolenta M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>NjrX15eRbqA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55CF8513-9333-466A-9C3F-3E497398CDB2</gtr:id><gtr:title>Self-mutilation in patients after nerve injury may not be due to deafferentation pain: a case report.</gtr:title><gtr:parentPublicationTitle>Pain medicine (Malden, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52ff41b339915ee3c4ae5a3fae0ffff6"><gtr:id>52ff41b339915ee3c4ae5a3fae0ffff6</gtr:id><gtr:otherNames>Kachramanoglou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1526-2375</gtr:issn><gtr:outcomeId>oxQ5gSWXFtY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1258E310-088E-4B46-8485-EFA080287D76</gtr:id><gtr:title>Short- and long-term depression at glutamatergic synapses on hippocampal interneurons by group I mGluR activation.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f1f054a23850a0fa11dfd04fb4f1335"><gtr:id>3f1f054a23850a0fa11dfd04fb4f1335</gtr:id><gtr:otherNames>Le Duigou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>BQ3wjTFQn8P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>002B428C-DC8E-4082-A9C6-786E63DD58FE</gtr:id><gtr:title>Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12934_24_22577229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>338A371E-554B-42C7-8FE1-1E9A3E8543BB</gtr:id><gtr:title>The distal hereditary motor neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>nQeWgt6hgKF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2DB975C-AD3B-4667-9629-5877A49794BF</gtr:id><gtr:title>Cortical excitability differences in hand muscles follow a split-hand pattern in healthy controls.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0632cd44e42b4033db3814a050afbf76"><gtr:id>0632cd44e42b4033db3814a050afbf76</gtr:id><gtr:otherNames>Menon P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>doi_55f98498434d0e0f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09C44252-2A5B-4D51-9202-975737C6AF81</gtr:id><gtr:title>Endocrine aspects of Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2540750285e87acecccb879082803203"><gtr:id>2540750285e87acecccb879082803203</gtr:id><gtr:otherNames>Bianchi ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>PVdTm5eRD24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4448237-FE71-4950-8121-23CCDD9CE583</gtr:id><gtr:title>Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6625258e6317377f9105e0e8dbec8a32"><gtr:id>6625258e6317377f9105e0e8dbec8a32</gtr:id><gtr:otherNames>Yis U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>LyJsb1iNCMs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B61979A4-1431-457E-86A9-9156EC5410A9</gtr:id><gtr:title>Towards a complete resolution of the genetic architecture of disease.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3da33927ae0fe73df3e7c6f9ee690b42"><gtr:id>3da33927ae0fe73df3e7c6f9ee690b42</gtr:id><gtr:otherNames>Singleton AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>an3LocNWSb4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB004993-914B-4762-8437-63ED2469F475</gtr:id><gtr:title>Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2a973f56d46a037f33b4fc6ba9f45b2"><gtr:id>c2a973f56d46a037f33b4fc6ba9f45b2</gtr:id><gtr:otherNames>Miller BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3077</gtr:issn><gtr:outcomeId>kBSRtNn2zDZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6A7158A-3C61-40BC-8685-624BEE83A09F</gtr:id><gtr:title>Muscle metabolic alterations assessed by 31-phosphorus magnetic resonance spectroscopy in mild Becker muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c426a60cf4406e959f41ae730e2ef2fc"><gtr:id>c426a60cf4406e959f41ae730e2ef2fc</gtr:id><gtr:otherNames>Tosetti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>FhNAMq49Nfg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88F94574-33DC-45A4-A2DE-4681E76C6849</gtr:id><gtr:title>Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61f2b8d084c5bbf0ac37b413cbcc29b8"><gtr:id>61f2b8d084c5bbf0ac37b413cbcc29b8</gtr:id><gtr:otherNames>Raja Rayan DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>d2cmTFNfcrV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7E61644-85EE-41A7-8587-2ABABE03C7D3</gtr:id><gtr:title>MMP-9 overexpression improves myogenic cell migration and engraftment.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe3f7a4604a114588ee989995c9d163a"><gtr:id>fe3f7a4604a114588ee989995c9d163a</gtr:id><gtr:otherNames>Morgan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>AWnBTY9Uhwf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC9C1899-1816-4CA9-95A8-92DBB72E419A</gtr:id><gtr:title>Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81487feecd00f449b4f5dac70d19f178"><gtr:id>81487feecd00f449b4f5dac70d19f178</gtr:id><gtr:otherNames>Morrow JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_12934_24_23810313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F1EED00-C565-4B4D-B896-8617B720D5E9</gtr:id><gtr:title>Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd55d049dbcc0d328614887ca48f1222"><gtr:id>fd55d049dbcc0d328614887ca48f1222</gtr:id><gtr:otherNames>Martikainen MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>585d666905cf16.69672386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA6C8FCA-2CB7-44E7-9E33-4D317D1358EE</gtr:id><gtr:title>In vivo assessment of HCN channel current (I(h)) in human motor axons.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d6175339259c694a8180bd92d5b6f2a"><gtr:id>6d6175339259c694a8180bd92d5b6f2a</gtr:id><gtr:otherNames>Tomlinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>ByA2rC7eTM2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7A3BD08-B0FB-420A-B10C-0E106BE3C34D</gtr:id><gtr:title>A novel Frabin (FGD4) nonsense mutation p.R275X associated with phenotypic variability in CMT4H.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>RhpKvLk3Amw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B186388E-2CE8-4FDD-83A0-93491AE254AD</gtr:id><gtr:title>Clinical and Molecular Characterization of Non-Dystrophic Myotonia</gtr:title><gtr:parentPublicationTitle>NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/199aa56e372aa4c0d7bc665ecded5a8b"><gtr:id>199aa56e372aa4c0d7bc665ecded5a8b</gtr:id><gtr:otherNames>Trivedi Jaya</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>h3GDXean8MW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>364511FB-451D-45F6-A8C7-ABEA7924FDB6</gtr:id><gtr:title>Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo.</gtr:title><gtr:parentPublicationTitle>Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1388-2457</gtr:issn><gtr:outcomeId>d4ppTHFAMJV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DF08EC4-F902-4F96-9A9B-EA4C023AFAA2</gtr:id><gtr:title>A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76e00af3054632a7f1e9c1cff9e43c54"><gtr:id>76e00af3054632a7f1e9c1cff9e43c54</gtr:id><gtr:otherNames>Carvalho OP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>rztXJ1gmQ5G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2495042D-A1A0-4FFF-808B-C117BA44FB98</gtr:id><gtr:title>Prevalence and orthopedic management of foot and ankle deformities in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c75792682149ca01317221ad3ac82be1"><gtr:id>c75792682149ca01317221ad3ac82be1</gtr:id><gtr:otherNames>Laur? M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>5a2fd41b494207.36915283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD5B6DBA-223D-4ABA-9295-07B69E01BBB7</gtr:id><gtr:title>NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_12934_24_23746447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11076F91-48FA-4A9F-902E-C734311C7651</gtr:id><gtr:title>Paroxysmal neuromyotonia: a new sporadic channelopathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20991a7f921e7b347c71ecefbf15b5ff"><gtr:id>20991a7f921e7b347c71ecefbf15b5ff</gtr:id><gtr:otherNames>Pulkes T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>DTecXPEhASj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B06B114C-3CBE-4442-ADE4-058945C3D310</gtr:id><gtr:title>Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a0807e96b153ba4e10e38f3a79a301a"><gtr:id>8a0807e96b153ba4e10e38f3a79a301a</gtr:id><gtr:otherNames>Cano SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pZjyCN3We9W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0D91154-C6B2-4217-BC5F-B357FC4BF7BC</gtr:id><gtr:title>Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/002dc518113cfcd49df817b7f8935a46"><gtr:id>002dc518113cfcd49df817b7f8935a46</gtr:id><gtr:otherNames>Scoto M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>doi_55f984984403a692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F242D24-F37A-4A3A-A4ED-9A86BAC3134E</gtr:id><gtr:title>Sleep and well-being in young men with neuromuscular disorders receiving non-invasive ventilation and their carers.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40c1d1c4009ad9d9e5fceff1d9ec2f1"><gtr:id>f40c1d1c4009ad9d9e5fceff1d9ec2f1</gtr:id><gtr:otherNames>Read J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>VmLNLu2EjJ1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21E13ED9-3C32-4999-86EC-C0193157ACFC</gtr:id><gtr:title>MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fe1def1775ffa43e3dab7458f576778"><gtr:id>9fe1def1775ffa43e3dab7458f576778</gtr:id><gtr:otherNames>DiFrancesco JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>40FA89D8D9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52943FC1-272C-4349-AD13-B084831318C0</gtr:id><gtr:title>A truncating PET100 variant causing fatal infantile lactic acidosis and isolated cytochrome c oxidase deficiency.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcd740097cdb9f5d82285952eb54e32e"><gtr:id>dcd740097cdb9f5d82285952eb54e32e</gtr:id><gtr:otherNames>Ol?hov? M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>5675dc24925fa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D1DF224-8402-468E-905B-07953380D93C</gtr:id><gtr:title>Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>stpfU9hF3Mw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F02815F6-524D-4C61-885E-276FAEB892DD</gtr:id><gtr:title>Renal function and mitochondrial cytopathy (MC): more questions than answers?</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebce6cf6481d3699fe4f10fc4e9b01c1"><gtr:id>ebce6cf6481d3699fe4f10fc4e9b01c1</gtr:id><gtr:otherNames>Hall AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>Axqu8hntiHV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58986777-5A94-4FF4-A150-689F33C88C0A</gtr:id><gtr:title>Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS).</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc3f233f373ed02719f6b6d5e5fa937"><gtr:id>abc3f233f373ed02719f6b6d5e5fa937</gtr:id><gtr:otherNames>Stevens JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>F86A0D6215B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59E6F74A-871C-4962-81CE-821B7F1B580D</gtr:id><gtr:title>Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b543b06313b787c174fd8fee9da7b7f5"><gtr:id>b543b06313b787c174fd8fee9da7b7f5</gtr:id><gtr:otherNames>Arechavala-Gomeza V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>HgRzoWvNKqk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65749D83-D2C5-4942-A4A8-A58B16417E40</gtr:id><gtr:title>Repeats, longevity and the sources of mtDNA deletions: evidence from 'deletional spectra'.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bdf431c05dc17295525a1856a93bf8a"><gtr:id>1bdf431c05dc17295525a1856a93bf8a</gtr:id><gtr:otherNames>Guo X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>BXXg8k7gz5P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11A83F45-BF32-4F57-B297-A783A81FA027</gtr:id><gtr:title>King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c20a8fed51528e885e0b4621b2f527e1"><gtr:id>c20a8fed51528e885e0b4621b2f527e1</gtr:id><gtr:otherNames>Dowling JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>Yn5jbeEhRGP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D11A5AF-E214-4FF8-B85D-BDE000768669</gtr:id><gtr:title>Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66e3a3043c15917b0e2b85faeda6cd6e"><gtr:id>66e3a3043c15917b0e2b85faeda6cd6e</gtr:id><gtr:otherNames>Neri M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>epq5Ti2eFQd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>694D0812-C8EB-4392-8972-F8F61E5EE45E</gtr:id><gtr:title>Phenotype expression in women with CMT1X.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cefdb0598df3b7bc24eb86676c6d3430"><gtr:id>cefdb0598df3b7bc24eb86676c6d3430</gtr:id><gtr:otherNames>Siskind CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>b49sCeWuGXD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E459DC68-63BB-47BC-B72E-BAFD6FEC3460</gtr:id><gtr:title>Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cfe3367645d225c21a352c13d7fb7e7"><gtr:id>8cfe3367645d225c21a352c13d7fb7e7</gtr:id><gtr:otherNames>Jungbluth H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>sVoJ56UfBxc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BCA9E30-50C2-440B-8A38-A4ED8BE89D1A</gtr:id><gtr:title>Chloride intracellular channel 1 (CLIC1): Sensor and effector during oxidative stress.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54e5ad2fe620bf4df8b7224ba8bba66c"><gtr:id>54e5ad2fe620bf4df8b7224ba8bba66c</gtr:id><gtr:otherNames>Averaimo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>NGr5KH5xifm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>334AA199-301C-4843-AACE-3D357A97C5F9</gtr:id><gtr:title>Mitochondria modulate the spatio-temporal properties of intra- and intercellular Ca2+ signals in cochlear supporting cells.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ce961d4b178bb975d7a65fb8228dedd"><gtr:id>3ce961d4b178bb975d7a65fb8228dedd</gtr:id><gtr:otherNames>Mann ZF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>STyzudTcrM5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25DE6B4A-16B3-4CD9-94F2-66F6F8CABF53</gtr:id><gtr:title>Variable phenotypes are associated with PMP22 missense mutations.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf0bc737932265eaa33cfdb00a4f429"><gtr:id>ccf0bc737932265eaa33cfdb00a4f429</gtr:id><gtr:otherNames>Russo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>hcYpv1bRBR4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>546DD8F3-DCE8-4F4D-8D28-10BB1883B923</gtr:id><gtr:title>A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ccd588457e2b396fae242688b972e96"><gtr:id>6ccd588457e2b396fae242688b972e96</gtr:id><gtr:otherNames>Hicks D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>qbr4dWtmQVR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A4170EA-C5A7-4D29-84BF-AF78A8F42758</gtr:id><gtr:title>The contribution of human synovial stem cells to skeletal muscle regeneration.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84e3707839d90302345838b73f672b7"><gtr:id>e84e3707839d90302345838b73f672b7</gtr:id><gtr:otherNames>Meng J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>DAE2eMDXMmA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06066786-9FB9-4079-B1A7-2D22F7D56AFE</gtr:id><gtr:title>Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb877e01dd9f33040f7fc09646ce4b6"><gtr:id>bcb877e01dd9f33040f7fc09646ce4b6</gtr:id><gtr:otherNames>Cottenie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>doi_55f98498437608b5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29C7CE4C-B986-422B-8261-784FC245A972</gtr:id><gtr:title>The intracellular localization and function of the ATP-sensitive K+ channel subunit Kir6.1.</gtr:title><gtr:parentPublicationTitle>The Journal of membrane biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c918cfd03314334ac62ba37f85ce99d"><gtr:id>0c918cfd03314334ac62ba37f85ce99d</gtr:id><gtr:otherNames>Ng KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2631</gtr:issn><gtr:outcomeId>VMRZxhahcyQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70DD9705-8754-4333-89F7-52018D7268D8</gtr:id><gtr:title>Differential diagnosis of congenital muscular dystrophies.</gtr:title><gtr:parentPublicationTitle>European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7d7dab9bcd362c812ec7147699561da"><gtr:id>d7d7dab9bcd362c812ec7147699561da</gtr:id><gtr:otherNames>Klein A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1090-3798</gtr:issn><gtr:outcomeId>bzEdSyjYVZJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>673B1140-19C0-4A54-9E26-030AC0644E99</gtr:id><gtr:title>Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase ? mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12934_24_22933815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEED275C-70D1-4420-BDED-7DA7E3A97ED4</gtr:id><gtr:title>MFN2 deletion of exons 7 and 8: founder mutation in the UK population.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/230c6ae6cfa4b1a456b4b475e336d4da"><gtr:id>230c6ae6cfa4b1a456b4b475e336d4da</gtr:id><gtr:otherNames>Carr AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>5697a8aee36137.66588073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50B0CBC0-55F4-490B-A318-699166AB0D50</gtr:id><gtr:title>MFN2 mutations cause severe phenotypes in most patients with CMT2A.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22b57c66b40731e5672fa33c20ea4da4"><gtr:id>22b57c66b40731e5672fa33c20ea4da4</gtr:id><gtr:otherNames>Feely SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>VKjPgH2bJgn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D6E621D-9015-4EEB-B59B-A6033B9FA4F1</gtr:id><gtr:title>Dysferlin-deficient muscular dystrophy features amyloidosis.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba8a579d7cfcf2206841e02f3d277a32"><gtr:id>ba8a579d7cfcf2206841e02f3d277a32</gtr:id><gtr:otherNames>Spuler S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>hUMUTuxqKiP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE56F2A5-F1ED-4D5B-BECD-32443F35044D</gtr:id><gtr:title>Antagonism of nerve growth factor-TrkA signaling and the relief of pain.</gtr:title><gtr:parentPublicationTitle>Anesthesiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1b8cbaf9055d747123f1f0b32babf92"><gtr:id>a1b8cbaf9055d747123f1f0b32babf92</gtr:id><gtr:otherNames>Mantyh PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-3022</gtr:issn><gtr:outcomeId>suEhPtGwLJe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C9FE945-E016-45D2-8F31-F9402AE6AD8A</gtr:id><gtr:title>Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes.</gtr:title><gtr:parentPublicationTitle>European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82ce5a8cae89d8c36210d29e251cbdaa"><gtr:id>82ce5a8cae89d8c36210d29e251cbdaa</gtr:id><gtr:otherNames>Bari?ic N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-3798</gtr:issn><gtr:outcomeId>fTpwLV32mMN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48E9DD92-8AF4-4348-A5B3-D9727FA1B5AC</gtr:id><gtr:title>Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaff144eb8c549f75ef3e66c1e865ad2"><gtr:id>aaff144eb8c549f75ef3e66c1e865ad2</gtr:id><gtr:otherNames>Mitchell JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5458f56e8b1b48.76719747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22B14F16-7B4C-43D6-8188-4F1F5AA67F41</gtr:id><gtr:title>MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3047b66658c89d193e22961bca635735"><gtr:id>3047b66658c89d193e22961bca635735</gtr:id><gtr:otherNames>Garrood P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>nM92WYouJVk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D6117FA-26E3-414C-A584-52FA3D5390E1</gtr:id><gtr:title>Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b62a53649f238c8ef4ad4969252d6c4b"><gtr:id>b62a53649f238c8ef4ad4969252d6c4b</gtr:id><gtr:otherNames>Cooper JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>4E1B438BD32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33582754-A998-47BE-B5D6-432CA544E8FD</gtr:id><gtr:title>Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/935c2caa3786e3263c3ecf508c2e3aa0"><gtr:id>935c2caa3786e3263c3ecf508c2e3aa0</gtr:id><gtr:otherNames>Chiu YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>gVgS4s5e85m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE7CC2C1-2AA1-47AF-882E-D1A0278D6BC0</gtr:id><gtr:title>O04 Efficacy of mexiletine in non-dystrophic myotonia: results of an international multi-centred randomised controlled trial</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f5c0e5506c2caa2b25922e10de34484"><gtr:id>1f5c0e5506c2caa2b25922e10de34484</gtr:id><gtr:otherNames>Rayan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>HuEjFKmiGqU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4762F3AA-D7AA-413B-B778-F37472A054B3</gtr:id><gtr:title>MFN2 mutations cause compensatory mitochondrial DNA proliferation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/110e3dc589769ce84dec29b85162fcd3"><gtr:id>110e3dc589769ce84dec29b85162fcd3</gtr:id><gtr:otherNames>Sitarz KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>U4K1dNXUhV7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C117B81-7D0A-4C22-A962-4D949E2C5480</gtr:id><gtr:title>Epilepsy in adults with mitochondrial disease: A cohort study.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e87940e6460d8a108148a5e207bd528"><gtr:id>0e87940e6460d8a108148a5e207bd528</gtr:id><gtr:otherNames>Whittaker RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56b4b3c6ebcc85.05732896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E209A04B-0CFD-483E-BC48-1479CB1A506C</gtr:id><gtr:title>P72 A histological evaluation of protein accumulation in inflammatory myopathies</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8655b80f35da06543063892dc80fc48b"><gtr:id>8655b80f35da06543063892dc80fc48b</gtr:id><gtr:otherNames>Brady S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>HRV2gqmrjNu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BC5D211-A16D-47B8-A92F-FB6F1CA9F7BB</gtr:id><gtr:title>Brain involvement in muscular dystrophies with defective dystroglycan glycosylation.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f54c8ff830d7a6a681055f61c4b96383"><gtr:id>f54c8ff830d7a6a681055f61c4b96383</gtr:id><gtr:otherNames>Clement E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>LhFe5k2p7cG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A4DE08A-4B19-43A2-994C-4ED84A230444</gtr:id><gtr:title>A novel mitochondrial tRNAGlu (MTTE) gene mutation causing chronic progressive external ophthalmoplegia at low levels of heteroplasmy in muscle.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9fed88b0ab0044cbcece97c7fd87c62"><gtr:id>b9fed88b0ab0044cbcece97c7fd87c62</gtr:id><gtr:otherNames>Alston CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>V2BsZcbYV38</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36DBB573-1420-4F07-BEC7-08F5EE1EAE55</gtr:id><gtr:title>Neurological diagnoses identify molecular processes.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>soPzXY6VfG7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B7A26F9-E6AA-441E-B3E8-5D108A9D8E48</gtr:id><gtr:title>LRPPRC mutations cause early-onset multisystem mitochondrial disease outside of the French-Canadian population.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcd740097cdb9f5d82285952eb54e32e"><gtr:id>dcd740097cdb9f5d82285952eb54e32e</gtr:id><gtr:otherNames>Ol?hov? M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56c31f14bfd253.04939879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61D739C2-9253-40A0-8F08-2171D877DA31</gtr:id><gtr:title>Marked hemiatrophy in carriers of Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>tN2wwXX5XBT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F13B66AD-F440-4D21-B008-48CA112581CB</gtr:id><gtr:title>Transcriptome analysis in mitochondrial disorders.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00816e2fbcbc517bedb2b8e68c77c4d7"><gtr:id>00816e2fbcbc517bedb2b8e68c77c4d7</gtr:id><gtr:otherNames>Elstner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn><gtr:outcomeId>f1pKtTkr5SS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1486F00-F9B0-45D2-9072-2239812F1B08</gtr:id><gtr:title>One gene, one or many diseases? Simplifying dysferlinopathy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80ea9d5dda7d9892b34764e9832dc19"><gtr:id>f80ea9d5dda7d9892b34764e9832dc19</gtr:id><gtr:otherNames>Bushby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>cQhDSmg5dyx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB12A0F6-C997-4DE4-B0CB-FA1CFD512F74</gtr:id><gtr:title>Sorting out the inherited neuropathies.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4732af7ef6ff3beb803fd47a10bc7e3f"><gtr:id>4732af7ef6ff3beb803fd47a10bc7e3f</gtr:id><gtr:otherNames>Reilly MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>UGnBwK2drwj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDB30197-119B-40D1-B4DF-DE2AB0750B75</gtr:id><gtr:title>Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de77f0f27280d3a1bdb52c2b38483b0f"><gtr:id>de77f0f27280d3a1bdb52c2b38483b0f</gtr:id><gtr:otherNames>Cornett KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>585d6665ed3a71.18958952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DED8962-5A5E-4C73-A49D-4A7A6BC3381D</gtr:id><gtr:title>The death panel for Charcot-Marie-Tooth panels.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a4f1a0d3c763c991cb1e014c42cb83a"><gtr:id>7a4f1a0d3c763c991cb1e014c42cb83a</gtr:id><gtr:otherNames>Amato AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>deaCaV28prz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BFB4EF7-9643-415A-8D1F-FD531110F2C5</gtr:id><gtr:title>Natural history of Ullrich congenital muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89a1c36287fb77df7b0a69754cf87977"><gtr:id>89a1c36287fb77df7b0a69754cf87977</gtr:id><gtr:otherNames>Nadeau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>D1d2Hg4GhsH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7283AD71-8F69-4AD2-A51F-A3195A125BFE</gtr:id><gtr:title>Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b09cec3df0253fb5c98e8674910a85a"><gtr:id>3b09cec3df0253fb5c98e8674910a85a</gtr:id><gtr:otherNames>Herrmann DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5458bb0b1342b1.55922679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2171D92-FD4D-4337-9C6B-55A33E3C234C</gtr:id><gtr:title>P50 Genetic dysfunction of MT-ATP6 can cause axonal Charcot-Marie-Tooth disease</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5799e4e3b4b2266172c49a21acaf02d"><gtr:id>f5799e4e3b4b2266172c49a21acaf02d</gtr:id><gtr:otherNames>Pitceathly R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>aaHCyXo6oqw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEB3A9A9-3B98-40EE-B7DD-DF455FCF8D77</gtr:id><gtr:title>P39 Prevalence study of skeletal muscle channelopathies in England</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>NJVc1wCMyYe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>897DD4E2-230F-4B01-8620-A6AA41FCB2F4</gtr:id><gtr:title>Muscle histology vs MRI in Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4345298aa80f7aab384e189cb31b897"><gtr:id>f4345298aa80f7aab384e189cb31b897</gtr:id><gtr:otherNames>Kinali M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>hEu4gqN4BWi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2436D20D-56EB-42A1-94AD-61B35D1115DB</gtr:id><gtr:title>GABAA receptor mutations in epilepsy (commentary on Lachance-Touchette et al.).</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5ddd5dcaa4de64212db06858b662189"><gtr:id>e5ddd5dcaa4de64212db06858b662189</gtr:id><gtr:otherNames>Reid CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>PbvUBdVtZk8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64029B82-064A-4703-880A-63979DC92170</gtr:id><gtr:title>Isolated motor conduction block associated with infliximab.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cbb9749bf7e50639403044c4e70caa6"><gtr:id>9cbb9749bf7e50639403044c4e70caa6</gtr:id><gtr:otherNames>Michell AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>dWkzMAkVTsZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>516D9828-DCF6-4B3E-AEFF-587D78994288</gtr:id><gtr:title>The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d12a81c1a41c39038e9286100f8688e7"><gtr:id>d12a81c1a41c39038e9286100f8688e7</gtr:id><gtr:otherNames>Muntoni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>UMM9FNKqUgi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA049E41-BDD6-4E25-B362-276C8F66439F</gtr:id><gtr:title>APOE and A?PP gene variation in cortical and cerebrovascular amyloid-? pathology and Alzheimer's disease: a population-based analysis.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7c17ed5c2cf001307b1ed15341ae8d2"><gtr:id>b7c17ed5c2cf001307b1ed15341ae8d2</gtr:id><gtr:otherNames>Peuralinna T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>MdxUQNhdefF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF8710A9-4CC9-4CB6-9A9F-506A9CA81A69</gtr:id><gtr:title>Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0a851b1e66126a42944d2b038e10b89"><gtr:id>f0a851b1e66126a42944d2b038e10b89</gtr:id><gtr:otherNames>Baets J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f9849843f1149b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>977BA5DD-5BC3-4348-BA29-A5D878CAD877</gtr:id><gtr:title>Distal weakness with respiratory insufficiency caused by the m.8344A &amp;gt; G &amp;quot;MERRF&amp;quot; mutation.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4ee6ba0f820764b5675e3c255fdb95a"><gtr:id>a4ee6ba0f820764b5675e3c255fdb95a</gtr:id><gtr:otherNames>Blakely EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_540e151e15179736c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1581575-89C9-4DF0-9E40-4E7BCEF59B2D</gtr:id><gtr:title>P82 Myofibrillar myopathies (MFM), valosin containing protein (VCP) and glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) genes' mutations are not associated with sporadic inclusion body myositis (sIBM)</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ec459bbc79239f24d8fa0c4e80ceb2e"><gtr:id>4ec459bbc79239f24d8fa0c4e80ceb2e</gtr:id><gtr:otherNames>Machado P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>chT6gEb7Kn1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>596F1428-50C1-4B80-8C4C-634692F063BB</gtr:id><gtr:title>Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/349c44726fe224ca60f332ec47e17fba"><gtr:id>349c44726fe224ca60f332ec47e17fba</gtr:id><gtr:otherNames>Sadnicka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>qP931Lr1UFo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5CB07BA-B96C-44A2-85E9-BC9AD65DC7B6</gtr:id><gtr:title>Reverse engineering gene network identifies new dysferlin-interacting proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e3b3c24657bb83ef0c7e83b42f45ab5"><gtr:id>1e3b3c24657bb83ef0c7e83b42f45ab5</gtr:id><gtr:otherNames>Cacciottolo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>iXqWp4djrip</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE411183-4FA2-47C5-97F1-4B9241A3ABA1</gtr:id><gtr:title>Phase II Therapeutic Trial of Mexiletine in Non-Dystrophic Myotonia: Secondary Outcomes Show Improvement in Symptoms and Signs of Myotonia</gtr:title><gtr:parentPublicationTitle>NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bf0852f8daf67f088fa24236c0cc4c9"><gtr:id>9bf0852f8daf67f088fa24236c0cc4c9</gtr:id><gtr:otherNames>Statland Jeffrey</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>MToq1GJpgJS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D34FCB12-0410-4D27-8D5F-51CB30D3D703</gtr:id><gtr:title>Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/298bb180e38e48cf69bf03d814af75c8"><gtr:id>298bb180e38e48cf69bf03d814af75c8</gtr:id><gtr:otherNames>Statland JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>doi_55faa1aa1c2e243e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>278EAB97-D579-4C07-81DC-51DA4452E344</gtr:id><gtr:title>Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d762df5fe9e490f49e65b1cbf91ad74"><gtr:id>9d762df5fe9e490f49e65b1cbf91ad74</gtr:id><gtr:otherNames>Lin YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pNkMBP7ThDt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB36B24B-2357-44EC-8D04-765F143D4F66</gtr:id><gtr:title>Muscle MRI in FHL1-linked reducing body myopathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/411c2a1b4a3b3567073adbd8e8d83066"><gtr:id>411c2a1b4a3b3567073adbd8e8d83066</gtr:id><gtr:otherNames>Astrea G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>SkSN2zGQY5P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B513F6F8-5351-4497-8B30-39D2E80F1539</gtr:id><gtr:title>P38 Episodic muscle and brain channels: Analysis of the PRRT2 gene and screening of a muscle channel panel</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabc2fa8e4f99435d8ff3eaf1407da03"><gtr:id>dabc2fa8e4f99435d8ff3eaf1407da03</gtr:id><gtr:otherNames>Gardiner A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>EKh5K57g9ve</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99B599F0-0EC1-467E-B15D-D0B4F4DBCD07</gtr:id><gtr:title>Extra-ocular muscle MRI in genetically-defined mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>56c4667778b402.84006603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3169CCAF-5015-4099-BEC0-D05760BB626B</gtr:id><gtr:title>Comparing gait performance of people with Charcot-Marie-Tooth disease who do and do not wear ankle foot orthoses.</gtr:title><gtr:parentPublicationTitle>Physiotherapy research international : the journal for researchers and clinicians in physical therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe8d4bae65c43048e8e437ae0e4fa742"><gtr:id>fe8d4bae65c43048e8e437ae0e4fa742</gtr:id><gtr:otherNames>Ramdharry GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1358-2267</gtr:issn><gtr:outcomeId>pm_12934_24_22228620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>677929DB-50A7-495E-A419-41DD2F292564</gtr:id><gtr:title>Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1825a11096392cdb4a65efacbb12473"><gtr:id>b1825a11096392cdb4a65efacbb12473</gtr:id><gtr:otherNames>Fitzgerald JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>LgKPVWzB1VA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68721E81-FB5C-447D-B6FB-8D8F19F96235</gtr:id><gtr:title>Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>aZmteTKifbM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0460BA23-90B7-41DB-9E3F-6C061D7F5B7D</gtr:id><gtr:title>Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improves muscle function in SOD1(G93A) mice.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f59700ff9f9f92aac818b39e71cf31cb"><gtr:id>f59700ff9f9f92aac818b39e71cf31cb</gtr:id><gtr:otherNames>Riddoch-Contreras J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>BA2sfpQcdco</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA869B53-8EAA-4849-86FC-CA90EA7349F7</gtr:id><gtr:title>168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT).</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4732af7ef6ff3beb803fd47a10bc7e3f"><gtr:id>4732af7ef6ff3beb803fd47a10bc7e3f</gtr:id><gtr:otherNames>Reilly MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>mFoHZyWrKVQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7090404-1231-40A5-A946-66FAC05C857B</gtr:id><gtr:title>Recent mitochondrial DNA mutations increase the risk of developing common late-onset human diseases.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_540e151e151863b40</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>306D9B65-EBF0-4849-BCDE-0EB1E081F279</gtr:id><gtr:title>Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutations.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51e45ccf4556ac9f2fa83f02f213325f"><gtr:id>51e45ccf4556ac9f2fa83f02f213325f</gtr:id><gtr:otherNames>Perli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56c31f13878717.86419626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>486CCF17-6E06-49C4-A36E-C4FF2607A60E</gtr:id><gtr:title>Batteries not included: diagnosis and management of mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Journal of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aceeebe176b2a13722db7069cd6fe796"><gtr:id>aceeebe176b2a13722db7069cd6fe796</gtr:id><gtr:otherNames>McFarland R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-6820</gtr:issn><gtr:outcomeId>kANHZb8TCT4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99CC068B-5F05-4C4D-AAD4-5FD7239B01D9</gtr:id><gtr:title>Pathogenic mitochondrial tRNA point mutations: nine novel mutations affirm their importance as a cause of mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4ee6ba0f820764b5675e3c255fdb95a"><gtr:id>a4ee6ba0f820764b5675e3c255fdb95a</gtr:id><gtr:otherNames>Blakely EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_12934_24_23696415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69AD1DC3-7885-481A-8E56-C417C5182953</gtr:id><gtr:title>Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/635fef5ad5b5349680dd4f0d69fe0846"><gtr:id>635fef5ad5b5349680dd4f0d69fe0846</gtr:id><gtr:otherNames>Garaud S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>sqfwaRi9kHE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>922BC478-8302-42C5-BB30-09315E45035F</gtr:id><gtr:title>Clinical implications of genetic advances in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_12934_24_24018473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A1278FD-A56C-4637-BE4E-0006E70768F7</gtr:id><gtr:title>Amyloid Neuropathies</gtr:title><gtr:parentPublicationTitle>ACJNR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>Hsxwm3ZsCwh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6571639D-C85D-451F-B316-771D0090AE28</gtr:id><gtr:title>Impaired mitochondrial bioenergetics determines glutamate-induced delayed calcium deregulation in neurons.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2312f559dcfb3144a0b4c3c4b307152"><gtr:id>a2312f559dcfb3144a0b4c3c4b307152</gtr:id><gtr:otherNames>Abramov AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>hCvfoAPotfY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB0F9394-8CD1-4DE7-9352-C1B0143CF27D</gtr:id><gtr:title>Molecular treatments in Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9055555dfa5493524f1a78a42db633"><gtr:id>ff9055555dfa5493524f1a78a42db633</gtr:id><gtr:otherNames>Guglieri M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn><gtr:outcomeId>nGS7imXD9KA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D67BD891-F9BF-462F-B951-0F01B77E3073</gtr:id><gtr:title>A quantitative measure of handgrip myotonia in non-dystrophic myotonia.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/298bb180e38e48cf69bf03d814af75c8"><gtr:id>298bb180e38e48cf69bf03d814af75c8</gtr:id><gtr:otherNames>Statland JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>pm_12934_24_22987687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7CD592F-1965-468B-8AEE-85C68E0A302A</gtr:id><gtr:title>Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>db4CHnU2SVX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56338759-6379-4B16-9756-7B736781B07F</gtr:id><gtr:title>Heterozygous SSBP1 start loss mutation co-segregates with hearing loss and the m.1555A&amp;gt;G mtDNA variant in a large multigenerational family.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d406079946f3d96dfc81e3954f097e6"><gtr:id>5d406079946f3d96dfc81e3954f097e6</gtr:id><gtr:otherNames>Kullar PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a995f5bacb9a9.07737254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31F24027-5A17-4A03-929D-10DD6594F3DD</gtr:id><gtr:title>Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d12a81c1a41c39038e9286100f8688e7"><gtr:id>d12a81c1a41c39038e9286100f8688e7</gtr:id><gtr:otherNames>Muntoni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>QySa19LBMDC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EE7A86F-A827-4294-88E6-E6108C0FC846</gtr:id><gtr:title>Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37d06c45219146e15e2d45a706037126"><gtr:id>37d06c45219146e15e2d45a706037126</gtr:id><gtr:otherNames>Popplewell LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>ATGj5a1CZWV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4692F11-4123-49E7-B99C-7B4693FCA2B7</gtr:id><gtr:title>Neurological manifestation of vitamin B12 deficiency.</gtr:title><gtr:parentPublicationTitle>The American journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d662d6acfea0c554112d7ddb2f748fef"><gtr:id>d662d6acfea0c554112d7ddb2f748fef</gtr:id><gtr:otherNames>Mankad K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9343</gtr:issn><gtr:outcomeId>773B2A5D6E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25065A75-C6BF-423C-B09B-2D743B4F7301</gtr:id><gtr:title>Hip flexor fatigue limits walking in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe8d4bae65c43048e8e437ae0e4fa742"><gtr:id>fe8d4bae65c43048e8e437ae0e4fa742</gtr:id><gtr:otherNames>Ramdharry GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>LpRfFTV3WG9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>069C6CF7-8BC5-4FC8-A24A-DEC42D5C00BB</gtr:id><gtr:title>Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>5675e5995b0a7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA38EAE8-875D-42DE-A3FA-8F70B4A8CA9A</gtr:id><gtr:title>Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4fe90f775f7ad2b26d983c719e78eb"><gtr:id>bd4fe90f775f7ad2b26d983c719e78eb</gtr:id><gtr:otherNames>Davidson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12934_24_22302274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8A163AA-9F0C-46B2-9989-932B8C10155C</gtr:id><gtr:title>P40 Episodic ataxia: screening candidate genes and genetic analysis of families</gtr:title><gtr:parentPublicationTitle>Neuromuscular Disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159c8c7cefbd596fac1d4f5555aa91ee"><gtr:id>159c8c7cefbd596fac1d4f5555aa91ee</gtr:id><gtr:otherNames>Jaffer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>JYiyh94KKgJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>018A3DD2-8C51-436C-856B-6BB4865A6D94</gtr:id><gtr:title>Neonatal hypotonia can be a sodium channelopathy: recognition of a new phenotype.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>EfmUq96i1w6</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601943</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>